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CHAPTER 1 
INTRODUCTION 
INTRODUCTION 
Several types of cell participate together with immunoglobulins and 
a variety of other soluble molecules in the defense system of or-
ganisms. Immunoglobulins are bifunctional molecules, consisting of 
a part involved in recognition and binding to antigens, and another 
part, the Fc moiety, which is essential for their biological func-
tion. A special group of membrane receptors which can interact with 
this Fc part of immunoglobulins, Fc receptors, provide an important 
link between humoral and cellular aspects of immunity. In this way 
antigen specificity (provided by antibody) is coupled to the effec-
tor mechanisms of Fc receptor-positive cells that by themselves are 
not antigen-specific. 
The existence of this type of receptor was first reported in the 
early sixties (1-3), and the term Fc receptor was suggested by 
Paraskevas et al. in 1971 (4). Fc receptors have a widespread dis-
tribution. They are found on all types of lymphocytes, on monocyt-
es, macrophages, granulocytes, mast cells, and platelets. Further-
more, they are expressed on a variety of endothelial and epithelial 
cells and even on several types of parasites and bacteria. The in-
duction of "Fc receptor-like" structures on cells after infection 
by viruses (5,6), and certain strains of mycoplasm (7) is also well 
known. Interaction of the Fc portion of an antibody with an Fc re-
ceptor can induce a variety of biological effects, e.g. phagocyto-
sis of opsonized particulate antigens, clearance of immune com-
plexes, degranulation, antibody-dependent cell-mediated cytotoxici-
ty, release of inflammatory mediators (such as prostaglandins and 
hydrolytic enzymes), generation of reactive oxygen species, and re-
gulation of immunoglobulin synthesis (for reviews see 8-14). 
Fc receptors may also be clinically relevant. The expression or 
function of Fc receptors has been reported to be abnormal in a num-
ber of human diseases. These include malaria (15), leprosy (16), 
autoimmune diseases such as systemic lupus erythematosus (17), and 
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different types of cancer (18). Detailed knowledge about Fc recep-
tors may furthermore be essential in view of the increased interest 
in the application of antibodies in clinical therapy and because 
previous studies have demonstrated that F(ab')2 fragments of anti-
bodies were therapeutically ineffective (19,20). Since the intro-
duction of the hybndoma technique by Köhler and Milstein in 1975 
(21), an increasing number of mouse monoclonal antibodies has been 
applied for immunotherapy in humans. They have been used in the 
therapy of cancer (22-24), immunosuppressive therapies after organ 
transplantation (25,26), and also in the treatment of autoimmune 
diseases such as autoimmune thrombocytopenic purpura (27). As human 
complement usually fails to lyse cells coated with mouse monoclo-
nals (2Θ), cellular effector mechanisms are probably important. 
Mouse antibodies bind poorly to human granulocytes (29), and cells 
of the mononuclear phagocyte system composed of monoblasts,promono­
cytes, monocytes, and macrophages (30) may therefore be the most 
important effector cells. Interestingly, monocyte-denved macro­
phages have been found to interact well with mouse anti-tumor anti­
bodies, and were furthermore able to destroy sensitized human can­
cer cells (31). 
Mammalian immunoglobulins are at present divided into five classes, 
designated IqG, IgA, IgE, IgM, and IgD, which are characterized by 
specific antigenic determinants in their heavy chains. Immunoglobu­
lin G, which is quantitatively the major serum immunoglobulin and 
therapeutically the most interesting one, can furthermore be divid­
ed into several antigemcally distinct subclasses. In humans these 
are named IgG1, IgG2, IgG3, and IgG4, whereas in the mouse, IgG 
subclasses are called IgGI, IgG2a, IqG2b, and IgG3. Receptors which 
interact with the Fc moiety of IgG, FcyR, on mononuclear phagocytes 
have been studied most intensively in the mouse system. Knowledge 
of mouse FcyR has progressed very well, both by the availability of 
purified immunoglobulins of the different mouse IgG subclasses and 
by the development of monoclonal anti-FcyR antibodies. Three diffe­
rent types of FcyR are currently recognized on mouse macrophages: 
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FcyRI, which binds monomenc mouse (m)IgG2a with high affinity, 
FcyRII, which interacts with aggregated or complexed antibodies of 
the mlgGI and mlgGZb isotypes, and finally a third type of FcyR, 
FcyRIII, which interacts with mIgG3 antibodies in immune complex 
form. Beside differences in ligand-binding specificity, these re­
ceptors are also differentially sensitive to the protease trypsin. 
FcyRI is trypsin-sensitive, whereas binding to FcyRII and III are 
not affected by this enzyme, a finding of considerable experimental 
importance (for reviews see 9,14,32). Furthermore, these types of 
FcyR have been observed to be modulated independently, both in vi­
tro and in vivo, which demonstrates that they are independently or­
ganized in the cell membrane (33). 
In May 1985, when we started these investigations, only a single 
class of FcyR on human monocytes had unequivocally been demonstrat­
ed, a sialoglycoprotein with a molecular weight of 72 kDa (ЗА), 
which interacts with high affinity (Ka=10 -10 M-'') with human 
IgG. Although all four human (h) IgG subclasses are bound by this 
receptor, their affinity was found to vary considerably. The sub­
classes hlgd and hIgG3 are bound much more efficiently than either 
hIgG2 or hIgG4 (35,36). On human peritoneal macrophages the exis­
tence of more than one type of FcyR was suggested from binding stu­
dies with hlgGI dimers (37). Evidence for a comparable multiplicity 
of FcyR on human monocytes was derived from a quite different type 
of experiments. In these studies the induction of human Τ cell pro­
liferation by mouse anti-CD3 antibodies in mononuclear cell suspen­
sions was analyzed. Cross-linking of CD3 antigens, via anti-CD3 an­
tibodies, by human monocyte FcyR was found to be essential for Τ 
cell mitogenesis (see Fig.1). By this type of experiments, human 
FcyR can be detected, which can functionally interact with mouse 
IgG, resulting in Τ cell proliferation (for review see 3Θ). Mono­
cytes from essentially all individuals supported induction of Τ 
cell proliferation by mIgG2a antibodies, whereas induction of Τ 
cell mitogenesis by mlgGI antibodies was mediated only by monocytes 
from about 70А of Caucasian individuals (39). Τ cell proliferation 
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T3/TCR 
Fig.1. Antibodies against CD 3/T cell receptor can induce resting Τ 
cells to proliferate. Fc receptor positive cells (e.g. mono­
cytes) are essential in this process. 
induced by mIgG2a antibodies was susceptible to inhibition by mono-
meric hlgG and heat-aggregated mlgGZa, while mlgGI-induced mitoge-
nesis could only be inhibited by aggregated mlgd and not by either 
hlqG or aggregated mIgG2a (40,41). It was furthermore observed that 
monocytes from individuals which supported the mlgGI-induced Τ cell 
proliferation efficiently (high-responder individuals; HR) also 
formed rosettes with mouse IgGI-sensitized erythrocytes, whereas 
monocytes from the other donors (low-responder individuals; LR) 
failed to do so (41). These data strongly suggested the presence of 
two different types of FcyR on human monocytes, one of them (the 
receptor which interacts with mouse IgGI) being polymorphic. The 
physiological functioning of both FcyR appeared mysterious. One of 
the receptors has an extremely high affinity for hlgG (Ka=108-10 
M ) and would be expected to be saturated continuously with hlgG, 
which is present at approximately 10"^M in human serum. The other 
FcyR seems to interact efficiently with mlgGI antibodies, but not 
with hlgG. 
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The objective of this thesis was to study the characteristics, in-
terrelation and function of the different types of FcyR on human 
monocytes. More specifically, we searched for an answer to the fol-
lowing questions: 
- What is the specificity of both FcyR with respect to different 
subclasses of human and mouse IgG? 
- What is the affinity of both types of FcyR for their respective 
ligands? 
- Are these FcyR indeed independent membrane structures (or, alter-
natively, is there a single structure with two independent bind-
ing sites)? 
-Are both FcyR functionally active (e.g. in antibody-dependent 
cell-mediated cytotoxicity)? 
- Are the two types of FcyR different with respect to protease-sen-
sitivity? 
- What is the physiological significance of the FcyR which can in-
teract with mouse IgG1 but apparently not with human IgG? 
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CHAPTER 2 
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MURINE IgGI ON HUMAN MONOCYTES AND CELL LINES 
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A new photometric method for the quantitation of Fc receptors 
for murine IgGl on human monocytes and cell lines 
J.G.J Van de Winkel ', W J M. Tax ', M С J. Van Bruggen ', C.E.P. Van Roozendaal ', 
H.W. Willems 2, J L.P Van Duijnhoven ', P.J.A. Capel ' and R.A.P Koene ' 
' Department of Medicine, Division of Nephrology, and ' Department of Pathology, St Radboud Hospital, University of Nijmegen. 
Nijmegen, The Netherlands 
(Received 10 Febniary 1987, accepted 17 March 1987) 
We have previously shown a polymorphism of human Fc receptors for mouse IgGl using an EA rosette 
technique in which human erythrocytes sensitized with a murine IgGl monoclonal antibody against 
glycophorin A acted as indicator cells We now describe a method to quantitate this EA rosetting using the 
pseudoperoxidase activity present in erythrocytes This photometric assay allows the sensitive quantitative 
determination of Fc receptor expression on human monocytes and cell lines Not only the human Fc 
receptor for murine IgGl can be studied in this way, but the method can also be applied to other Fc 
receptors An important factor in this type of rosette assay appears to be the amount of negative charge 
present on the surface of the indicator erythrocytes. Using alcian blue as a probe, we found that this 
negative charge is higher on human erthyrocyles than on sheep erythrocytes, which may contribute to a 
better signal-to-noise ratio. The method described facilitates (he characterization of Fc receptors and 
permits the rapid screening of monoclonal anti-Fc receptor antibodies 
Key words Fc receptor, human. Monocyte, Cell line. Photometric assay, Pseudoperoxidase activity 
Introduction 
Membrane-associated receptors, recognizing the 
Fc portion of immunoglobulins (FcR), play im­
portant roles in the immune system (for review, 
see Unkeless et al, 1981) Because of the growing 
interest in (he clinical use of murine monoclonal 
Correspondence to J G J Van de Winkel Department of 
Medicine Division of Nephrology, Si Radboud Hospital, Geert 
Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands 
Abbreviations ASA, 5'-aminosalicylic acid, BSA, bovine 
serum albumin, FcR, receptor(s) for the Fc region of im­
munoglobulins, FCS. foetal calf semm, HRBC, human 
erythrocytes, IF, immunofluorescence, m, munne, OD, optical 
density, PBS, phosphate-buffered saline, RBC erythrocytes. 
SRBC, sheep erythrocytes 
antibodies for immune therapy, it is important tc 
gain more insight into the structures on humar 
effector cells which can mediate interactions wit! 
murine immunoglobulins The interaction of mlgC 
with human FcR has been analyzed primarily ir 
studies on the monocyte-dependent induction о 
human T-cell proliferation by anti-CD3 mono 
clonal antibodies From these studies it was con 
eluded that virtually all individuals have monocyte 
FcR for mIgG2a and that the monocyte FcR fo 
mlgGl (Tax et al, 1983, 1984), as well as th 
human FcR for mIgG2b antibodies (Tax et al 
1985) are polymorphic. 
There are various methods for studying Fcl 
expression directly (reviewed by Kerbel et al 
1983) Of these methods EA resetting is a we 
established and sensitive assay to study FcR. Vis 
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udì quantitation of EA rosettes however, is labori-
ous In this report wc describe a very sensitive 
photometric assay by which the FcR for mlgGl 
(which is very difficult to study in direct assays 
(Tax et al, 1984)) on both monocytes and cell 
lines can be studied by FA rosetting We used the 
erythrocyte-associaled pseudoperoxidase activity 
(Naumann, 1964) to quantitate the binding of 
human erythrocytes to monolayers of cells in mi-
crotitre plates The Fc dependency of the signal 
obtained was studied and furthermore it was 
shown that this assay is also suitable to study the 
expression of other Fc receptors such as that for 
human IgG 
The present method can facilitate the char-
acterization of FcR on human cells in different 
types of studies (e g, rosette inhibition studies, 
modulation experiments), and permits the rapid 
screening for anli-FcR antibodies 
Materials and methods 
Cell lines 
Human myeloid (HL-60), monocytic (U937), 
erythromyeloid (K562), B-lymphoblastoid (SB), 
and Τ lymphoblastoid (Molt-4) cell lines were cul­
tured in RPMI 1640 medium This medium was 
supplemented with 10% heat-inactivated FCS 2 
mM glutamme, 1 mM sodium pyruvate, and 
gentarmcin (50 jug/ml) 
Peripheral blood monocytes 
Mononuclear cells were isolated from buffy 
coals on a Percoli (Pharmacia, Uppsala, Sweden) 
gradient ( J = 1 072 g/ml) at 4° С Monocytes were 
purified from mononuclear cells by counterflow 
centnfugation in an elutnation system enabling 
continuous monitoring by flow cytometry as de­
scribed by De Mulder et al (1981) The punty of 
the monocytes obtained was evaluated in cyto-
cenlnfuge preparations after staining for non­
specific esterase and with May-Grunwald-Giemsa 
The final suspensions consisted of at least 90% 
monocytes Viability of monocyte suspensions was 
assessed by trypan blue dye exclusion and ex­
ceeded 98% after elutnation 
Since monocytes from different individuals 
show functional variability we considered it ad­
vantageous to have fixed and well-defined batches 
of these cells The purified monocytes were there­
fore cryopreserved as described by Shah et al 
(1984) and used later Both recovery and viability 
of cryopreserved monocytes were excellent (> 70% 
and > 95%, respectively) 
Because of the polymorphism of monocyte FcR 
for mlgGl antibodies, the accessory function of 
isolated monocytes was studied in mitogenesis as­
says as described by Tax et al (1983) Only mono­
cytes which supported the proliferation of human 
T-lymphocytes, induced by murine anti-CD3 anti­
bodies of the IgGl subclass, were used for the 
studies described in this report 
Comparison of two photometric assays for human 
erythrocytes 
Erythrocytes can be quantitated using the ab-
sorbance of haemoglobin (Cooper el al, 1984) and 
also by the pseudoperoxidase-cataly^ed conver­
sion of a suitable substrate such as ASA (Nau­
mann, 1964) 100 μΐ of serial dilutions of HRBC 
(in 50 mM phosphate buffer, pH 6 0) were dis­
pensed into the wells of a flat-bottomed microtitre 
plate (Costar, Cambridge, MA) To half of the 
wells 100 μΐ of the same buffer was added, and 
after mixing the OD was determined in a Titertek 
Multiskan Readings were performed at 405 nm, 
the extinction maximum of erythrocyte-associaled 
haemoglobin The other half of the wells was 
supplemented with 100 μΐ of 50 mM phosphate 
buffer, pH 6 0, containing 1 6 mg/ml ASA and 
0 144% ν/ν Η2θ 2 (final concentration) and in­
cubated for 30 mm at room temperature After 
mixing, the absorbance at 450 nm was measured 
Since the latter method proved to be more sensi­
tive (see results section) we preferred this tech­
nique for the quantitation of EA rosettes 
Sensitization of human erythrocytes 
A 0 5% suspension of HRBC in PBS was in­
cubated for 30 mm at 37° С with various dilutions 
of antibody For mlgGl EA rosetting we used 
ascites of an IgGl monoclonal antibody against 
glycophorm A (a generous gift from M Bos, 
Central Laboratory of the Netherlands Red Cross 
Blood Transfusion Service, Amsterdam, The 
Netherlands) Human IgG EA rosetting was per­
formed with Rhesus-positive HRBC and a poly-
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clonal antiserum against Rhesus D (Merz&Dade, 
Dudingen, Switzerland) HRBC incubated with 
PBS alone served as controls for non-specific 
binding After incubation, sensitized (and, as a 
control, unsensiti7ed) HRBC were washed, resus-
pended at 0 5% in RPMI 1640 containing 5% FCS, 
and used within 30 mm 
Microscopic EA rosette assay 
200 μΐ of a monocyte suspension (2 X106 
cells/ml in RPMI 1640 with 5% FCS) and 50 μΐ 
of sensitized HRBC suspension were mixed, 
centnfuged (4 mm at 20 x g), and incubated for 1 
h at 4 0 C Monocytes with at least three bound 
HRBC were scored as rosettes, using a microscope 
with 400 X final magnification 
Photometric LA rosette assay 
First, monolayers of either monocytes or cell 
lines were prepared With monocytes, 100 μΐ of a 
cell suspension (4 χ IO6 cells/ml in RPMI 1640 
with 10% FCS) were dispensed into individual 
wells of a 96-well flat-bottomed microtitre plate 
and incubated for 1 h at 37° С Non-adherent 
cells were removed by one wash in warm PBS 
(37 0C), in which the plates were immersed verti­
cally and moved back and forth three times 
In order to obtain monolayers of cell lines, 
these cells were coated to microtitre plates Poly­
styrene microtitre plates were precoated with poly-
t -lysine (0 1 mg/ml in PBS) for at least 1 h at 
room temperature After three washes with PBS, 
100 μΐ of a cell suspension (4 Χ 106 cells/ml in 
RPMI 1640 with 10% FCS) were dispensed into 
each well and the plate incubated at room temper­
ature for 1 h After centnfugation (5 mm at 300 X 
g), non-adherent cells were washed away as de­
scribed above 
To each well, containing a monolayer of either 
monocytes or a cell line, 100 μΐ of a 0 5% suspen­
sion of sensitized HRBC were added and in­
cubated for 1 h at 4 0 C After this incubation, the 
plates were washed thnce by immersion in warm 
PBS as desenbed above To each well 200 μΐ of a 
freshly prepared substrate solution, 0 8 mg/ml 
ASA dissolved in 50 mM phosphate buffer, pH 
6 0, containing 0 072% v/v H 2 0 2 was added After 
30 mm, extinction was measured at 450 nm in a 
Titer lek Multiskan 
To correct for variation in background ab-
sorbance values between experiments a binding 
index was calculated for each expenment as fol­
lows 
[l - (£450/^450)] x 100 = binding index 
where Eii0 is the extinction at 450 nm in wells to 
which HRBC without sensitizing antibody were 
added, and EA
 4i0 the extinction at 450 nm in 
wells to which sensitized HRBC were added 
The HRBC suspensions sensitized with differ­
ent dilutions of antiserum were always tested in 
duplicate The observed variation in binding in­
dices was small (usually less than 10%) All expen-
ments were performed at least three times and 
representative expenments are shown 
F(ab'); fragments 
Pepsin digestion of the monoclonal anti-glyco-
phorin A antibody and subsequent isolation of the 
F(ab')2 fragments was performed as described by 
Capei et al (1979) The purity of the fragments 
obtained was analyzed by SDS-PAGE 
Immunofluorescence 
The level of sensitization of HRBC with anti-
glycophorm A antibody was evaluated by incubât 
ing 100 μΐ of a 1% suspension of sensitized HRBC 
in IF buffer (PBS containing 0 1% sodium azide 
and 1% BSA, Cohn Fraction V, Sigma, St Louis, 
MO) with 100 μΐ of a 1 50 dilution of (Fab 
fragments of) goat anti-mouse Ig (H&U)-FITC 
(Cappel, Malvern, PA) After incubating for 30 
nun at room temperature the cells were washed 
two times, fixed with 1% paraformaldehyde and 
subsequently analyzed by an Ortho 50-H flow 
cylometer In each sample the fluorescence inten­
sity from 10000 cells was determined and the 
mean fluorescence intensity was calculated from 
the histograms 
To test antigen-binding capacity of the F(ab')2 
fragments of IgGl anli-glycophorm A, the inhibi­
tion of HRBC sensitization was studied in the 
following way To 50 μΐ of HRBC (1% suspension), 
50 μΐ of F(ab')2 fragments at a 1 50 dilution in 
IF buffer were added and incubated for 30 mm at 
room temperature After this period 50 μΙ of in­
tact anti-glycophonn A antibody, in various dilu-
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lions were added to each suspension and in­
cubated for another 30 mm at room temperature 
The cells were then washed and incubated with 
100 μ\ of subclass-specific goat anti-mouse IgGl-
FITC (Nordic Tilburg The Netherlands) al a 
1 50 dilution for 30 mm (room temperature) 
After washing two times, the brightness of fluores­
cence was scored on a scale of negative to strongly 
positive on a Zeiss fluorescence microscope 
Modulation of Fc receptors 
Flat-bottomed microtitre plates were coated 
overnight with BSA (10 Mg/ml in PBS) at 4 0 C 
After three washes either 100 μΐ PBS (control) or 
100 μΙ of a rabbit anti-BSA antiserum (Dako, 
Copenhagen Denmark), at a saturating 
concentration as determined by ELISA, were ad­
ded to each well for 1 h at room temperature The 
plates were washed thrice and 100 μΐ of a mono­
cyte suspension (4 χ IO6 cells/ml in RPMI 1640 
with 10% FCS) were added to each well and the 
plates incubated for 90 mm at 37" С After this 
incubation non-adherent cells were washed away 
and FcR expression determined photometrically 
as described above 
Quantitation of anionic sites on erythrocytes 
The number of anionic sues on RBC was 
measured by studying the binding of alcian blue 
8GX (Sigma, St Louis, MO) as has been de­
scribed in detail by Levin el al (1985) RBC from 
three different species, man, sheep and rabbit, 
were washed and suspended in PBS at a final 
concentration of 1 2 X IO9 cells/ml 1 ml of the 
suspensions of RBC was mixed with 1 ml of alcian 
blue solution (at increasing concentrations) and 
incubated at 37° С for 30 mm After removal of 
the cells by centnfugation the optical density of 
the supernatant was measured at 650 nm At this 
wavelength the optical density of alcian blue is 
linearly related to its concentration From the 
difference in optical density between the original 
solution and the supernatant after removal of the 
cells, the amount of alcian blue bound to the cells 
was determined 
Results 
Detection of erythroc vtes bv direct measurement of 
haemoglobin absorbance and b\ quantitation of 
haemoglobin catalyzed pseudoperoxidase actwity 
Before we studied the binding of sensitized 
HRBC to human cells, we first investigated the 
detection of HRBC by different photometric 
methods In Fig 1 the haemoglobin absorbance of 
HRBC and the Η RBC-associated pseudoper­
oxidase activity are shown In preliminary experi­
ments with graded numbers of HRBC optimal 
conditions for measunng the pseudoperoxidase 
activity had been determined In Fig 1 it is shown 
that by using the pseudoperoxidase activity a much 
higher sensitivity of HRBC detection can be 
reached compared with direct measurement of 
haemoglobin absorbance The threshold for detec­
tion of HRBC is about ten-fold lower when using 
HRBC-associated pseudoperoxidase activity and 
the slope of the curve is also much steeper than 
when haemoglobin absorbance is used for the 
detection of HRBC A linear response was ob­
tained up to 8 x 105 HRBC/well 
Comparison of microscopic and photometric EA 
rosette assays for the detection of FcR for murine 
IgGl on human monocytes 
By changing the concentration of antibody used 
for sensitization of the erythrocytes the amount of 
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Fig 1 Comparison of measurement of haemoglobin ab­
sorbance directly (at 405 nm A) and after haemoglobin cata 
lyzed conversion of ASA (at 450 nm •) Extinction was 
determined in duplicate microtitre wells io which fixed num­
bers of HRBC were added 
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Fig 2 Comparison of EA IgGl rosette formation by microscopic and photometric methods A Immunofluorescence of indicator 
HRBC sensitized with different dilutions of anti-glycophonn A monoclonal antibody В Percentage of EA rosettes С Binding 
indices in the photometric assay 
bound IgG could be regulated When the dilution 
of sensitizing antibody was plotted against the 
amounl of bound antibody (as reflected in the 
intensity of indirect immunofluorescence) a 
sigmoid curve was obtained (Fig 2A) There was 
a good correlation between the degree of sensitiza­
tion of HRBC, and the percentage of EA rosettes 
either scored visually (Fig 2Я) or photometrically 
(Fig 2C) In all the experiments with monocytes 
presented in this report we used 4 x 105 cells/well 
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Fig 3 A Binding to human monocytes of HRBC which have been sensitized with intact IgG (*) antibody directed against 
glycophonn A, and when sensitized with the F(ab ' ) 2 fragments of the antibody (•) В Binding of intact IgG anti-glycophonn A to 
HRBC, as determined by ι rranuno fluorescence using FITC-labelled subclass-specif IL antibodies (A) , is inhibited when the HRBC 
have been prei neu bated with the F(ab')2 fragments of the antibody (•) 
It is noteworthy that at this cell density, direct 
measurement of haemoglobin absorbance (at 405 
nm) was inadequate to quantitate rosetting 
Molt 4 gives no signal in the photometric assay 
whereas other tell lines exhibit binding of sensi­
tized HRBC 
Fc dependency of signals obtained in the photometric 
EA rosette assay 
In order to ascertain that the signals we ob­
tained in the photometric assay of the FcR for 
mlgGl were truly a manifestation of an interac­
tion between FcR and the Fc portion of im­
munoglobulin molecules, we prepared F(ab')2 
fragments of the anti-glycophorm A antibody No 
residual IgG could be delected after pepsin di­
gestion and purification of the F(ab')2 fragments 
(not shown) When this preparation was used to 
sensitize HRBC no signal was found in the photo­
metric EA rosette assay (Fig ЗЛ) The F(ab/)2 
fragments did bind to HRBC as seen by indirect 
fluorescence (data not shown), and were able to 
inhibit the binding of intact and-glycophonn A 
antibody as illustrated in Fig 3B From these 
results we conclude that the signals obtained in 
the photometric EA rosette assay are indeed Fc-
dependent 
Assay of murine IgGI FcR on human cell lines 
Fig 4 shows that the photometric method is 
suitable for the assay of FcR for mlgGl on hu­
man cell lines The level of FcR expression vanes 
considerably between different lines Cell line 
Fig 4 
human 
11 14 116 1-64 
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Binding of HRBC sensitized with mlgGl antibody to 
cell lines 
Assay of human IgG FcR on human cell lines and 
monocytes 
Above we showed that the photometric method 
can be used for studies of the FcR for mlgGl Fig 
5 illustrates that the 'classical'/high affinity FcR 
for human IgG can also be assayed by the photo­
metric method In this assay we used a human 
antiserum against rhesus D to sensitize Rhesus 
D-positive HRBC When comparing Figs 4 and 5 
it is apparent that the expression of FcR for 
mlgGl on cell lines does not correlate in all 
instances with the expression of FcR for human 
IgG The human erythromyeloid cell line K.562, 
for example, binds HRBC sensitized with human 
IgG poorly, whereas mlgGl-sensitized HRBC were 
bound very well by this cell line In contrast, cell 
line Molt-4 does not give any signal in either the 
assay for the human IgG FcR or for mlgGl FcR 
The expression of the FcR for human IgG on 
monocytes is clearly positive and comparable to 
that on the cell lines U937 and Ηί-60 (Fig 5) 
Modulation of FcR on human monocytes 
Cell surface Fc receptors can be modulated 
when (he cells are incubated with immune com­
plexes coated to a solid support (Michl el al, 
1979) In Fig 6 we show that FcR can be mod­
ulated from the apical surface of human mono­
cytes In this expenment the human IgG FcR are 
"Έ, MONOCYTES 
116 1€4 1256 11024 
HUMAN IgG DILUTION 
Fig 5 Binding of HRBC sensitized with human IgG lo 
human monocytes (dashed line) and vanous cell lines 
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Fig 6 Modulation of FcR on human monoc>tes by immune 
complexes Monocytes were incubated on BSA coated micro-
titre plates only (A) or on plates which had been coated with 
BSA and subsequently incubated with rabbit anti BSA anil 
body (•) FcR. expression for human IgG was then determined 
pholometncally 
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Fig 7 Alcian blue binding to erythrocytes from man (A), 
sheep (•) and rabbits (O) 
negative charge than SRBC Rabbit erythrocytes 
showed a very low binding of alcian blue 
modulated by rabbit IgG, complexed to BSA This 
indicates that rabbit IgG can interact efficiently 
with the FcR for human IgG on human mono­
cytes In similar experiments, using immobilized 
immune complexes containing mlgGl, we could 
modulate the monocyte FcR for mlgGl (not 
shown) This data shows that the photometric 
assay can be applied to study the modulation of 
human Fc receptors 
Negative charge of erythrocytes from different species 
During our studies on human FcR interacting 
with mlgG of different isotypes, we observed that 
HRBC gave higher binding indices in the photo­
metric assay and belter reproducibility than SRBC 
The low binding indices found with SRBC were 
due to high non-specific binding of unsensitized 
erythrocytes to monolayers of both human mono­
cytes and cell lines Since the negative charge on 
the RBC surface is an important factor in relation 
to its binding to other cells (e g, non-specific 
binding to cell lines), we studied whether there 
were profound differences between human, sheep, 
and rabbit erythrocytes with respect to this 
parameter Therefore, we measured the binding of 
alcian blue 8GX to different types of erythrocytes 
Fig 7 shows that HRBC can bind more alcian 
blue to their surface and therefore have a higher 
Discussion 
Detection of FcR can be performed very sensi­
tively by EA rosette assays Microscopic EA rosette 
assays are commonly used but require labonous 
visual counting procedures Furthermore, the 
problem bf instability of rosettes interferes with 
the reliable evaluation of the percentage of FcR-
positive cells Quantitation of EA rosette proce­
dures can be performed sensitively and reproduci-
bly using 5lCr-labelled erythrocytes (Jungi, 1985) 
This method suffers from some disadvantages, 
such as time-consuming labelling procedures, 
shedding of label and problems of isotope han­
dling Rummage and Leu (1985) descnbed a 
method by which EA rosettes were quantitated by 
measuring the erythrocyte haemoglobin ab-
sorbance at 405 nm These authors used sensitized 
sheep erythrocytes to detect FcR on munne mac­
rophage monolayers The sensitivity of their 
method was similar to that of 5,Cr-labelled 
erythrocyte assays A similar photometnc method 
for the quantitation of erythrocyte phagocytosis in 
munne macrophages was descnbed by Cooper et 
al (1984) Recently, Jungi (1985) reported the use 
of erythrocyte-associated pseudoperoxidase activ­
ity to quantitate the phagocytosis of sheep 
erythrocytes in human monocytes and macro-
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phages This method was shown to be more sensi-
tive than assays based on the use of 5'Cr-labelled 
erylhrotytes A disadvantage of the method of 
Jungi is the fact that lysis of mononuclear cells is 
required Quantitation of erythrocytes in detergent 
lysates of phagocytes is prone to error, because of 
the endogenous peroxidase activity of monocytes 
Also, the presence of FcR on cell lines cannot be 
quantilated by this method since not all cell lines 
phagocytose the sensitized erythrocytes 
In this report we present a new pholomelnc 
method by which binding of Fc to different types 
of FcR on human monocytes and cell lines can be 
reproducibly quantitated with high sensitivity By 
measuring HRBC-associated pseudoperoxidase 
activity a much higher sensitivity was reached 
than by determination of haemoglobin absorbance 
directly The method reported by Rummage and 
Leu (1985), employing haemoglobin absorbance, 
proved to be too insensitive in the detection of 
FcR for mlgGl on human monocytes Using our 
technique HRBC could be used for detecting be-
tween 1 X 104 and 8 x 105 erythrocytes/well with 
linear calibration curves This sensitivity matches 
that of the method desenbed by Jungi (1985), but 
our method has the additional advantage that FcR 
on cell lines which do not actively phagocytose 
can also be studied Cell lines have been extremely 
valuable for our knowledge of the functional char-
acteristics of FcR (Unkeless et al, 1981) 
Sheep erythrocytes may not be the indicator 
erythrocytes of choice for EA rosette assays for 
two reasons First, unsensitized SRBC form 
rosettes with human T-cells which may be present 
in the cell suspensions to be studied Secondly, 
SRBC have a low negative surface charge, which 
could give nse to high non-specific binding of 
these erythrocytes We studied the negative surface 
charge on human, sheep, and rabbit erythrocytes 
by comparing the binding of the cationic dye 
alcian blue to these cells In most studies only the 
sialic acid content has been compared on 
erythrocytes from different species (Aminoff et al, 
1976) The sialic acid content of the cell mem-
brane, however, is not the only parameter respon-
sible for the negative charge of cells, as was shown 
recently by Levin et al (1985) We found that 
SRBC bind significantly less alcian blue than 
HRBC, which indicates that they possess a much 
lower cell surface negative charge Rabbit 
erythrocytes did not bind much alcian blue, which 
is consistent with their low sialic acid content 
(Aminoff et al, 1976) The differences in alcian 
blue binding cannot be caused by the differences 
in surface area between the erythrocytes from 
different species (as can be calculated from the 
volumes of the different erythrocytes (Wessels and 
Veerkamp, 197J)) It is likely that the high, nega-
tive charge of HRBC contributed significantly to 
the positive results we obtained when using these 
erythrocytes as indicator cells in EA resetting 
experiments 
We have previously reported that FcR for 
mlgGl can be detected by EA rosetling on mono-
cytes from those individuals who exhibit a mito-
genic response to mlgGl anti-CD3 antibodies (Tax 
et al, 1984) We now show that the binding of 
IgGl sensitized HRBC to such monocytes can be 
quantitated using the pseudoperoxidase activity of 
the erythrocytes Furthermore, with this method 
FcR for mlgGl can also be demonstrated on cell 
lines K.562, U937, and HL-60 Lemke et al (1985) 
could detect FcR for mlgGl only on K562 and 
found furthermore a weak expression on HL-60 
and no expression on U937, using sensitized sheep 
erythrocytes as indicator cells These results fur-_ 
ther accentuate the sensitivity of our indicator 
system 
Our study suggests that the FcR for human 
IgG are present on the U937 and HL-60 cell lines, 
but are hardly detectable on the relatively undif-
ferentiated K.562 cell line When using indicator 
erythrocytes, sensitized with human IgG, we occa-
sionally (at very low dilutions of sensitizing anti-
serum) observed a low degree of rosette formation 
with K.562 This observation is in agreement with 
the work of other investigators, who showed that 
K562 cells possess low affinity FcR, while U937 
and HL-60 cells have high affinity FcR specific 
for the Fc fragment of human IgG (McCool et al, 
1985) Similar results were obtained by Anderson 
and Looney, as is evident from their recent review 
on the different types of FcR for human IgG 
(Anderson and Looney, 1986) Other authors (e g, 
Perussia et al, 1982), using indicator erythrocytes 
sensitized with rabbit antibody, observed a high 
degree of rosette formation with K562, an inter-
mediate degree with U937 and a low degree with 
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HL-60. One explanation for this discrepancy could 
be that the FcR on K562 have a higher affinity for 
rabbit IgG than for human IgG (in contrast to 
FcR on human monocytes which have similar 
affinity for rabbit IgG and human IgG (Woof et 
al, 1986)). Furthermore, it is important to realize 
that the results from FcR assays are dependent on 
the sensitivity of the assay, and on the precise 
conditions employed 
In conclusion, we describe a new, sensitive and 
straightforward FcR assay based on the quanti­
tation of EA rosetting with human indicator 
erythrocytes, sensitized with human or munne IgG, 
by using the haemoglobin-catalyzed pseudoper-
oxidase activity. This method can be used for the 
characterization of FcR on human cells in differ­
ent types of studies such as the modulation of 
FcR on immune complex-coated substrates or in 
rosette-inhibition studies (manuscript in prepara­
tion). The photometric assay should also be val­
uable for the screening of new anti-FcR mono­
clonal antibodies, which can then be used to study 
FcR in greater detail. 
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We have previously reported a polymorphism in the mitogemc effect of murine (m) IgGl anti 
С D3 monoclonal antibodies This polymorphism was genetically determined and could be 
attnbuled to polymorphism of the Fc receptor (I cR) lor m IgGl present on human monocytes 
We have now extended these studies bv quintitaiing FcR expression on monocytes and cell 
lines by a recently developed ЕЛ rosette assay using the ervthrocyte associ ited pseudoperox 
idase ictivity The data show that the polymorphism of the monocyte FcR for mlgG 1 is based 
on ι quantitative rather than an absolute difference I urlheimorc this I cR is specific lor 
mlgG 1 tind does not bind mlgG2a or mIgG2b nor surprisingly human led The expression of 
this FcR on cell lines correlates with their accessory function m IgG I antl С DT induced Τ cell 
proliferation mlgG2a can inhibit the rosctting of monocytes with erythrocytes scnsiti/cd with 
human IgG The FcR detected by this rosette technique can interact with all four human IgG 
subclasses but not with mlgGl or mlgG2b The expression of this tvpe of FcR on human cell 
lines correlates well with their ability to support mIgG2a anti С m induced mitogenesis I hese 
direct measurements of FcR expression support the concepì that human monoevtes have two 
independent FcR with affinity for mouse IgG one receptor specihc for mIgG2a (which also 
binds human IgG) and a second specific for mlgGl 
Jun (J J \an de Winkel Deparírmnt of Mediane Divtuon of \ephroìo^\ Sí Radboud 
Hospital Geírt Grooteplein /nidH 6525 GA Nipnegen The Vitfurlands 
Interaction of the Fc moiety of an antibody with 
an Fc receptor (FcR) can induce a great diversity 
of biological effects [24] I he expression of FcR 
has been reported to be abnormal in a variety of 
human diseases [IS] FcR may also be important 
for the immunotherapeutical use of murine 
monoclonal antibodies 
Heterocytophihc interactions of murine 
immunoglobulins with human monocytes have 
been analysed in studies on the monocyte 
dependent induction of human I cell prolifera 
tion by antibodies against the CD3 antigen The 
mitogemc properties of anti CD3 antibodies 
were shown to be isotypc dependent Anti 
bodies of the mIgG2a subclass induced pro 
hferation of Τ cells in essentially all human 
individuals although one defective familv has 
been reported [4] mlgGl anti C D 3 antibodies, 
however were mitogemc in 70% of healthy 
Caucasian individuals but not in the remaining 
30% [22] The induction of Τ cell proliferation 
by mIgG2b anti C D 3 antibodies was observed in 
only a small minority (less than 10% ) of normal 
individuals [21] We showed previously that the 
polymorphism of the milogenic effect of mlgGl 
anti C D 3 antibodies is due to a polymorphism of 
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the FcR for mlgGl on human monocytes [19] 
On the basis of both functional and biochemical 
studies, the presence of different FcR for human 
IgG has been suggested on human monocytes 
(reviewed by Anderson & Looncy [1]) 
Cell lines that are thought to be representative 
of normal cells at a particular stage of matura­
tion or differentiation have been extremely 
valuable for our present knowledge of FcR We 
compared the accessory function of cell lines (in 
antibody-induced Τ cell milogenesis) and their 
FcR expression with a newly developed DA 
rosette assay [24] These variables were also 
studied on human monocytes The FcR on 
monocytes, mediating antibody-induced Τ cell 
proliferation, have previously been analysed by 
studying the inhibition of Τ cell mitogenesis by 
human sera or purified human IgG [10 15] We 
now report a detailed characterization by rosette 
inhibition studies of FcR on monocytes The 
results suggest the presence of two types of FcR 
on human monocytes with different affinities for 
homologous and heterologous IgG (of the 
various subclasses) 
MATFRIALS A N D METHODS 
Cell linei Human myeloid (KG 1 HL 60) monocy 
tic(U917) erythromyeloid (KS62) В lymphoblasioid 
(Düudi) and 1 lymphoblastoid (Moll 4) cell lines 
were cultured in RPMI1640 medium (Dutch modified 
lion containing both Hepcs and sodium bicarbonate) 
supplemented with 1()гг heat inactivated klal calf 
serum 2 тм glutaminc 1 тм sodium pyruvate and 
gentamycin (SO/tg/ml) This mixture will he referred 
to as complete medium 
Мопосмеі Peripheral blood mononuclear cells 
(PBMC) were obtained from huffy coats by centri 
fugation on a Percoli (Pharmacia Uppsala Sweden) 
gradient (j=1072g/ml) at 4°C Monocytes were 
purified from PBMC by counterflow centnfugation 
The final suspensions obtained by this procedure con 
tamed at least 909ί monocytes (as determined by 
May-Grunwald-Giemsa and non specific esterase 
staining) Viability was greater than W/c as ducr 
mined by trypan blue exclusion Because of the fune 
tional variability in monocytes from different 
individuals wc considered it advantageous to have 
fixed and well defined batches of ihcsc cells The 
purified monocytes were therefore cryoprescrved and 
used later Both (he recovery and viability of 
crvoprcscrved monocytes were excellent (>70 r i and 
>95r/< respectively) 
Τ lymphoíytes Lymphocytes were purified from 
PBMC by clutnalion Τ lymphocytes were isolated 
from this suspension by nylon wool filtration and 
rosetting with sheep erythrocytes treated with 
aminocthyhsothiouronium bromide |1] 
Ig preparaliom For the charactcnralion of FcR on 
human monocytes three different murine monoclonal 
antibodies were used PAI (IgGl anlibod) against 
idiotypic determinant on В С LL cells produced by F 
Prcyers Nijmegen) 1 1 3 1 (lgG2b anti mouse H 2 
déterminant) [14] and 2 2 1 (lgG2a anti mouse la 
determinant) [14] All antibodies were purified from 
ascites fluid by (NH4),S04 precipitation followed by 
different chromatographic procedures |П] No 
residual antibodies of a contaminating subclass could 
be dctccied by double diffusion in agarose 
Pure human IgG subclass proteins were isolated 
from the sera of patients with multiple myeloma After 
(NH.,) SOj precipitation and DEAL-Sephadcx chro 
maiographv the isolated proteins were tested for 
impurities If necessary the preparations were further 
purified hy affinity chromatography on Sepharose-
protcin A (IgGl) or Scpharose anti IgG subclass [8] 
I he obtained proteins were checked for impurities and 
IgG subclass content in Immunoelectrophoresis and 
radial immunodiffusion 
Prolcin concentrations were determined 
spcctrophotometncally at 2K0 nm with an extinction 
coefficient t |
 m
 of 14 Τ for IgG 
Binding of aggregated muniie IgG Affinity purified 
mouse monoclonal antibodies at it) mg/ml phosphate 
buffered saline (PBS) of Ihe subclasses lgG2b IgGl 
and lgG2a were aggregated by heating at (iVC for 2 
18 and 2S mm respectively Ten micrograms of each 
antibody preparation were incubalcd at 40C wiih \i.t 
monocytes Binding of aggregates was subsequently 
assayed by indirect immunofluorescence with fluores­
cein conjugated F(ab ), fraction of sheep anti mouse 
IgG antibody Cappcl Malvern Pa USA) Fluores­
cence was determined with an Ortho SO Η flow cylo 
meter In each sample ihe fluorescence mlcnsity from 
10 000 cells was measured 
Sensitization of human emhromet A 0 We 
suspension of human erythrocytes (HRBC) in PBS 
was incubated for 10 minai 170С with various dilutions 
of antibody For mlgG 1 EA rosetting we used ascites 
of an IgGl monoclonal antibody against glycophonn 
A (a generous gift from M Bos CLB Amsterdam. 
The Netherlands) Human IgG ГЛ rosetting was per 
formed with Rhesus D positive HRBC and a commer 
cially available polyclonal antiserum against Rhesus D 
(Merz & Dade Dudmgen Switzerland) HRBC incu 
bated with PBS alone served as controls for non­
specific binding After incubation sensitized (and as a 
control unsensitizcd) HRBC were washed resus 
pended in RPMI 1640 containing Wt FCS and used 
within 10 mm 
Microscopic FA rosette arwn Two hundred micro 
litres of a monocyte suspension (2ХІ06 cells/ml in 
RPMI 1640 with S<7f FCS) and SO p\ of sensitized 
HRBC suspension were mixed ccnlrifuged (4 mm at 
20 g) and incubated for 1 h at 4°C Monocylcs with at 
least three bound HRBC were scored as rosettes 
Photomelni LA rosette a\\u\ FcR expression can 
be quantitated wilh high sensmviiv by using the 
erythrocyte associated pseudoperoxidase activity 
which wc recently described in detail (24] Briefly 
monolayers of cither monocytes or cell lines were pre 
pared in % well flat bottomed mitrotitre plates (Cos 
tar Cambridge Mass USA) Sensinzcd HRBCwcrc 
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dispensed into the wells and incubated for 1 h .it 4°C, 
after which the plates were washed in PBS The level 
of EA rosctting was quantilatcd b> addition of a 
freshlv prepared peroxidase substrate solution 
0 8 mg/ml 5' aminosalicylic acid, dissolved in 50 т м 
phosphate buffer, pH 6 0, containing 0 072# v/v 
Η-.Oi to each well After 10 mm the extinction was 
measured at 450 nm in a Tuertck* Multiskan 
To correct for variation between experiments in 
background absórbante values, a binding index (BI) 
was calculated for each experiment as follows 
В1 = [1-(Е450/ПА450)|х1(Ю 
where E450=extincnon at 4S0 nm in wells to which 
HRBC mihoui sensitizing antibody were added. 
FA450=extinction at 450 nm in wells to which sen-
suizeei HRBC were added Duplicate samples were 
run for each dilution of antiserum used for sensitiza­
tion of II RBC and the observed variation in BI value*. 
was small (usually less than 109i ) 
Rosette Inhibition studies Monocytes were dis 
pensed into individual wells of microtitre plaits and 
after adherence and washing awav the nonadherent 
cells 50 u\ of inhibitor (or, as a control, RPMI 1640 
alone) were added The affinity-purified proteins, 
whose inhibitory effects were to be tested were 
depleted of aggregates by ultracentrifugation (1 h at 
KM) 000 g 4°C) and rapidh snap frozen in small ali-
quots in liquid nitrogen These proteins were stored at 
- 2 0 4 and thawed once just belorc use in the inhibi­
tion experiments After incubation for 15 mm at 40C, 
50 u\ ol a 1 f/( suspension of sensitized HRBC (or asa 
control unsensiti/ed IIRBC) in complete medium 
were added to each well and intubated for 4^ mm at 
40C The level of FcR expression was quantitattd by 
the photomeint FA rosette assay In all experiments 
the optimal level of HRBC sensm/ation was deter­
mined separately for eath batch of monotytts I he 
inhibition studies were performed at a Itvel of HRBC 
sensitization that onl\ just gave a maximal BI in the 
pholometnt assay (edge of the binding plateau see 
Results) The results are expressed as the pertentage 
of inhibition calculated as 
EA45() ( +inhibitor)-L 450 ( +inhibitor) 
1 — ; xHX) 
EA450( inhibitor)-L450(-inhibilor)J 
/ vmphotyte ittmulation with antt-C Dì The anti-
CD1 antibodies used in the present study were W 112 
(IgCi2rt) [20] and monoclonal antibody LCHT1 
(IgGl) a kind gift from Dr Peter Beverley (London. 
UK) [1] I cell proliferation in PBMC suspensions 
induced by anti-CDÏ monoclonal antibodies was 
measured as described prcsiously [22] Briefly mono 
nuclear cells in complete medium were intubated for 
72 h at 170C with monoclonal antibody in U-bottomed 
wells of microtitre plates I he intorporation of 
pHJthymidme (added 18 h before the end of the 
incubation) was measured by liquid scintillation 
counting 
Ί he accessory function of purified monocytes in the 
anti-CDl-mduccd mitogenesis of Ί cells was studied 
by incubating 2xl(H monocytes, 1 x КГ purified Τ 
cells, and anti-CDl antibody for 72 h at 170C in U-
Human Fc Receptors for Murine Ig 
bottomed microtitre wells pH]thymidine uptake was 
assayed as described above 
When cell lines were used in T-cell proliferation 
experiments, these were first treated with mitomycin 
С The cells were therefore incubated al 2 5x10*' 
cells/ml for 60 mm at 370C with mitomycin С 
( 100 ¿/g/ml) (Sigma St L ouïs, Mo , USA) I he cells 
were washed three times with PBS onte with com 
plete medium and resuspendtd m complete medium 
1x10s mitomycin C-trcated cells. 1x10" I tells and 
anti-CDl antibody were cultured for 72 h at 17 С 
after which plljthymidine incorporation was assaved 
R E S U L T S 
Binding of aggregated murine IgG to monocytes 
We characterized monocytes from over НИ) 
human individuals for their accessory function in 
dnti-CD3-induced Τ cell proliferation Mono­
cytes from all the tested individuals supported 
the proliferation of Τ cells by mIgG2d anti-C D4 
antibodies About "MY/c of all tested (Caucasian) 
individuals (low-rcsponder individuals. I R) 
possessed monocytes that did not support I tell 
proliferation induced by mlgGl anti CD4 anti-
ΗΓ1 
A ì t ON H )l 
I 
В I tu' 
I ! ι. 
D kjCii' 
HUOfif >( LNf E N U N , [v 
FK. 1 Binding of aggregated antibodies of different 
isotypes to monocytes from an LR and an HR 
individual measured by indirect immunofluores­
cence Histograms represent background staining (A) 
and binding of aggregated antibodies of the IgGl (B 
P A l ) , I g G 2 a ( C 2-2-1), and IgG2b (D Vl-1-1) sub­
classes The results are representative of similar 
experiments performed on monocytes from five I R 
and six HR individuals 
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bodies (or only to a very limited extent at high 
antibody concentrations) Monocytes from the 
other donors support the induction of Τ cell 
proliferation by mlgGl antibodies over a wide 
range of antibody concentrations (high-res-
ponder individuals HR) Monocytes did not 
support the proliferation induced by mlgG2b 
anti-CD3 antibodies The few exceptions that do 
respond to this subclass [21 ] were not included in 
our cell panel Aggregrated mlgG2a bound to 
monocytes from individuals of both the MR and 
LR phenotype (Fig 1) This is consistent with 
the accessory function of both monocyte batches 
in mlBG2a-induced Τ cell mitogenesis In 
contrast. mIgCi2b aggregates did not bind, 
which correlates with the failure of mlgG2b anti-
CD3 antibodies to induce Τ cell proliferation in 
these individuals HR monocytes bound signifi­
cantly more mlgGl aggregates than LR mono­
cytes in all donors tested The fluorescence 
intensity obtained by the binding of mlgGl 
aggregates to HR monocytes was low. and this 
assay is too insensitive for detailed characteriza­
tion of this type of FcR on human cells FcR 
were therefore studied in other types of FcR 
assays 
Differential binding of EA-mlgCI by HR and 
LR monocytes 
We have previously reported [19] that FcR for 
mlgGl can be detected on monocytes from HR 
individuals by an EA rosette technique using 
HRBC sensitized with a monoclonal IgGl anti­
body directed against glycophonn A The Fc 
dependency of EA rosettmg was demonstrated 
by showing that HRBC sensitized with F(ab')> 
fragments of anti-glycophorm A antibody (at 
high concentrations) did not form EA rosettes, 
either counted visually or measured by the 
photometric assay [24] When very high concen­
trations of sensitizing antibody are applied, a 
low degree of rosettmg is also seen with LR 
monocytes when rosettes are scored visually or 
by the photometric assay (Fig 2) At lower con­
centrations of anti-glycophorin antibody. 
rosettes arc only formed with HR monocytes 
The apparent absence of FcR expression on LR 
monocytes as suggested from the immuno­
fluorescence results with aggregated mlgGl 
(Fig 1) is caused by the low sensitivity of this 
assay Both the immunofluorescence assay and 
the EA rosette assay, however, clearly discrimi­
nated between HR and LR individuals In the 
photometric EA rosette assay we regularly used 
4 x КГ monocytes per well When lower cell con­
centrations were used, the plateau of BI, 
decreased in parallel (not shown) The dilution 
factor of antibody/antiserum at which half maxi­
mal EA rosettmg is observed, the BI SOÇf value 
(Bis« ) was found to be relatively constant 
(regardless of the number of cells per well) for a 
particular batch of monocytes (or cell line) Sig-
nificant differences exist between HR and LR 
60 
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FIG 2 Comparison of EA-mlgGl rosette formation by monotytcs from an 1 R( A) and an 
HR ( · ) individual by microscope (A) and photometric (B) methods Each point in the 
figure represents the mean of duplicate determinations 
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FIG 3 Comparison of H Rand LR individuals in mlgO 1 anti CD1 induced Τ cell prolifera 
tion and m a direct assay for mlgGI FcR Accessory function (shown in A) was tested by 
incubating PBMC and monoclonal antibod) UCHT1 ( 1 Ml (ХЮ dilution of ascites) for 72 h 
at Т7°С Stimulation indices were calculated by dividing cpm of incorporated ['Hlthymidine 
in the presence of UCИГ1 by background cpm obtained in the absence of antibod> BI4 
values (presented in B) were determined by the photometric EA rosette assay Each point 
in the figure represents data from one individual the bars indicale means for the various 
groups Statistical analysis Wilcoxon two sample test 
monocytes in both Τ cell mitogenesis and 
photometric EA rosette assavs (Fig 3) In each 
individual photometric resetting experiment, 
В\чг values observed for HR monocytes were 
found to be higher than the corresponding 
values for LR monocytes Furthermore, when 
using identical numbers of monocytes in the 
rosette assay, HR monocytes had a higher BI 
plateau than LR monocytes These results sug 
gest a relative rather than an absolute difference 
in FcR expression for mlgGI between mono­
cytes from HR and LR donors 
EA rosene inhibition studies 
In order to characterize the FcR in more 
detail we performed inhibition studies wtth 
monomenc immunoglobulins In all expen 
ments indicator erythrocytes were used sen 
sitized with antibody concentrations giving 
optimal signals in the EA rosette assays FcR for 
mlgGI were assayed by using indicator erythro 
cytes sensitized with a monoclonal anti-
glycophonn A antibody By using Rhesus D 
positive HRBC sensitized with a human 
alloserum against Rhesus D we could detect 
FcR for human IgG with high sensitivity 
Haemagglutmation assays indicated that m the 
latter case the indicator HRBC were coated 
mainly with human IgGl and IgG3 (results not 
shown) FcR on monocytes detected by using 
EA-mlgGl were markedly inhibited only by 
mlgGI but not by mIgG2a or mIgG2b whereas 
the FcR for human IgG was strongly inhibited by 
mIgG2a but not at all by mlgG 1 or mIgG2b (Fig 
4) All human IgG subclasses were inhibitory for 
rosette formation of human monocytes with 
EA-human IgG (Fig 5) None of the human 
IgG subclasses gave significant inhibition of the 
mlgGI resetting Human immunoglobulins of 
S80 
260 
Ü5 
Ï20 
MURINE IgGl 
ROSETTING 
HUMAN IgG 
ROSETTING 
Ж 
§Ш §8$ §§§ §§§ §§§ §88 
CGI ф2а lgC2b IgGl lgG2a lgG2b 
CONC OF INHBTOR ( Mfl/ml ) 
FIG 4 Inhibition of rosene formation between sen 
sitized HRBC and human monocytes by monomenc 
murine immunoglobulins of different isotypes The 
results shown are the means of two experiments 
37 
J G J Van de Winkel et al 
MUnUE kjGl HUMAN kjG 
FIOSETTING TOSETTMG 
IgCI >gG2 lgG3 lgG4 IgGl lgG2 kjG.'l k|G4 
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Fifí S Inhibition of rosette formation between sen-
sitized HRBC and human monoc>tes by monomeric 
human immunoglobulins of different subclasses I he 
results shown are the means of three experiments 
the classes [gM and IgA were ineffective as 
inhibitor m both types of EA rosettmg with 
human monocytes (results not shown) Hetero-
logous rabbit IgG has frequently been used to 
study FcR on human cells The inhibitory effects 
of rabbit and human sera (as a source of IgG) on 
both types of E A rosetting were tested Both 
sera inhibited the rosetting with human IgG-
scnsitized H R B C (80% inhibition at 2 5% 
serum), whereas mlgGl E A rosetting remained 
unaffected (even at VQ0/c serum, results not 
shown) All the data from the inhibition studies 
support the concept that different types of FcR 
are assayed by the two EA rosette assays 
Correlation of FcR expression on human cell 
lines with accessory [unction m anti-CD3-
mduced Τ cell proliferation 
When studying the accessory function of 
human cell lines in anti-CD3-induced Τ cell pro­
liferation we observed a high degree of variation 
in stimulation indices between individual experi­
ments Variation in FcR-mediated functions of 
cell lines between individual experiments is well 
known, and is probably related to changes in the 
number of FcR expressed during the various 
phases of the cell cycle [6] Despite these quan­
titative differences, however, the general pat­
tern of accessory activity shown by the cell lines 
remained the same Because of this variability, 
both functional (T cell mitogenesis) and direct 
FcR assays were performed on the same day for 
Тлвіь I Correlation of FcR expression for murine 
IgGl on human eell lines with accessory lunUion in 
IgGl anti-CDVinduced I tell proliferation 
Stimulation 
index 
Accessory 
cells* 
Molt-4 
Daudi 
HL-60 
KGl 
U937 
К^62 
rs¡!=0 89 
Ρ « ) 02 
B I „
r
t 
0 
ΉΟΟ 
9ЫХ) 
11.200 
IS.SOO 
56,000 
*Accessory function was tested by mcubaling 
mitomycin C-trcated accessory cells, Τ cells, and 
monoclonal ant ibody U C H T l (1 50.000 dilution of 
ascites) for 72 h at 17°C 
t B I M r values were determined by the photometr ic 
E A rosette assay 
^Stimulation indices were calculated as in legend to 
Fig 3 
^ The relat ionship between the BI4 )r values and the 
observed st imulat ion indices was assessed using the 
Spearman rank correlat ion method 
URcsults are representat ive for three exper iments 
each cell line In Table I the accessory function 
of different cell lines in m l g G l anti-CD3-
tnduced Τ cell proliferation is compared with 
EA rosetting All cell lines, with the exception of 
Molt-4. display rosetting with H R B C sensitized 
by the mlgG 1 antibody The extent of accessory 
function correlates well with results from the 
rosette assay These results suggest that the FcR 
mediating the stimulation of Τ cells by mlgGl 
anti-CD3 antibodies is identical to the one 
assayed by the photometric F A rosette assay 
Remarkably, LI937 has a high stimulation index 
in the mitogenesis assay relative to its FcR 
expression 
When FcR expression for human IgG was 
studied on cell lines (Table II) , we observed a 
different pattern for several lines than was found 
for m l g G l K562, for example, interacts well 
with mlgGl-sensiti/ed H R B C but poorly with 
H R B C sensitized with human IgG The expres­
sion of FcR for human IgG as measured by EA 
rosetting is in accordance with accessory func­
tion in mIgG2a-induced Τ cell mitogenesis 
(Table II) This indicates that mIgG2a can inter­
act with the FcR, which is assayed by the rosette 
assay using E A - h u m a n IgG, as was also sug-
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IABLL 11 Correlation of FcR expression for human 
IgG on human cell linei wiih accessory function in 
lgG2a anti CD! induced Τ cell proliferation 
Stimulation 
index 
Accessory WT42 
cells* B!,, + (Ig02a)t 
Molt 4 Ü I IH 
К%2 2 S 2 1 
Daudi 6 0 3 9 
KOI 1-11 5 1 
HL60 427 IS 8 
U 937 SHO 45 3 
r<) = l (X) 
P < n (X)l 
' A c c e s s o r y function was les ted by incubating 
mitomycin С treated accessory cells Τ cells and 
monoclonal antibody Wl 32 (50 ng/ml) for 72 h at 
37T 
+BI41 values were determined by the photometric 
EA rosette assay 
^Stimulation indices were calculated as in legend to 
Fig 3 
§For assessment of the relation between Bl,,.-
valucs and the observed stimulation indices the 
Spearman rank correlation method was used 
f Results are representative for three experiments 
gested from the inhibition experiments (Fig 4) 
Again, U937 displays high accessory function 
relative to its FcR expression 
DISCUSSION 
Previously we have analysed the interaction of 
human monocytes with mouse IgG in Τ cell pro 
hfcration studies and observed that inIgG2a 
anti CD3 antibodies were mitogenic with all 
donors and that mlgGl and mIgG2b antibodies 
could induce Τ cell proliferation in only part of 
tht human population ( 19 21 22] The polymor­
phism of the mitogenic effect of mlgGl anti-
CD3 antibodies was found to be due to polymor­
phism of the FcR for mlgGl present on human 
monocytes [19] The FcR on human cells, 
mediating interactions with mlgGl antibodies, 
are very difficult to study in direct assays Mono­
merie mlgGl does not bind to a reasonable 
extent, and when using sheep erythrocytes sen­
sitized with mlgGl antibodies, no rosette forma­
tion could be observed [19] In the present study 
both immunofluorescence with aggregates of 
mlg, and EA rosetting (using HRBC) were used 
to detect FcR for different mlgG subclasses on 
human monocytes 
Immunofluorescence with aggregates can be 
used as a direct assay for the presence of FcR, as 
illustrated in Fig 1, although fluorescence inten 
sity is rather low Furthermore binding studies 
with aggregates lend to be poorly reproducible 
because of variations in the size and stability of 
aggregates in purity, and in the degree of mono­
mer contamination Therefore we preferred to 
quantitate FcR by means of rosette assays The 
number of erythrocytes bound can be quantified 
by means of the pseudoperoxidasc activity pre­
sent in these cells [24] 
Monocytes from Η R individuals gave a higher 
degree of rosette formation at all dilutions of 
sensitizing antibody than LR monocytes FcR 
for mlgGl could be demonstrated on LR mono 
cytes only when exceedingly high concentrations 
of sensitizing antibody were used To our 
knowledge, this is the first direct evidence for 
relative rather than absolute differences in FcR 
expression of mlgGl on monocytes from HR 
and I R individuals On the basis of mitogenesis 
experiments, Clement el al [5] have already sug­
gested the presence of relative rather than 
absolute defects' in LR monocytes These 
investigators observed that monocytes from LR 
individuals could support antibody-induced Τ 
cell proliferation only at very high concentra­
tions of mlgGl anti-CD3 antibodies incontrasi 
to HR monocytes, which also supported Τ cell 
proliferation at much lower concentrations 
Their results, however, can be explained by the 
presence of FcR for mlgGl on LR monocytes, 
but another possibility is that coating of anti 
CD3 antibodies to the wells of the microtitre 
plates caused sufficient cross-linking to induce Τ 
cell proliferation Other authors have observed 
that anti CD3 antibodies on solid substrates 
(e g bound to Sepharose beads [19], or to goat 
anti mouse IgG coated microtitre plates [4] or 
coated directly to the wells of microtitre plates 
[7]) can induce Τ cell proliferation in the absence 
of monocytes 
The data obtained with EA rosetting suggest 
that either far less FcR are present, or that the 
affinity of the FcR on LR monocytes for mlgGl 
is much lower than on HR monocytes The 
second possibility is supported by studies of 
Looney e/ al [16], who described a monoclonal 
antibody (IV 3) with specificity for the FcR for 
mlgGl, which binds to both HR and LR mono­
cytes with similar intensity (as judged to micro­
fluorometry) Using this antibody, inhibition 
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studies in our own laboratory showed strong 
inhibition (>80%) of rosetting with EA-mlgGl 
and no inhibition of hlgG EA rosettes, thus 
confirming the specificity of monoclonal anti-
body IV 3 for the FcR for mlgGl (results not 
shown) Anderson et al [2] furthermore 
observed differences in isoelectric focusing pat-
terns of purified FcR for mlgGl from HR and 
LR monocytes 
We found evidence from rosette inhibilion 
studies for two types of FcR on human mono-
cytes The first type can interact well with 
mlgGl-sensiti¿ed H RBC and can be inhibited 
by mlgGl antibodies and not by mIgG2a or 
mIgG2b antibodies, human IgM, IgA or IgG or 
rabbit serum The second type of FcR interacts 
well with human IgG sensitized indicator 
erythrocytes This FcR can be inhibited by 
mIgG2a antibody and not by murine antibodies 
of the IgGl or IgG2b isotypes Furthermore all 
human IgG subclasses as well as rabbit serum 
inhibited this receptor In this assay we used high 
concentrations of IgG subclasses to demonstrate 
clearly the difference in human IgG binding by 
the two types of receptors With this concentra-
tion range it is clear that the human IgG FcR can 
bind all four subclasses Binding affinity for the 
various subclasses however, may be different 
The finding that neither IgM nor IgA interacted 
with the two types of FcR on human monocytes 
emphasi7cs the importance of the Fc portion of 
IgG in the interaction with these FcR This was 
fürther substantiated by our finding that purified 
Fc fragments exhibited similar inhibition charac-
teristics to whole human IgG (results not 
shown) Previously, other authors have 
described the inhibitory effects of human serum 
or human IgG on either anti-CD3-induced Τ cell 
proliferation [10, 15]oranti-CD3-inducedinter-
leukin 2 (IL-2) release from Jurkat cells [11] 
These studies indicate that only the mIgG2a-
mduccd effects are inhibited by human IgG, and 
that the mlgGl-induced effects are not affected 
Furthermore, all four human IgG subclasses 
were found to inhibit the mIgG2a-induced 
human Τ cell mitogenesis [15] 
Ideally we should have assayed the FcR on 
human cells mediating interactions with 
mIgG2a, by using erythrocytes sensitized with 
mIgG2a antibodies Such antibodies, however, 
were not available at the lime when we per­
formed the studies desenbed above Recently 
we obtained mIgG2a switch variants of the 
(mlgGl) monoclonal anti-glycophonn A anti­
body used to assay the FcR for murine IgGl 
Preliminary results show that the patterns of 
FcR expression on human cell lines obtained by 
using either human IgG- or mIgG2a-sensitized 
erythrocytes are similar, which substantiates our 
findings that both types of antibodies interact 
with the same receptor structure on human cells 
Cell lines can be used as accessory cells in anti-
CD3-induced Τ cell mitogenesis When the 
induction of Τ cell mitogenesis by anti-CD3 anti­
bodies of the mlgG 1 and mIgG2a subclasses was 
studied, different patterns emerged The expres­
sion of FcR for mlgGl on cell lines correlated 
well with accessory function in mlgGl-induced 
mitogenesis The expression of FcR for human 
IgG correlated with the accessory function in 
mIgG2a-induccd Τ cell proliferation of cell 
lines By using cell lines with variable expression 
of FcR for human IgG. we could positively iden-
tif\ this receptor as the one mediating interac­
tions with mIgG2a antibodies in anti-CD3-
induced Τ cell mitogenesis This is consistent 
with the data obtained in the rosette inhibition 
studies, where we found that mIgG2a inhibits 
the FcR for human IgG 
A high level of rosette formation between 
U937 and 111.-60 cells and EA-human IgG was 
observed, whereas K562 demonstrated little 
rosette formation with these indicator cells 
These results indicate that the FcR for human 
IgG on the U937 and HL-60 cell lines differ from 
those of the relatively undifferentiated K562 cell 
line These data correspond to the findings of 
other investigators, who have shown that №62 
cells possess low affinity FcR, and U937 and 
HI -60 cells high affinity FcR specific for the Fc 
fragment of human IgG [17] The mveloid cell 
line KG 1 appears to possess FcR for both mlgG 1 
and human IgG, which has not been reported 
before With heavily sensitized Η RBC we could 
detect FcR for mlgGl on several cell lines This 
type of FcR was previously reported to be absent 
onsomeof these lines (e g onU937[12]) These 
results accentuate the sensitivity of our indicator 
system, and furthermore illustrate that the 
detection of FcR is strictly dependent on the 
type of assay and on the conditions applied 
Only some cell lines were previously studied 
in functional assays Looney et al [16] studied 
the accessory function of Daudi and U937 cells 
in anti-CD3-induced Τ cell proliferation and 
observed that U9V7 supported the mitogenesis 
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induced by both m l g G l and mIgG2a antibodies, 
whereas Daudi supported the mitogenesis by 
mlgGl antibodies only Other investigators 
studied the induction of IL-2 release from Jurkat 
cells by murine anti-CD3 antibodies of different 
subclasses K562 could only support IL-2 release 
induced by m l g G l anti-CD3 Ш 3 7 supported 
IL-2 release by both m l g G l and mIgG2a anti­
bodies [11] Such results, which are in agreement 
with our data , indicate that functional assays 
may be used as indirect FcR assays 
The interpretation of functional assays, 
however, is complicated for reasons such as the 
production of immunomodulatory factors, 
which varies between different cells (e g pro­
duction of prostaglandin Π [9]), and might sig­
nificantly affect the results 
In conclusion, the results of our studies sup­
port the concept that different human FcR are 
involved in the binding of murine IgGl and 
IgG2a Further biochemical and functional 
studies will be necessary to characterize these 
receptors in more detail. 
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We have developed a sensitive, straightforward method for the quantitation of surface-bound IgG on 
sensitized erythrocytes. The assay is based on the consumption by sensitized cells of anti-IgG antiserum 
The remaining anti-IgG is quanlitated in a second incubation by precipitation with 1 2 5I-IgG in the 
presence of polyethylene glycol. Calibration curves for this assay were constructed using known amounts 
of unlabeled IgG. The method can be performed in microtitre plates and eliminates the use of purified 
anti-erythrocyte antibodies, or highly punfied specific anti-IgG anlisera. The results were completely 
consistent with those of immunofluorescence assays, but our method was much more sensitive, less than 
500 molecules of IgG per cell being detected reproducibly. The technique is not labonous and takes much 
less time than previously described methods with similar sensitivity 
As an example of the applicability of this test, the implications of ligand density for the detection by 
EA rosetting of Fc receptors on human monocytes are shown. The results suggest that a large vanation 
exists in the affinity of the different types of Fc receptors for their ligands. 
Key words Sensitized erythrocyte; Radiometric assay, Fc receptor, human; Antibody-coaled erythrocyte resetting 
Introduction 
Erythrocytes are widely used as indicator cells. 
Many erythrocyte membrane antigens are well 
charactenzed and many antisera of known 
Correspondence to J GJ Van de Winkel, Department of 
Medicine, Division of Nephrology, University Hospital 
Nijmegen, Geert Grooteplein Zuid β, 6525 GA Nijmegen, The 
Netherlands 
Abbreviations ADCC, antibody-dependent ceU-medialed 
cytoloucity; B-CLL, chrome lymphocytic leukemia of В origin, 
BSA, bovine serum albumin, CD, cluster of differenliation, 
EA, antibody-coated erylhrocyle, FcR, receptor(s) for the Fc 
fragment of Ig, b, human, HR, high responder, HRBC, human 
erythrocyte^), IF, immunofluorescence, LR, low responder; 
m, munne, PBS, phosphate-buffered saline, PEG, polyethylene 
glycol 6000, RIA, radioimmunoassay 
specificity are readily available. Furthermore, the 
immobility of surface components in the HRBC 
membrane, which is relatively unique among 
eukaryotic cells (reviewed by Singer, 1974), is ad­
vantageous in many types of assay. Antibody-
sensilized human erythrocytes are frequently used 
as targets in ADCC, and in the detection and 
quantitation of FcR (EA rosette assays). EA reset­
ting using antibody-sensitized HRBC can be very 
sensitive, and FcR have been desenbed which can 
be detected using sensitized HRBC but not the 
sensitized erythrocytes from other species (e.g., the 
FcR for mlgGl on human monocytes; Tax et al., 
1984). An important aspect in the detection of 
FcR is the degree of erythrocyte sensitization and 
this can be very high on HRBC when suitable 
antibodies are used. The well-known dependence 
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of rosette formation and ADCC on the degree of 
antibody sensitization (Shaw et al, 1979) em­
phasizes the need to study this variable in more 
detail 
Antibody density on sensitized erythrocytes can 
be quantitated by several techniques When the 
anti-erythrocyte antibody is available in purified 
form (which is generally not the case), direct bind­
ing studies can be performed (Jungi and Baran-
dum, 1985) Assays based on the use of 125I-labeled 
anti-IgG have been described (Merry et al, 1982), 
but these were laborious and suffered from prob­
lems such as nonspecific binding of the anti-IgG 
to red cells (Rearden and Masouredis, 1980) 
Membrane-bound IgG can also be quantitated 
using 125I-protein A (Langone et al, 1977), but 
this method suffers from disadvantages such as 
unknown and variable binding stoichiometry, and 
absence of affinity of protein A for certain sub­
classes of immunoglobulins 
In this report we present a new, straightforward 
technique by which the degree of erythrocyte 
sensitization can be quantitated This method es­
sentially measures the decrease in the capacity to 
precipitate l2SI-labeled IgG by an anti-IgG anti­
serum, which has previously been incubated with 
sensitized HRBC The assay can be performed in 
microtitre plates, and is much less time consuming 
than previously reported methods The method 
has been applied to quantitate the binding of both 
a monoclonal mouse antibody and a polyclonal 
human antiserum against well-charactenzed anti­
gens on HRBC (glycophonn A, and rhesus D 
antigen, respectively) The mouse IgGl antibody 
against glycophonn A has been used previously m 
an EA roselting assay to demonstrate that a genetic 
polymorphism exists in the Fc receptor for mouse 
IgGl on human monocytes (Tax et al, 1984) This 
polymorphism in Fc receptors for mouse IgGl is 
in tum responsible for a polymorphism in the 
induction of Τ cell proliferation by mouse IgGl 
anti-CD3 antibodies (Tax el al, 1983) and defines 
the so-called high-responder (HR) and low-re-
sponder (LR) phenotypes The quantitative data 
obtained with the radiometric assay are discussed 
in relation to the detection of the Fc receptor for 
human IgG, and the HR and LR Fc receptor for 
mouse IgGl 
Materials and methods 
Ig preparations 
For the quantitation of mlgGl antibody mole­
cules on sensitized HRBC, we used a murine IgGl 
monoclonal antibody for the construction of 
calibration curves This antibody, PAI (directed 
against an idiotypic determinant on B-CLL cells, 
produced in our laboratory by F Preyers) was 
purified from ascites fluid by (NH^SO,, precipi­
tation, followed by different chromatographic pro­
cedures as described by Lems et al (1984) No 
residual antibodies of subclasses other than mlgGl 
could be detected by double diffusion in agarose 
(i e , more than 99 9% pure) 
The degree of HRBC sensitization by human 
antibodies was determined by using hlgG, pun 
fied from human serum by ammonium sulphate 
precipitation and DEAE-Sephadex (Pharmacia, 
Uppsala, Sweden) chromatography The final 
preparation of human IgG was checked for impur­
ities and IgG content in Immunoelectrophoresis 
and radial immunodiffusion In some experiments 
punfied hIgG3 was used, isolated from the sera of 
patients with myelomas by ammonium sulphate 
precipitation and affinity chromatography The 
hlgG preparations (99 9% pure) were from the 
Department of Immune Reagents Production, 
Central Laboratory of the Netherlands Red Cross 
Blood Transfusion Service, Amsterdam 
After isolation, all fractions were depleted of 
aggregates by ultracentnfugation (1 h at 100 000 Ж 
g, 4° С) and the protein concentrations de­
termined by the method described by Bradford et 
al (1976) using bovine gamma globulin (Bio-Rad, 
Munich, F R G ) as a standard The IgG prepara­
tions were diluted in PBS, containing 0 1% sodium 
azide and 0 1% BSA (Cohn fraction V, Sigma, St 
Louis, MO, U S A ) , and snap frozen in small 
ahquots in liquid nitrogen The proteins were 
stored at - 2 0 ° С and thawed once, just before 
use in the radiometric expenments 
Radioiodmation 
After ultracentnfugation a fraction of the puri­
fied Ig of both mlgGl and hlgG was used for the 
preparation of radiolabeled antigen SO /ig of the 
antibodies were labeled with 0 3 mCi Na 1 2 5 I (Ra-
diochemical Centre, Amersham, U K ) , using the 
chloramine-T method (Hunter, 1973), resulting in 
a specific activity of 3 μ€ι/μξ 125I-IgG Free 
iodine was separated from protein-bound label by 
Sephadex G-2S (Pharmacia, Uppsala, Sweden) 
chromatography Labeled proteins were diluted in 
PBS, containing 01% NaNj and 01% BSA, and 
stored at 4° С for up to 1 month 
Sensitization of human erythrocytes 
To obtain sensitized HRBC, a 0 5% suspension 
of the cells (m PBS containing 01% BSA) was 
incubated for 30 mm at 37° С with various dilu­
tions of antibody HRBC, sensitized with mlgGl, 
were obtained using ascites of an IgGl mono­
clonal antibody against glycophonn A (a kind gift 
from M Bos, CLB, Amsterdam, The Netherlands) 
HRBC coated with hlgG antibody molecules were 
prepared using a human polyclonal antiserum 
against rhesus D (Merz & Dade, Dudingen, 
Switzerland) HRBC mcubated with PBS (with 
0 1 % BSA) alone served as controls (unsensitized 
erythrocytes) in the radiometric assay. After in­
cubation, sensitized HRBC were washed twice, 
resuspended and used immediately 
The rhesus phenotypes of the HRBC were de­
termined at the Blood Bank, Nijmegen, The 
Netherlands 
Immunofluorescence 
The binding of different Ig preparations to 
HRBC was estimated by using indirect im­
munofluorescence 100 μΐ of a 1% suspension of 
sensitized HRBC in IF buffer (PBS containing 1% 
BSA and 0 1 % sodium azide) were incubated with 
an equal volume of (Fab fragments of) fluoro-
chrome-labeled anlisera, diluted 1 in 50 m IF 
buffer HRBC, sensitized with mlgGl, were in­
cubated with goal anti-mouse Ig (H&L)-FITC 
(Cappel, Malvem, PA, U S A ) , and hlgG-sensi-
tized HRBC with goat anti-human IgG (H&L)-
FITC (Cappel, Malvern, PA, U S A ) After a 30 
min incubation at room temperature, the cells 
were washed two times, fixed with 1% paraform­
aldehyde and subsequently analyzed by an Ortho 
50-H flow cytomeler The fluorescence mtensity 
from 10000 cells was determined, and the mean 
fluorescence intensity was calculated from the 
histograms 
Radiometric assay 
The erythrocyte-bound antibodies were 
quantilated by their ability to inhibit the binding 
of standardized amounts of 125I-lgG by anti-IgG 
antisera The binding of 125I-IgG was quantitated 
by precipitation of the immune complexes with 
6% PEG, a concentration which did not affect 
uncomplexed antibodies 
The optimal amount of anti-IgG to precipitate 
a fixed amount of '25I-IgG was determined as 
follows A dilution senes of either rabbit anti-hu­
man IgG (CLB, Amsterdam, The Netherlands), 
prepared by immunization of animals with Fc 
fragments of hlgGl and hlgGl, sheep anti-human 
IgG3 (Nordic, Tilburg, The Netherlands) or goal 
anti-mouse IgGl (Meloy, Spnngfield, VA, U S A ) 
antisera was incubated with a fixed amount of 
radiolabeled human IgG, IgG3 or mouse IgGl, 
respectively (approx 10000 cpm/well) m a final 
volume of 150 μΐ in PBS, supplemented with 
0 07% BSA, 01% sodium azide, and a final con­
centration of 6% PEG for 18 h at 4°C in round-
bottomed microtitre plates (Costar, Cambridge, 
MA, U S A ) Thereafter the plates were centnfu-
gated (45 mm at 1600 Xg, 4°C), 75 /il of the 
supematanls were transferred to Micronic tubes 
(Flow, Irvine, U K ) and radioactivity was counted 
in an LKB gamma counter The percentage pre­
cipitation of labeled IgG was calculated by com-
panson with the value obtained m the absence of 
antiserum In all cases this last value deviated less 
than 5% from the input, indicating no sponta­
neous precipitation of l25I-IgG in the presence of 
6% PEG The minimal amount of antiserum which 
still precipitated the maximal amount of 125I-IgG 
was further used in the assays 
A calibration curve was obtained by the in­
cubation of a dilution senes of known amounts of 
human or mouse IgG for 1 h at room temperature 
with the optimal amount of antiserum in a final 
volume of 100 /il After centnfugation (10 mm at 
600 x g, room temperature), 50 μ 1 of this mixture 
was placed in fresh microtitre wells and incubated 
with a fixed amount of 125I-IgG for 18 h at 4°С m 
an end-volume of 150 μΐ, with a final concentra­
tion of 6% PEG in PBS contammg 0 07% BSA, 
01% NaN], and further handled as descnbed 
above 
To determine the total amount of erythrocyle-
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bound antibody, vanable numbers of sensitized 
HRBC were incubated with the fixed amount of 
anti-IgG sera in the same way as described for the 
calibration curve Controls without HRBC and 
with unsensitized HRBC were included in each 
experiment In both types of control a maximal 
precipitation of labeled antigen was found in all 
experiments, indicating that none of the anlisera 
bound nonspecifically to HRBC or to the wells of 
the microtitre plates After incubation, the micro-
titre plates were centnfuged for 10 mm at 600 X g 
(room temperature) and SO μΐ of the supematants 
were incubated with 125I-IgG in the presence of 
6% PEG in a final volume of ISO μΙ for 18 h at 
4 ° C, and further handled as described above, and 
the percentage inhibition of the precipitation of 
'"l-IgG was calculated The quantity of HRBC-
associated IgG could be calculated using the 
calibration curve, determined in the same expen-
ment, and converted to molecules per cell, because 
the number of HRBC was known The molecular 
weight of IgG was assumed to be 160000, and it 
can be calculated that 1 ng of IgG corresponds to 
approximately 3 8 X 10' molecules of IgG 
All radiometric determinations were performed 
in triplicate and the means are shown in the 
figures All expenments were performed at least 
three times and representative expenments are 
shown 
EA resetting of human monocytes 
Monocytes were purified from buffy coats as 
previously desenbed (Van de Winkel et al, 1987) 
The HR and LR phenotype of monocytes from 
different donors was studied in mitogenesis assays 
as described by Tax et al (1983) The induction of 
human Τ cell proliferation by murine anti-CD3 
antibodies UCHT1 (mlgGl, a kind gift from Dr 
Peter Beverley, London, UK.), and as a positive 
control WT32 (mIgG2a, Tax et al, 1983) was 
studied with isolated monocytes as accessory cells 
After isolation and characterization in mitogen­
esis assays, EA rosette formation between 
monocytes and HRBC sensitized with different 
types of antibody molecules was performed as 
previously described (Van de Winkel et al, 1987) 
Briefly, sensitized HRBC (prepared as desenbed 
above) were dispensed into microtitre plates, con­
taining monolayers of monocytes, and incubated 
for 1 h at 4° С The extent of EA rosetting was 
quantitated using the erythrocyte-associated 
pseudoperoxidase activity, measured photometri­
cally at 450 nm A binding index was calculated 
for each experiment (to correct for variation in 
background absorbance values) as follows 
[l - (Eti0/FMS0)] X 100 = binding index 
where £4 ,0 is extinction at 450 nm in wells to 
which HRBC without sensitizing antibody were 
added, and £A450 IS extinction at 450 nm in wells 
to which sensitized HRBC were added 
The HRBC suspensions sensitized with differ-
ent dilutions of antiserum were tested in duplicate 
and each experiment was performed at least three 
times 
Results 
Quantitation of IgG antibody molecules on sensi-
tized HRBC 
The principle of the radiometric assay used for 
quantitation of the degree of HRBC sensitization 
is illustrated in Fig 1 A titration curve was con-
structed for each antiserum, to estimate the ap-
propriate working dilution (Fig 1/4) Both un-
labeled soluble IgG (calibration curve) and IgG 
bound to the surface of sensitized HRBC con-
sumed anti-IgG antiserum, resulting in a di-
minished binding of ,25I-labeled IgG in the second 
incubation (Figs IB and 1С) The amount of 
surface-bound IgG was determined by interpola­
tion in the linear part of the calibration curve, at 
equivalent percentages of precipitated labeled IgG 
A percentage close to 50% of the maximal precipi­
tation was chosen for this calculation 
The number of sensitized HRBC used per assay 
vaned with the degree of sensitization HRBC 
coated with optimal amounts of mlgGl anti-gly-
cophonn A antibody already caused a measurable 
signal in the assay when 2 5 Χ 10* cells were used, 
whereas 5 Χ 103 cells, sensitized with human anti­
bodies against rhesus D, had to be used to observe 
detectable inhibition of the secondary precipita­
tion reaction Unsensitized HRBC were included 
in each experiment, and were never found to bind 
o/0 of I human IgG precipitated 
100 -, A 
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Fig 1 Radiometnc analysis оГ the degree of HRBC sensitization b) a human anti rhesus D antiserum Л Titration curve for 
anti-IgG antiserum The amount of 1 2 5 I-hIgG which was precipitated (in the presence of PbG) b> anti-hlgG is plotted against the 
serial dilution of the antiserum The arrow indicates the antiserum dilution used for В and С В Inhibition of the precipitation 
reaction by previous incubation of anti-hlgG antiserum with known amounts of soluble hlgG (calibration curve) С Inhibition of the 
precipitation reaction by previous incubation of anti hlgG antiserum with HRBC sensitized with human anti rhesus D antibody 
Rhesus phenolypc of HRBC CCDec 
anti-IgG antiserum The maximal number of 
HRBC used per assay was 5 X 107, at which con­
centration no agglutination was observed 
Comparison of radiometric and fluorometnc assays 
in the detection of cell surface-bound IgG 
When the dilution of sensitizing antt-erythro-
cyte antibodies was varied the amount of cell-
bound IgG was also regulated Fig 2 shows that a 
sigmoid curve was obtained when the amount of 
cell-bound mlgGl (measured by the radiometric 
assay) was plotted against the concentration of 
sensitizing anli-glycophorm A monoclonal anti­
body A similar curve was obtained when the 
amount of cell-bound mlgGl was evaluated by 
indirect immunofluorescence The radiometric as­
say, however, was much more sensitive When the 
amount of cell-bound murine IgGl was lower 
than approximately 2 X IO4 molecules/cell, im­
munofluorescence could no longer discriminate, 
whereas radtometry still did This effect was even 
more pronounced when HRBC were sensitized by 
a human anti-rhesus D antiserum (Fig 3) In this 
case, the level of sensitization was much lower 
than with mlgGl-sensttized cells, and im­
munofluorescence could not discriminate between 
the different degrees of coating, despite the fact 
that positive cells were identified by the cytofluo-
rometer 
Since a human alloantiserum was used for the 
detection of rhesus D antigens on HRBC, we were 
murine IgGi molecules/ 
erythrocyte (»ra 3 ) * — * 
mean fluorescence 
intensity ' 
16 64 256 
reciprocal dilution oí murine IgGi UIO 3) 
Fig 2 Sensitization of HRBC with different dilutions of 
murine IgGl anli-glycophorm A monoclonal antibody, 
quanlitated by the radiometnc method (A) and by indirect 
immunofluorescence ( Δ ) 
human IgG rroteCules ' -
erythrocyte [.Ю ') ·—· 
mean Пиогезсепсе 
intensity*—о 
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TABLE 11 
DETECTION LIMITS OF THE RADIOMETRIC ASSAY 
? S 32 128 
reciprocal dilution of human IgG 
Fig. Э Sensiuzation of rhesus D-posiüvc HRBC (phenoiype: 
CCDee) with different dilutions of human anti-rhesus D antl-
senjm, quanütated by the radiomemc assay (·) and by indirect 
immunofluorescence (O). 
interested to know which of the human subclasses 
bound to the cells. Indirect haemagglulination as-
says indicated that human IgGl and IgG3 were 
present (results not shown). The radiometric assay 
revealed that 60 ± 14% (mean ± SD, six individual 
experiments) of the sensitizing antibody were 
IgG3. 
Reproducibility and sensitivity of the radiometric 
method 
The maximal degree of HRBC sensitization was 
measured for HRBC from 14 different individuals 
Type of IgG л " 
MunnelgGl 15 
Human IgG 12 
Mimmal delectable 
amount of unlabeled 
inhibitor ь (ng/assay) 
27±06(18-4 2) c 
3.5 ±1.3 (1.5-6.4) 
Minimal delect­
able degree 
of HRBC sensi­
tization (mole-
cules/HRBC) 
160-250 d 
170-360 
* Number of experiments performed 
b
 Each value represents the lowest amount of unlabeled IgG 
causing more than 20% inhibition m an individual experiment 
c
 Mean and standard deviation is given, and (m brackets) the 
range of values obtained 
d
 Calculated for maximal number of erythrocytes/assay (5 χ 
10') 
(Table I). Anti-glycophorin A antibody sensitized 
HRBC to a much higher degree than anti-rhesus 
D antiserum. Vanations between triplicates, as 
well as variations observed between different sam­
ples (of sensitized HRBC) from one donor, within 
each individual experiment were smaller than 5%. 
Furthermore, when the sensitization of HRBC 
from one batch was measured more than once, the 
variation between the individual experiments was 
less than 10% (for both types of antibody; results 
not shown). It can be observed that the anti-rhesus 
D antiserum gave a low degree of sensitization of 
rhesus D-negative HRBC. Anti-glycophonn A an­
tibody sensitized rhesus D-positive and -negative 
HRBC to a comparable degree. 
A few nanograms of IgG can be delected by 
the radiometric assay (Table II). The minimal 
TABLE 1 
QUANTITATION OF IgG ANTIBODY MOLECULES ON OPTIMALLY SENSITIZED H U M A N ERYTHROCYTES 
Sensitizing antibody Erythrocytes Estimated number of 
IgG antibody molecules/ 
erythrocyte (X 10" 3) 
Anti-glycophonn A monoclonal antibody (murine IgGl) HRBC 16 419 ± 50 (344-493) " 
Anu-rhesus D polyvalent anuseram (human IgGl + IgG3) ' D-posilive HRBC 10 19 ± 3 (17- 26) * 
Anti-rtiesus D polyvalent antiserum (human IgGl + lgG3) D-negauve HRBC 4 2 ± 1 (2- 3) 
1
 Number of expenments performed. 
b
 Mean and standard deviation is given, and (in brackets) the range of values obtained ш individual expenmenls 
c
 Assessed by haemagglulination. 
d
 Rhesus phenotypes of HRBC were ccDEe (two donors), CcDec (five donors), CcDEe (one donor), CCDee (two donors), and ccdee 
(four donors). 
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amount of molecules per cell that can be assayed 
was calculated by dividing the lowest detectable 
amount of IgG by the maximal number of HRBC 
per assay which can be used Table II shows that 
less than 500 molecules of IgG per cell could be 
easily assayed by the radiometric method 
LR monocytes No differences were observed be­
tween HR and LR monocytes with respect to 
human IgG EA rosette formation 
Discussion 
EA resetting using HRBC sensitized by human IgG 
or murine IgGl 
Antibody-coated erythrocytes (EA) can be used 
to detect and quanlitate FcR on cells We used 
HRBC sensitized with human IgG or murine IgGl 
to measure the expression of the FcR for human 
IgG, and the polymorphic FcR for mlgGl, respec­
tively Monocytes of both the HR and the LR 
phenotype were used in these studies When the 
effect of hgand density was studied, sinking dif­
ferences were observed between human IgG-
sensitized and mlgGl-sensitized HRBC (Fig 4) 
Approximately 2700 molecules of human 
IgG/HRBC produced half-maximal roselting with 
human monocytes In contrast, approximately 
85 000 molecules of mlgGl/HRBC were needed 
for half-maximal rosetting with HR monocytes In 
order to get half-maximal rosetting with LR 
monocytes and EA-mlgGl, approximately 165 000 
molecules/cell were needed Apart from the fact 
that twice as many mlgGl molecules/HRBC were 
needed to obtain half-maximal rosetting with LR 
monocytes, compared to HR monocytes, the max­
imal level of rosette formation was also lower for 
t 1 
s-
/ 
- . tA hlsG 
j 
FA mlQG 
/ 
! 
/ J 
— 
HR) 
I B ) 
Fig 4 ЕГГесІ of hgand density on ihe EA-rosette formation of 
human monocytes wilh EA hlgG ( · ) and EA mlgGl Rosei 
ting with EA-mlgGl was investigated for monocytes from 
individuals of both the HR (A) and LR ( Δ ) phenotype 
In this report we describe a very sensitive 
method for the quantitation of surface-bound IgG 
on sensitized erythrocytes The data from the ra­
diometric assay correlated well with im­
munofluorescence measurements The radiometric 
assay was, however, considerably more sensitive 
A few hundred molecules of IgG/cell could be 
detected reproducibly 
Other methods of a similarly high sensitivity 
have been descnbed Dixon et al (1975) described 
a complement lysis inhibition assay for the quanti­
tation of anti-platelet antibodies, which was mod­
ified by Kurlander et al (1978) to study antibody 
binding lo HRBC This technique, however, was 
'cumbersome and not suitable for routine use' 
(Dixon el al, 1975) Smith et al (1970) descnbed 
a techmque for the measurement of immuno­
globulin bound to human lymphocytes, which was 
based on the binding of anti-IgG serum to cells, 
and quantitation of residual binding lo 125I-labeled 
Fab in the same tube Saturated ammonium 
sulphate was used to precipitate '"l-Fab-antibody 
complexes in a one-step assay This procedure was 
very labonous and took at least 3 days Other 
assays based on the consumption of anti-Ig anli-
sera by sensitized cells, and subsequent quantita­
tion by radioimmunoassay were described by 
Rabellmo et al (1971) for the quantitation of 
surface Ig on human lymphocytes, and by 
Jensemus and Williams (1974) for the quantitation 
of rat Ig in detergent lysates of cells All these 
methods are considerably more labonous and time 
consuming than our method and cannot be per­
formed in microtitre plates 
Using the radiometnc assay we found an aver­
age of 19000 molecules of anti-rhesus D antibody 
bound to each HRBC This value is in accordance 
with those obtained by other methods (e g, Kur-
lander el a!, 1978, Jungi and Barandun, 1985) 
Rochna and Hughes-Jones (1965) observed dif­
ferences in D antigen expression between vanous 
phenotypes, although a considerable overlap was 
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found for the more 'common' phenotypes 
Hughes-Jones et al (1971) studied D antigen ex­
pression on 'rare' phenotypes (eg, - D - ) , and 
observed much higher numbers of D antigen sites 
on these cells In this study we have used only 
HRBC of the more general phenotypes, and our 
data correspond very well with those reported by 
Rochna and Hughes-Jones (1965) Most authors 
have reported the degree of erythrocyte sensiti­
zation after subtraction of binding to rhesus D-
negative HRBC Our finding that a small amount 
of anti-rhesus D antiserum binds to rhesus D-
negalive HRBC, is generally observed (and cor­
rected for by subtraction of binding to rhesus 
D-negative HRBC, e g . Kurlander et al, 1978, 
Merry el al, 1982) This nonspecific binding may 
be related to the fact that an alloantiserum was 
used, which presumably was not completely de­
void of other reactivities We feel that it is better 
to give total rather than corrected values for 
erythrocyte sensitization, because all sensitizing 
antibodies are important for interaction with FcR 
Our estimate of the total amount of anti-glyco-
phonn A antibody molecules bound per HRBC 
(approximately 419 000 molecules/ cell) is m 
agreement with the values reported by others 
Marchesi et al (1972) estimated that the total 
amount of glycophonn A molecules/HRBC was 
about 500000 These data indicate that the radio­
metric assay can be used for quantitative measure­
ments Furthermore, it appears that the anti-gly-
cophonn A monoclonal antibody we used is spe­
cial in that it can give an extremely high degree of 
sensitization, without causing agglutination of the 
HRBC Other anti-glycophonn A monoclonal an­
tibodies tested by us, e g . El IB (Ochiai et al, 
1983) were able to sensitize HRBC to about 
200000 molecules/cell but under such conditions 
agglutination was observed When this antibody 
was diluted to a concentration which no longer 
caused agglutination, only 10000 molecules of IgG 
were found to be bound/HRBC, which was too 
low for detection of the mlgGl FcR on human 
monocytes 
Sensitized HRBC can be used to quantilate 
FcR on human monocytes (Van de Winkel et al, 
1987) Our results suggest that large differences 
exist in the affinity of different types of FcR for 
their hgands Rhesus D-positive HRBC sensitized 
with human IgG at less than 3000 molecules/cell, 
yielded half-maximal resetting with human mono­
cytes This value is similar to the one found by 
Kurlander et al (1978) for the phagocytosis of 
anti-rhesus D-sensitizcd HRBC by monocytes At 
least 30 times more murine IgGl molecules/ 
HRBC have to be present for half-maximal reset­
ting with monocytes from HR individuals Al­
though variations in relative antigen mobility may 
underly such differences, surface components in 
the HRBC membrane tend to be immobile (Singer, 
1974) The most likely explanation for these find­
ings is that the affinity of the mlgGl FcR on 
human monocytes for its ligand is very low LR 
monocytes need indicator cells with approximately 
twice as many mlgGl molecules/HRBC for half-
maximal resetting, compared with HR monocytes 
The very high numbers of anti-erythrocyte anti­
body molecules/cell required for roselting with 
mlgGl-coated indicator cells may also explain the 
inability of several authors to detect this type of 
FcR on human monocytes Using sheep erythro­
cytes sensitized with the mlgGl monoclonal anti­
body MAS 014 (Sera-lab, Sussex, U К ) we ob­
served that up to 70000 molecules/cell could be 
detected This degree of sensitization may be too 
low to promote sufficient interaction with the 
mlgGl FcR to result in EA rosette formation 
since we were unable to detect the mlgGl FcR 
using these sensitized sheep erythrocytes (Tax et 
al, 1984) 
In conclusion, we describe a new, sensitive, and 
reproducible method for the detection of antibody 
molecules on sensitized erythrocytes The assay 
can be performed in microtitre plates, is not 
labonous, and the total procedure lakes less than 
20 h We have used this method to analyze the 
degree of sensitization of HRBC which is required 
for EA rosetting to occur Our results show that 
for rosetting a much higher number of murine 
IgGl antibodies must be bound to the surface of 
HRBC compared to the amounts of human IgG 
required This method can also be used for the 
quantitation of antibody binding to other cells 
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SELECTIVE MODULATION OF TWO HUMAN MONOCYTE Fe RECEPTORS FOR 
IgG BY IMMOBILIZED IMMUNE COMPLEXES1 
JAN G. J . VAN DE WINKEL.2 3 HANS L. Ρ VAN DUIJNHOVEN, RENÉ VAN OMMEN, 
PETER J . A. CAPEL,3 AND WIL J . M. TAX 
F r o m t h e Department of Medicine. Uluislon of Nephrology. University Hospital Nljmeqen. Nijmegen. The Netherlands 
Two types of IgG FcR. FcRI and FcRII, are consti-
tutlvely expressed by human monocytes. FcRI (iden-
tified by mAb 32.2) binds human (h) IgG, FcRD (iden-
tified by mAb Г .З) has a low affinity for hlgG but 
interacts strongly with murine (m) IgGl. These re­
ceptors can be assayed by using indicator E sensi­
tized by hlgG (EA-hlgG) or mlgGl (EA-mlgGl), re­
spectively. We further characterized these two FcR 
by modulation studies by using substrate-immobi­
lized immune complexes containing rabbit IgG, goat 
IgG, or one of the mouse Ig c lasses or subclasses. 
After incubating monocytes in microliter wells con­
taining such immune complexes, binding of the two 
types of indicator red cells on the apical surface of 
the monocytes was quantitated using a photometric 
assay employing the pseudoperoxidase activity of 
E. No effect on the binding of sensitized E was ob­
served after incubation of monocytes with immune 
complexes containing mouse IgE, IgA, or IgM, or 
F(ab'b fragments of rabbit IgG. High concentrations 
of immune complexes containing IgG of mouse, rab­
bit. or goat, however, were able to induce a decrease 
in binding of both types of sensitized E, suggestive 
of modulation of both FcRI and FcRII. At lower 
concentrations of immune complexes, more selec­
tive patterns of modulation emerged. Under these 
conditions, immune complexes containing mlgGl or 
mIgG2b, or, surprisingly, goat IgG induced a selec­
tive decrease in the binding of EA-mlgGI (FcRII mod­
ulation), while Immune complexes containing 
mIgG2a or rabbit IgG mainly affected the binding of 
EA-hlgG (FcRI modulation). 
By using anti-FcR mAb Г .З, it was confirmed that 
FcRD was modulated from the apical surface of 
monocytes after incubation on immune complex 
coated substrates. Selectivity of FcR-modulation 
was demonstrated by showing that under these con­
ditions binding of anti-C receptor mAb, and several 
other anti-monocyte mAb did not decrease. 
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Many Important biologic effects are mediated by FcR. 
among which are endocytosls of immune complexes, an­
tibody-dependent cell-mediated cytotoxicity, and the re­
lease of biologically active mediators (reviewed by Morgan 
and Weigle (1 )) For a better understanding of these proc­
esses, a more detailed knowledge of the structure and 
function of FcR. as well as their relation with other cell 
surface receptors is essential 
In the last few years knowledge about human mono­
cyte FcR for IgG has progressed rapidly By analyzing the 
monocyte-dependent Induction of human Τ cell prolifer­
ation by murine antl-CD3 antibodies, the presence of two 
types of FcR was suggested FcRI4 can interact with 
mlgG2a and mlgGS mAb. and proliferation induction is 
inhibited by hlgG FcRII Interacts with mlgGl mAb and 
cannot be inhibited by monomeric hlgG (2-4) More In­
formation about these FcR has been obtained by the 
availability of different monoclonal anti-receptor anti­
bodies FcRI has an approximate M
r
 of 70 kDa and Is 
defined by mAb 32 2, whereas FcRII Ьаь an approximate 
Mf of 40 kDa and is recognized by mAb IV 3 (reviewed by 
Anderson and Looney (5)) Although immunopreclpita-
tion studies clearly suggest that the two FcR are Inde­
pendent structures, this evidence cannot be regarded as 
definite since the detergents used to prepare cell lysates 
might have disturbed an association of these membrane 
Ag 
The relation between different membrane receptors 
can be studied by using Immune complex-coated sub­
strates When monocytes or macrophages are plated on 
a surface containing Immobilized immune complexes. 
FcR specific for the Fc moiety of the antibody involved 
move from the apical surfaces of the cells to the area of 
contact, where they are trapped (6-14) The cells are then 
no longer capable of FcR-medlated binding (and phago­
cytosis) at their apical cell surfaces The relation between 
different cell surface receptors could thus be studied, by 
using both specific probes for the receptors (e g , sensi­
tized E or anti-receptor antibodies), and different types 
of llgands CR and FcR have been shown to modulate 
Independently in this type of study both on human mono­
cytes (7. 9, 10) and on murine macrophages (6, Ö. 14) It 
has furthermore been shown that the two types of CR 
(CRI and CR3) can be modulated independently on hu-
man monocytes (11) For murine macrophages it was 
4
 Abbreviations used In this paper FcRI monocyte 72 kDa receptor 
mediating resett ing with red cells coated by human antl rhesus D IgG 
1-cRll monocyte 40-kOa receptor medlallng rosette formation with inu 
rlne IgGl sensitized E h human m murine CK С rereptorts) HSA 
h u m a n serum albumin HRBC h u m a n E EA antibody sensitized h u m a n 
E 
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shown that the expression of different types of FcR was 
regulated selectively after infection of mice with bacillus 
Calmette GuerIn These In vivo observations were fur 
thermore shown lo correlate with selective modulation 
on substrate Immobilized Immune complexes in vitro 
( 15) For human monocytes similar experiments have not 
yet been described 
In this study we analyzed the speciflclty of the two 
types of FcR for IgG on human monocytes by modulation 
of these receptors by using Immobilized immune com 
plexes containing Ig of different species These hetero 
cytophlllc interactions with human monocytes are as yet 
not well defined and are of Importance for a better un 
derstandlng of the in vivo effects of гпЛЬ or polyclonal 
antibodies which are currently used In clinical therapy 
FcR were detected by using two types of sensltl/ed E LA 
hlgG and FA mlgGl (16 17) EA h IgG binding to mono 
cytes was previously shown to be Inhibited both by mon 
omeric hlgG and by mIgG2a but not by mIgG2b or mlgG 1 
EA mlgGl binding was Inhibited by monomeric mlgGl 
only and not at all by hlgG m IgG 2 a or m IgG 2 b (16) 
Rosettes were quantltaled by using the HRBC associated 
pseudoperoxldase activity by a sensitive photometric 
method (18) 
Our results show that at high llgand concentrations 
the two types of FcR for IgG were modulated together 
whereas at low llgand concentrations selective modula 
tlon for the receptors was found 
MATERIA!^ AND METHODS 
Monocyfes Cytapheresls of healthy volunteers was applied to 
obtain white blood cell suspensions Monocytes were Isolated from 
these suspensions by Percoli (Pharmacia Uppsala Sweden) cenlrlf 
ugallon and counlerflow centri fugai Ion as described before (16) 
Monocyte suspensions consisted for at least 90% of monocytes (eval 
uated In (ytocenlrlfuge preparations after staining for nonspecific 
esterase and with May Grunwald Glemsa) and viability was high 
(>Э % assessed by trypan blue exclusion) Purified monocytes were 
either used Immediately or were cryopreserved (19) and their acces 
sory function was studied In mltogenesls assays (3) With respect to 
mlgGl and mlgG2b polymorphism of monocyte FcH has been de 
scribed (3 4 20) Only monocytes which supported the proliferation 
of human Τ lymphocytes Induced by murine anti CD3 antibodies of 
the IgGl and IgG2a subclasses but not of the IgG2b subclass were 
used for the studies described In this report All experiments pre 
sented In this paper have been performed by using cryopreserved 
monocytes but were repeated at least once using freshly Isolated 
monocytes which yielded similar results 
Antibodies Antl DNP hybrldoma IGLL M (mJRE) (21) was ob 
talned from American Type Culture Collection (Rockvllle MD) An 
(NH b^SO« precipitate of culture supernatant was used In the exper 
Iments Purified myeloma protein MOPC 315 (mlgA) reactive with 
DNP (22) was obtained from Litton Ulonetlcs (Kensington MD) Antl 
DNP mAb MAS 057 (mlgM) (23) was obtained as ascites from Sera 
lab (Sussex UK) Antl DNP mAb D1G10 (mlgGl) and D1B12 
(mIgG2b) were produced in our own laboratory after Immunization 
of BALB/c mice with DNP keyhole limpet hemocyanin and by fusion 
with Sp2/0 cells Culture su per nata π ts of these mAb were used for 
the construction of surface immobilized Immune complexes A rab 
bit hyperimmune antl DNP serum was provided by Dr Lems (De 
partment of Medicine Division of Nephrology Nijmegen The Nelh 
erlands) and the IgG fraction of goat antl DNP hyperimmune serum 
by Dr de Viies (Department of Medicine Division Rheumatology 
Nijmegen) Ascites of myeloma protein 5T2 (mrgC2a) (24) reactive 
with DNP was provided by Dr Radi (TNO Rijswijk The Netherlands) 
and was purified by (NlUbSO« precipitation followed by different 
chromatographic procedures (25) Anil BSA mAb 6007 11 (mlgGl) 
was produced by Dr Van de Broek (Department of Medicine Division 
of Rheumatology Nijmegen) and was used as ascites The IgG frac 
tlon of hyperimmune rabbit anil BSA serum was obtained from 
DAKO (Copenhagen Denmark) and the IgG fraction of hyperlm 
mune goat antl BSA antiserum from Sigma Chemical Co (St Louis 
MO) Antl HSA antibodies produced in rabbits were obtained as 
purified whole IgG and as P(ab Ь fragments from Cappel (Malvern 
PA) Purified antibodies (and antibody fragments) were analyzed by 
Immunnelectrophoresis and double diffusion In agarose No residual 
antibodies of a contaminating (subclass could be detected (i e more 
than 99 9% pure) The antlbodv classes and subclasses were further 
ι on firmed by an Fl ISA (26) by using (siib)class spet if le antibodies 
from both Nordic (Tilburg The Netherlands) and Meloy (Springfield 
VA) 
A mlgGl antl human glycophorln A mAb was used to senbltl/r 
HRBC (4) The hybrldoma producing this antibody was provided by 
M Bos (CLI3 Amsterdam The Netherlands) To sensitize the HRBC 
with human IgG we used a human alloantlserum against rhesus D 
obtained from Merz & Dade (Dudlngen Switzerland) 
mAb OKM1 directed against CR3 (27) and OKM5 against mem 
brane Ag ρθθ (28) were obtained from Ortho Diagnostics (Rarllan 
NJ] mAb antl Leu M3 against a monocyte/macrophage specific Ag 
p55 (Clone MtfP 9) (29) antl Leu M5 reaitlng with pl50 95 (30) and 
antl CRI (Clone 44D) (31) were obtained from Becton Dickinson 
(Mountain View CA) Culture supernatanl of mAb IV 3 (antl 40 kDa 
FrR) (17) was a generous gift of Dr Clark Anderson (Ohio State 
University Columbus OH) 
/mmobíJizaííon of immune complexes Flat bottomed mlcrotlter 
plates [Costar Cambridge MA) were supplemented with 100 μ] of 
either BSA (Cohn fraction V Sigma) BSA DNP(Calblochem Behring 
La Jolla CA) or HSA (Merleux Lyon France) diluted In PBS to 
concentrations varying from 0 1 »ig/ml to 1 mg/ml and Incubated 
overnight at 40C After three washes cither 100 μΐ PBS (control) or 
100 μϊ of a saturating concentration of antibody were added to each 
well for 1 h at room temperature After incubation the plates were 
washed thrice and were used immediately 
Saturating concentrations of antibodies were determined In a 
sensitive ELISA (26) by using high concentrations of coated Ag (0 5 
to 1 0 mg/ml) The saturating concentrations were routinely used 
except for some experiments in which the degree of substrate sen 
sltlzatlon was varied (see Results) Furthermore at these concentra 
tlons no contaminating Ig of another (sub)class could be delected by 
FLISA by using (subclass specific antibodies (26) in any of the 
antibody preparations Culture supernatants of hybrldomas were 
used when available Otherwise we used either ascites or purified Ig 
which yielded similar results 
Sensitizar ion of E Sensitization of HRBC was performed as we 
described before (1Θ) Briefly 0 5% suspensions of HRBC were In 
cubaled with serial dilutions of antl HRBC antibodies (or as a control 
for nonspecific binding with PBS alone) for 30 mm at 37*C After 
Incubation sensitized (and as a control unsensltlzed) HRBC were 
washed resuspended at 0 5% In RPMI ]640contalnlng5% FCS and 
used within 30 min 
Ouandíattue EA rosette assai/ Control or Immune complex 
coated mlcrotlter wells were supplemented with 100 μϊ of monocyte 
suspensions (4 x 10" cells/ml In RPMI 1640 with 10% FCS) and 
incubated for 90 min at 37eC After incubation nonadherent cells 
were washed away and FcR expression was determined on monocyte 
monolayers as we described before (16) Briefly sensitized HRBC 
were dispensed Into the mlcrotlter plates and Incubated for 1 h at 
40C The extent of EA rose« Ing was quant Rated by using the E 
associated pseudoperoxldase activity measured photometrically at 
450 nm A binding index was calculated for each expcrlmenl (to 
correct for variation In background absorbancc values) as follows 
(1 - (Емо/ЕАде)] x 100 - binding Index 
E4SO Extinction at 450 nm in wells to which HRBC mtihout sensi 
tlzlng antibody were added 
ЕЛ««, Extinction at 450 nm In wells to which sensitized HRBC 
were added 
Previously we demonstrated the Fc dependency of EA resetting 
by showing that HRBC sensitized with (high concentrations) of 
Ffab lì fragments of antl glycophorln A antibody did not cause a 
positive signal In the photometric assay ( 1 ) The HRBC suspensions 
sensitized with different dilutions of antl sera were always tested In 
duplicate duplicate values deviated less than 10% 
ELISA Jor monocyte membrane Ag Monocytes (4 к IO5 cells/ 
well) were Incubated for 30 min at 370C In mlcrotlter plates which 
had been previously coated first with BSA ( 10 «ig/ml) then with poly 
L lysine (Sigma 100 *ig/ml) and finally with either rabbil anti BSA 
IgG or PBS (as a control) Afler centrifugal ion (5 min at 200 x g) the 
cells were fixed In 0 025% glularaldehyde (20 min at room temper 
ature) washed by vertical Immersion In warm PBS (370C) and to 
avoid nonspecific binding the plates were coaled with a 1 % solution 
of gelatin (Dlfco Laboratories Detroit Ml) In PBS (1 h at 37BC) After 
washing saturating amounts of mAb were added to duplicate wells 
and incubated (45 min at 37eC) After incubation and washing 
peroxidase conjugated goat anti mouse L and H chain antibodies 
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(Nordic Tilburg the Netherlands) were added and Incubated for 45 
min at З/'С The plates were washed and the amount of bound 
antlbodlcb was quantitated by adding a substrate solution containing 
5'-amlnosallcyllc acid [26) and after 30 min the extinction was 
determined at 450 nm In a Tltertek Mulllscan 
RESULTS 
incubation of monoeyíes tDÍth ímmobííízed immune 
complexes can affect the binding of sensitized HRBC 
FcRl and FcRH can be independently detected by EA-
rosettlng by using ΕΛ-hIgG or EA-mlgGI. respectively 
(16). When monocytes were incubated in microtiter wells 
containing a high concentration of Immune complexes of 
HSA and rabbit IgG anti-HSA, the binding of both EA-
hlgG and EA-mlgGI indicator cells (sensitized with dif­
ferent amounts of antibodies) was strongly decreased In 
comparison to monocytes incubated in wells containing 
only HSA No such decrease in EA-rosettlng was ohserved 
when F(ab')2 fragments of rabbit anti-HSA IgG were used 
(Fig 1) These findings suggest that the diminution in 
binding of sensitized HRBC is dependent on interaction 
of monocytes with the Fc-molety of IgG in Immune com­
plexes. This conclusion was supported by the experi­
ments summarized in Table I The extent of indicator 
HRBC binding Is presented here only at one (maximal) 
level of HRBC sensitization (1 е.. at the edge of binding-
plateau) and Ag were coated by using a concentration of 
100 Mg/ml The table shows that no decrease in binding 
of sensitized HRBC was observed when monocytes were 
plated In immune complex-coated wells containing either 
mlgE. mlgA, or mlgM Similar results were obtained with 
higher concentrations (>100 /ig/ml) of coated Ag (results 
not shown) Monocyte monolayers which had been Incu­
bated on Immune complex-coated substrates containing 
any of the murine IgG subclasses, displayed a decreased 
binding of both types of indicator cells A similar de­
creased binding was observed for Immune complexes 
containing different rabbit or goat IgG antibodies These 
data Indicate that, when Immobilized Immune complexes 
were present In high concentrations, both types of FcR 
apparently had a similar pattern of reactivity 
Incubation of monocytes with immobilized immune 
complexes selectively affects FcR expression We next 
studied whether the Incubation of monocytes with im­
mobilized immune complexes Indeed affects the expres­
sion of FcR, and furthermore, whether this effect is 
specific or Involves nonspecific co-modulation of mono­
cyte membrane Ag For this purpose, we used a panel of 
mAb. Including m Ab IV 3. which Is directed against FcRII 
on human monocytes (17), and which we previously 
found to Inhibit EA-rosetting between these cells and EA-
mlgGl for over 80%. whereas EA-rosettlng with EA-hlgG 
remained unaffected (16) Table Π shows that by incu­
bating human monocytes on rabbit anti-BSA IgG contain­
ing Immune complex-coated substrates, binding of mAb 
IV 3 decreased by about 50% In parallel experiments we 
observed (under identical conditions) a decrease of ap­
proximately 70% In binding of both types of indicator 
cells to the monocytes This reduction Is presumably due 
to the modulation of FcR from the apical surface of 
monocytes to the substrate-adherent part of their mem­
brane, as was also shown in the murine system (12 14) 
Another mAb, 32.2 (32) directed against FcRI on human 
monocytes (generously provided by Dr Clark Anderson. 
Ohio State University), was also tested but yielded too low 
a signal in our assay system and could not be used for 
these studies The results in Tabic II show that interac­
tion of monocytes with Immune complex-coated surfaces 
does not Induce redtslrlbution of unrelated monocyte 
membrane proteins CRI and CR3 on human monocytes 
did not co-modulate with FcRII. nor did the monocyte 
membrane Ag detected by antl-Leu-M5 (p 150.95). anti-
Leu-M3 (p 55), and OKM5 (ρ Θ8) 
Effect of Ugand concentration on modulation of FcR. 
Both for human (9, 10) and murine (6. 12) monocytes/ 
macrophages the extent of FcR modulation Is clearly 
dependent on the amount of substrate-Immobilized im­
mune complexes At high concentrations of Immune com­
plexes (Ag coaling at 100 Mg/ml or more), no selective 
effect on the modulation of the two FcR was observed 
When the concentration of Ag (and therefore the amount 
of Immune complexes) was lowered, however, selective 
patterns of modulation emerged, as Is Illustrated In Fig­
ure 2 for the mlgG2a mAb 5T2 The amount of DNP-BSA 
used for coating was varied (100 Mg. 5 Mg or 0 5 Mg/ml) 
and subsequently a saturating amount of the antl-DNP 
antibody was added At lower immune complex concen­
trations. FcRI was gradually modulated more strongly 
than FcRII When Ag was coated at a fixed concentration 
of 10 Mg/ml and the amount of complexlng anti-DNP mAb 
was varied, similar results were obtained (data not 
shown). 
When mAb of three different murine IgÇ Isotypes were 
tested in modulation studies at varying Ag concentra-
tions, two different patterns were observed as Is shown 
In Figure 3 The extent of Indicator HRBC binding Is 
presented only at a maximal level of HRBC-sensitizatlon. 
Dind.ng mdex 
Figure I Modulation of cwo types oí FcR on 
human monorytes by surfact-bound Immune 
complexes Monorytrn were cultured In microti-
ter wells coaled with HSA only (100Mft/ml O) or 
In wells coated with HSA and subsequently In-
cubated with a saturating amount of either 
F(ab'b fragments [A] or whole IgG (·) of rabbit 
antl-HSA antibody After Incubation the expres-
sion of FcR was assayed photometrically by using 
EA-hlgG [A] or EA m IgG I (B) sensitized a( dif-
ferent dilutions of antibodies Results are repre-
sentative for three experiments 
fc
~-=i= 
^k. 
• ^ 
16 64 256 1 0 2 Ί 
гроргссаі dilution ol питап IgG reciprocal dilution o* mur лр IgOi 
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TAHLL I 
Binding oj s rnstf tzcd Ь io monot yíes incubai ed on dllferent immune 
complex coa ted substrateч" 
SiitmtriilcC.Mird w 
Inimunr lomplFN 
[ISA DNPf lGFLMI" 
H.SA DNPIMOPC G l i l 
RSA DNP (MAS OS7I 
BSA DNI' [5T2) 
ІІЬА I ) N P ( D i n i 2 ] 
KSA U N P p i O l O ) 
BSA (6007 1 1 ) 
BbA (rahbll anil DSA) 
KSA »ЧР (гаЬЫІ anil DNP| 
BSA [Roal ami 1ISA] 
BSA DNP (fioat antl DNP) 
i h 
ІвсІаед/^іЬеІаяя 
mIgE 
mlRA 
mlfiM 
mlp,C2a 
mlB02B 
mlßCl 
mlBGI 
rlRG" 
rlRC 
RlEO-
eigc 
BIndlneorVnslil/rd 
ННВГ 
(% ol Conlroli 
LA hl|ïG 
102 ± 2 ' 
96 ± 13 
95 ± I I 
5t i 
22 ± 11 
28 ± 11 
17 ± 11 
1 ± 5 
13± 12 
15± 11 
11 ± « 
FA mlgUl 
91 =S 
101 * 2 
102 ± 2 
β ± 11 
4 + 5 
20 ± 3 
1 7 ± 5 
11 ± 8 
20 ± 5 
4 t S 
β ± 7 
"Monix-ytes w t r e Inruhated In mlcrotltrr wells coaled with BSA or 
BSA DNP (10O »Jf4/ml| only (control welW) or In welU which had been 
coaled with HSA/BSA DNP and subsequently Incubateti with a n optimal 
con re m Mt Ion oí the Indicated antibodies ( immune complex wells) After 
incubation ihe binding of different Indirator HRBC was quantt iated by 
using their pseudoperoxldase arllvlly a s described In Maferiois a n d 
Methods The results are expressed a s percent ol control binding calcu 
lalcd by the following formula 
[I- A^v) [Immune complex) F«» (Immune complex)] EA.vi (control) - Ε,ν, (control) J x 100 
* Substrate coaling wllh thr antibody name In parenthèses 
' Results represent Ihe mean ± SD of three or more Individual expert 
ment s 
• г - rabbit 
' f t - g o a t 
TABLE II 
/mmobilized i m m u n e rompiejres decrease the expression of monocyte 
Ft H but not of other membrane proteins" 
m A b 
I V I 
Anil CRI 
OKM1 
Anil L i u M5 
Antl l.eii 
OKM5 
M l 
A« 
FcRII 
C R I 
Г И З 
p l S O 95 
ρ 55 
ρ β β 
Relativa Ag ЕяргаэЮп 
0 54 ± 0 09 (б)-
I 22 ± 0 35 (6) 
I 09 ± 0 11 |6| 
1 09 ± 0 17 [б] 
1 03 ± 0 Οβ (3) 
Ι 02 ± 0 18 |6) 
"Microliter piales were coated with 10 ng/ml BSA followed bv PBS 
(control) or rabbit antl BSA IgG (Immobilized Immune complex) Mono· 
cyles were Incubated a n d binding of the indicated mAb was assayed by 
FUSA as described In Materiate a n d Methods 
* Results represent the ratio of the FUSA signal obtained with mono­
cytes lhat had been incubated with immobilized Immune complexes 
relative to Ihe signal from monocytes Incubated In Ihe control wells 
Experiments were performed In duplicate wells a n d the mean ± SD of 
three to six experiments (as Indlcalrd In parentheses) is given 
as In Table I An essential difference between Table 1 and 
Figure 3 Is the concentration of immune complexes at 
which the experiments were performed a high Ag con­
centration ( 100 Mg/ml) for Table I, and low concentrations 
(0 5 to 1 μβ/m 1) for Figure 3 As was also shown In Figure 
2 at low Ag concentrations mIgG2a mAb 5T2 reproduc-
Ibly modulated FcRI stronger than FcRII A different 
pattern was found for mlgGl mAb D1G10, which shows 
greater selectivity for the FcR assayed by EA-mlgGl 
(FcRII) Comparable results were obtained with a mlgGl 
mAb with reactivity for BSA This mAb (6007-11) mod­
ulated FcRII by 51% (mean of three experiments). 
whereas FcRI was not modulated at low Ag concentra­
tions By using mAb D1BI2 (mIgG2b). FcRI was modu­
lated by approximately 40%, whereas under the same 
conditions FcRII disappeared almost completely (for 
about 97%. Fig 3), indicating that m IgG 2 b antibodies 
interact preferentially with FcRII (as was also found for 
mlgGl) 
Two modulation patterns were observed when the ef-
IqG (.4J*: 
Figure 2 Effect of substrate eenelUzallon on modulation of FcR on 
h u m a n monocytes Monocytes were Incubated In microliter wells coated 
with DNP BSA only (O) in concentrat ions of 100 (ig/ml (A S] 5 Mg/ml (C 
П) orO Sjift/ml (fc F) or In wells coated with BSA DNP and subsequently ' 
Incubated wllh mlgC2a antl DNP mAb (5T2 · ) After Incubation FcR 
expression was determined by using ΕΛ hlgG (А С E) or EA mlgGl (B 
D F) as Indicator cells In the photometric assay Results are representa 
tlve for four experiments 
fects of rabbit and goat IgG In Immune complex form 
were evaluated (Fig 4) Rabbit IgG antl BSA selectively 
modulated FcRI Similar results were obtained by using 
a rabbit antl-BSA-DNP antibody which modulated FcRI 
by 48% (mean of four experiments), whereas FcRII re­
mained unaffected By contrast, goat IgG antl-BSA, re-
produclbly affected the binding of EA-mlgG 1 (FcRII) more 
strongly than the binding of EA hlgG (FcRI) This effect 
was also observed when a goat antl-BSA DNP antibody 
was tested (63% modulation of EA-mlgGl binding, and 
no modulation of FcRI mean of three experiments) 
Our results Illustrate that not only the degree of FcR-
modulatlon was strictly dependent on the amount of 
substrate-І m mobilized immune complexes, but that this 
parameter had also an Important effect on the apparent 
selectivity of modulation of FcR on human monocytes 
Human monocytes constltutlvely possess two types of 
FcR for IgG. FcRI and FcRII (reviewed by Anderson and 
Looney (5)) These receptors can be studied in rosette 
assays by using EA-hlgG and EA mlgGl. respectively, as 
Indicator cells (16 17) We have previously shown that 
at least 30 times more mlgGl molecules than hlgG mol­
ecules have to be present per erythrocyte for half-maxi­
mal resetting to occur with monocytes which suggest 
that there Is a large difference In affinity between the 
two types of FcR (33) Previous studies on the Inhibition 
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•/o of control binding • 
F i g u r e s FfOcl of subs t ra te Immobilized Im 
muñe complexes containing different murine IgG 
subclasses on the modulation ol FcR on human 
monocytes Monocytes were Incubated in wells 
coated with DNP IK>A only (control) or In wells 
which had been coated with DNP BSA and sub 
sequen!lv with either mlgGZa mAb (ST2 DNP 
BSA 05jig/mlJ т | д С 2 Ь т А Ь ( Ш В 1 2 DNP BSA 
0 5 nft/ml) or mlgGL mAb (D1G10 DNP OSA 1 
tig/ml) Control wells had been coated u l l h DNP 
BSAatO 5μ£/ΐη1 0 5 л й / т І a n d l (ig/ml гечрес 
lively Binding of 1Ш13С sen sinceri with either 
h IgG [A) or mlgGl (Я| was. quant l tated using the 
photometric assay Results are expressed ач per 
cent of control binding a s described In Table I 
T h e m e a n s ± SD of three Individual exper iments 
a r c presented 
100· 
80-
60-
40-
20-
7ZZ 
Ï 
τ 
л 
JL 
'ê-
m г^Ч 
тідбго тІдОго m IgG ι m IgG го тІдСгь mlgGi 
*fù of control binding 
Figure 4 ЕГГегІ of rabbit a n d goat IgG In sur 
face bound Immune complexes on the modulation 
of FcR on h u m a n monocytes Monocytes were In­
cubated In wells coated with BSA only (control) or 
in wells which had been coated with BSA a n d 
subsequently with either rabbit IgG anil BSA (BSA 
0 1 fig/ml) or goal IgG a n t i BSA (BSA 10 μ£/τπ| | 
Control wells had been coated with BSA at 0 1 jig/ 
i n l a n d Ι Ομβ/πιΙ respectively Binding of fc A hlgQ 
(A) and EA mlgGl (fl) was quant l ta ted phutomelr · 
Ically Results are expressed a s percent of control 
binding a s described In Table I Results show the 
mean ± SD of three Individual exper iments 
anti-BSA 
of resetting by monomelic Ig and anti-FcR mAb (16. 17) 
have suggested that the two FcR are Independent In the 
present study we Investigated the specificity of the dif­
ferent FcR for Ig of different species by using modulation 
of FcR by immobilized Immune complexes containing a 
defined (sub)class of Ig 
When we plated human monocytes In immune com­
plex-coated microliter plates containing relatively high 
concentrations of immune complexes, binding of both 
EA-hlgG and EA-mlgGl was virtually abolished This 
effect was only observed In plates coated with IgG-con­
taining immune complexes, and was dependent on the 
presence of the Fc-moiety since immune complexes con­
taining Ffab'Ja fragments were Ineffective Furthermore, 
when monocytes were Incubated with Immune complexes 
containing either mlgA, mlgE. or mlgM antibodies, rosette 
formation was not affected Since receptors for IgE (34), 
IgA (35). and IgM (36) have previously been described on 
human monocytes, these results indicate that the binding 
sites of these Ig are located on structures different from 
those for IgG The existence of different FcR for the 
various classes of Ig as Independent structures was pre­
viously also suggested by Inhibition studies performed 
with both murine macrophages (37) and human mono­
cytes (34-36) 
The Incubation of monocytes with immobilized im 
muñe complexes Induced a decrease in binding of antl-
FcRII mAb IV 3 as shown in Table 11. although the de-
crease In binding of this mAb was less as compared with 
the decrease in binding of EA-mlgGl in parallel experi-
ments Similar results have been described in the mouse 
macrophage model by using mAb 2 4G2 (12-14) As dis-
cussed by Michl et al (13) anti-FcR antibodies may have 
access to FcR at sites that are no longer accessible to 
sensitized erythrocytes The decreased binding of mAb 
IV 3 In our model supports the concept that modulation 
of FcR is indeed responsible for the observed decrease In 
binding of sensitized E A shift of FcR from the apical 
site to the substrate-adherent part of the cells during 
incubation on immobilized Immune complexes Is the 
most likely explanation for this type of modulation (Θ, 
12-14) Although anti-FcR mAb have been frequently 
used for modulation studies, Michl et al (13) showed that 
several processes may contribute to decreased binding of 
anti-FcR mAb and concluded that "only E (IgG) binding 
provides an accurate assessment of the rate of FcR re­
moval from macrophages' upper surface " Our experi­
ments also indicate that Incubation of monocytes on 
immobilized immune complexes did not cause a general 
redistribution of membrane antigens FcRII was modu­
lated independently of both types of CR on human mono­
cytes. as has been described previously also for FcRI (7, 
9. 10) The experimental findings are most likely ex­
plained by a random movement of FcR within the mem­
brane of monocytes, and the effect of substrate-adherent 
Immune complexes is the trapping of FcR diffusing into 
61 
S E L E C T I V E M O D U L A T I O N O F HUMAN M O N O C Y T E F c R F O R IgG 
the segment of the plasma membrane, which Is in contact 
with the substrate 
Because a stoichiometric relationship between the 
number of IgG molecules bound to Immobilized Ag and 
the extent of FcR-modulation was observed for murine 
macrophages ( 12). we studied the effect of this parameter 
in our system By varying the amount of coated Ag, the 
concentration of immobilized immune complexes could 
be manipulated Different patterns of modulation were 
revealed for the various types of Ig. when modulation was 
studied on immune complex-coated substrates contain­
ing different amounts of llgands At low concentrations 
of Immune complexes, antibodies of the m IgG 2a Isotype 
selectively modulated FcRI, and Immune complexes con­
taining mlgGl or mIgG2b showed selectivity for FcRII 
Immune complexes containing mIgG2b, however, also 
modulated FcRI to a significant extent (at low Ag concen­
trations) Comparable results have been obtained by Eze-
kowitz et al (15) studying mouse macrophages, who re­
ported that Incubation of macrophages with substrate-
Immobilized immune complexes containing mIgG2b 
strongly inhibited the binding of mIgG2b-sensitlzed К but 
also had a significant inhibitory effect on the binding of 
mlgG2a-sensitized E Rabbit IgG exhibited specificity for 
FcRI in the modulation experiments, whereas goat IgG 
was surprisingly found to modulate FcRII to a greater 
extent than FcRI. 
All the data in this work can be explained by assuming 
that both types of FcR have affinity for all of the IgG 
llgands we tested Another assumption which also has to 
be made Is that differences in affinity exist between the 
two FcR Each FcR will display the highest affinity for 
the homologous ligand. and a much lower affinity for 
heterologous llgands Experimental evidence to support 
this hypothesis has been described for both murine mac­
rophages (3Θ, 39) and human cells of monocyte/macro­
phage origin (40) With the human monocytic cell line 
U937. binding of two types of llgands (mlgG2a and aggre­
gated mlgG2b) was Inhibited 30 to 135 times more effi­
ciently by the homologous ligand than by the heterolo­
gous one (40) On the basis of these results, of studies 
with anti-FcRII mAb IV.3, and of experiments studying 
trypsin sensitivity of binding, Jones et al (40) proposed 
two different FcR for IgG on human monocytic cells In 
our opinion, the observed cross-reactivities can only be 
explained by extensive homologies between the different 
types of llgands Strong homologies have Indeed been 
described for the different murine IgG subclasses (41, 
42) Extensive homology was also found between rabbit 
and mouse CHf fragments (14) 
As a consequence of the high affinity of FcR for im­
mune complex-coated substrates these cross-reactlvlties 
arc amplified and cause the observed co-modulation of 
the two types of FcR at relatively high concentrations of 
Immobilized Immune complexes. Differences In the con­
centration of immobilized Immune complexes may also 
explain (he conflicting results which have been reported 
for FcR-modulation on murine macrophages Sung (14) 
reported receptor co-modulation on macrophages plated 
on different Ag-antlbody complexes, whereas Ezekowitz 
et al (15) clearly demonstrated selective modulation of 
FcR on murine macrophages 
An efficient interaction of murine IgG2b antibodies 
with human monocyte FcR has previously been reported 
to be absent both when binding of monomerlc and poly­
meric forms were tested (16. 40. 43). Only under condi­
tions of low Ionic strength a significant m[gG2b aggregate 
binding to FcRII on human cell lines was observed (40) 
Our results support those of Jones et al. (40). and fur­
thermore accentuate the high affinity of FcR for Ag-
bound IgG Whether the interaction observed between 
FcRII and mIgG2b-contalnlng immune complexes Is am­
plified by changes In ionic strength of the medium under 
the conditions employed is not known However, since 
FcR have previously been shown to mediate Ion channel 
activity (44), the concentration of FcR at the substrate-
adherent part of the monocytes Is probably high and the 
volume of the membrane-substrate Interface very small, 
this possibility may not be too farfetched. 
An efficient interaction between Fc and FcR under 
these conditions was also suggested by the observed de­
crease in binding*of the two types of Indicator HRBC by 
monocytes Incubated on Immune complexes containing 
goat IgG. since goat IgG in monomerlc form interacts very 
poorly with human monocyte FcR (45) Furthermore, 
when modulation of FcR was studied on substrates, 
coated with goat IgG in a non-Ag specific way, no effects 
were found (46) In both these studies only FcRI was 
assayed The observed preference of goat IgG for FcRII 
was also found for immune complexes containing poly­
clonal rat IgG (results not shown). This Indicates that 
FcRII does not Interact exclusively with mlgGl antibod­
ies. The Isotype(s) of rat IgG mediating the interaction 
with FcRII are currently studied in our laboratory by 
using different rat mAb 
In conclusion, we demonstrate here that the two types 
of FcR for IgG on human monocytes can be modulated 
selerlively on substrate-Immobilized immune complexes. 
The pattern of modulation was found to be critically 
dependent, both on the type of Immobilized ligand. and 
on the amount of immobilized Immune complexes We 
furthermore conclude that the two FcR are Independent 
from each other (and from CR). FcRI Interacts primarily 
with h IgG and cross-reacts with m IgG 2a, FcRII has a low 
affinity for monomerlc h IgG but interacts strongly with 
mlgGl. Both types of receptors also appear to have affin­
ity. although much lower, for other (sub)classes of IgG. 
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CHAPTER 6 
ACTIVITY OF TWO TYPES OF Fc RECEPTORS, FcyRl AND FcyRII, IN HUMAN 
MONOCYTE CYTOTOXICITY TO SENSITIZED ERYTHROCYTES 
Jan G.J. van de Winkel, Ger J.J.C. Boonen, Peter L.W. Janssen, 
Arjen Vlug, Nancy Hogg, and Wil J.M. Tax 
Scandinavian Journal of Immunology: in press 
SUMMARY 
Human monocytes constitutively express two types of Fc receptors 
for IgG, FcyRI and FcyRII. FcyRI has a high affinity for human IgG, 
whereas FcyRII interacts poorly with human IgG, but cross-reacts 
with mouse IgGI. Previous studies showed furthermore that FcyRII is 
polymorphic. Monocytes from different individuals can either have a 
high, or weak interaction with mouse IgG1 (high-, respectively 
low-responder individuals; Ш or LR). 
We have investigated the cytotoxicity of human monocytes to two 
types of sensitized erythrocytes. Erythrocytes sensitized with hu­
man IgG (EA-human IgG) were used to assay FcyRI function, and ery­
throcytes sensitized with mouse IgG1 (EA-mouse IgG1 ) were used to 
assay FcyRII. Both types of FcyR were observed to mediate ADCC, 
which was further characterized by using different monoclonal 
anti-FcyR antibodies and monomenc IgG's. Lysis of EA-human IgG was 
inhibited by both monomenc human IgG and mouse IgGZa in a dose-de­
pendent way and also by anti-FcyRI mAb 10.1. Cytolysis of EA-mouse 
IgGI was inhibited by monomenc mouse IgG1 and by two anti-FcyRII 
mAb, IV.3 and CIKM5. Antibodies of the mouse IgG2b isotype affected 
neither type of ADCC. The effectivity of cytotoxicity mediated by 
either of the FcyR was studied using targets sensitized with a ca­
librated number of IgG molecules, and was found to differ dramati­
cally. At least 20 times more IgG molecules per target cell were 
necessary to obtain half-maximal cytotoxicity mediated by FcyRII 
than for FcyRI-mediated cytolysis. Furthermore, HR monocytes were 
more effective than LR monocytes in mediating FcyRII-dependent cy­
totoxicity. These studies demonstrate that FcyRII can mediate ADCC, 
although a higher degree of target cell sensitization is reguired 
than for FcyRI-mediated ADCC. 
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1. INTRODUCTION 
Unstimulated human monocytes express two types of receptors for the 
Fc moiety of IgG (FcyR). The first type, FcyRI, has an approximate 
molecular weight of 70 kDa and binds human IgG as well as mouse 
IgG2a and rabbit IgG with high affinity. FcyRII has an approximate 
molecular weight of 40 kDa, interacts poorly with aggregated human 
IgG, has no detectable affinity for monomenc human IgG, and cross-
reacts with mouse IgG1 (reviewed in 1,2). Differences in structure 
and cellular distribution of the two receptors were demonstrated 
- inter alia - by mAb with reactivity for either FcyRI (3,4), or 
FcyRII (5,6). Furthermore, it has recently been shown that the two 
types of FcyR can be modulated independently from each other (7). 
Both FcyR were previously analyzed in detail in Τ cell prolifera­
tion experiments, in which FcyR on monocytes are reguired to sup­
port anti-CD3 induced Τ cell proliferation. Monocytes from essen­
tially all donors were observed to mediate interactions with mouse 
(m) IgG2a antibodies (FcyRI-mediated (1,4,8)). Monocytes of some 
donors (about 30% of Caucasian individuals) were observed to be un­
able to support anti-CD3 induced Τ cell proliferation by mlgd mAb 
(low-responder individuals; LR). Monocytes of the other individuals 
(high-responders; HR) were found to support induction of Τ cell mi-
togenesis by mlgGI mAb effectively (8,9). This polymorphism has 
been attributed to FcyRII on monocytes (9), is genetically deter­
mined, and results from structural differences in FcyRII of HR and 
LR monocytes (10). Further functional studies analyzing both FcyRI 
and II have been scarce, although it has been shown that both re­
ceptors are involved in superoxide production (3). 
Antibody-dependent cell-mediated cytotoxicity (ADCC) is a poten­
tially important immune defense mechanism (11). Until now, most 
studies have analyzed the function of FcyRI in ADCC with human mo­
nocytes as effector cells. Efficient cytotoxicity to erythrocytes 
coated with different human (12,13) or rabbit (14) antibodies has 
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been reported, indicating that FcyRI is able to mediate cytotoxici-
ty. This was also suggested by studies of Koprowski and colleagues, 
who analyzed the cytotoxicity of human monocytes to various tumour 
targets sensitized with different mouse mAb. These authors general-
ly found that only mlgGZa mAb, and not mAb of other isotypes (e.g. 
mlgGI, mIgG2b) were effective (15-17). These studies suggested that 
FcyRII could not function as a trigger molecule in monocyte-mediat-
ed cytotoxicity. 
We analyzed the cytotoxicity of human monocytes to sensitized ery-
throcytes, both as a model of cellular cytotoxicity and because of 
its possible relevance for diseases such as autoimmune haemolytic 
anemia (12,13). Two types of target cells were used, HRBC sensitiz-
ed with human IgG (EA-human IgG), or with mouse IgG1 (EA-mouse 
IgG1), which were previously found to interact with FcyRI or 
FcyRII, respectively (5,18). Both types of FcyR were found to me-
diate cytotoxicity but their efficiency was different. Furthermore, 
we observed differences in FcyRII-mediated cytolysis of targets be-
tween HR and LR individuals. 
2. MATERIALS AND METHODS 
2.1. Monocytes. 
White blood cell suspensions were obtained by cytapheresis of heal-
thy volunteers. Monocytes were isolated from these suspensions by 
Percoli (Pharmacia, Uppsala, Sweden) centrifugation and elutnation 
as described before (19). Monocyte fractions consisted for at least 
90% of monocytes (evaluated in cytocentnfuge preparations after 
staining for non-specific esterase and with May-Grünwald-Giemsa), 
and viability was more than 9855, as assessed by trypan blue exclu-
sion. Since monocytes from different individuals show functional 
variability we considered it advantageous to have fixed and well-
defined batches of these cells. The purified monocytes were there-
fore cryopreserved (20) and used later. Both recovery and viability 
of cryopreserved monocytes were excellent (> 70л and > 95%, respec­
tively). All experiments presented in this report were repeated at 
least once using freshly isolated monocytes, which yielded similar 
results. 
2.2. Anti-FcyR monoclonal ant ibodies. 
The receptors involved in the cytotoxicity of monocytes to sensi­
tized erythrocytes were characterized by using different anti-FcyR 
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monoclonal antibodies. The anti-FcyRI antibody used was mAb 10.1 
(4), whereas anti-FcyRII antibodies employed were mAb IV.3 (5) ob-
tained from Clark Anderson, and mAb CIKM5 (6), a kind gift from 
Glenn Pilkington. 
2.3. Ig preparations. 
For the characterization of monocyte FcyR involved in ADCC to HRBC, 
and for quantitation of the number of IgG molecules on the target 
cells, we used the following Ig preparations. The mouse mAb used 
were PA1 (IgGI antibody against idiotypic determinant on B-CLL 
cells, produced by Frank Preyers, Nijmegen), 3-1-3-1 (IgG2b anti-
mouse H-2 determinant)(21), and 2-2-1 (IgG2a anti-mouse la determi-
nant)^!). These antibodies were purified from ascites fluid by 
(NHif^SOi! precipitation, followed by different chromatographic pro-
cedures (22). No residual antibodies of a contaminating subclass 
could be detected by double diffusion in agarose (i.e. more than 
99.9% pure). In some experiments we used human IgG, which was puri-
fied from human serum by ammonium sulphate precipitation and DEAE-
Sephadex (Pharmacia, Uppsala, Sweden) chromatography. The final 
preparation of human IgG was checked for impurities and IgG content 
in Immunoelectrophoresis and radial immunodiffusion, and appeared 
99.9% pure. 
After isolation, all fractions were depleted of aggregates by ul-
tracentrifugation (1 h at 100,000 g, ¿PC), and the protein concen-
trations were determined by the method described by Bradford et 
al. (23) using bovine gamma globulin (Bio-Rad, Munich, F.R.G.) as a 
standard. The proteins were rapidly snap-frozen in small aliquots 
in liquid nitrogen, stored at -20PC and thawed once, just before 
their use in the experiments. 
2.4. Τ cell proliferation assay 
The accessory function of monocytes in anti-CD3 induced Τ cell pro­
liferation was studied for all donors as described before (8). 
Anti-CD3 mAb used were WT32 (mIgG2a)(24), and UCHT1 (rnlgd) (25), 
a kind gift of Peter Beverley (London, U.K.). 
2.5. Cytotoxicity assay 
Human monocytes from different donors were tested for their ADCC 
capacity in a I^çj- release assay in which antibody-coated human 
erythrocytes were used as target cells. A quantity of IO8 HRBC were 
suspended in 0.3 ml PBS containing 100 μΟι 51ς
Γ
 (sodium Chromate, 
Radiochemical Centre, Amersham, U.K.) and incubated at З^С. After 
30 mm, the incubation volume was increased to 1 ml, and an equal 
volume of sensitizing antibody (or PBS, as a control) was added. 
Two types of sensitizing antibodies were used. In order to obtain 
EA-human IgG we used a human antiserum against rhesus D (Merz & 
Dade, Du'dingen, Switzerland) in combination with rhesus D-positive 
HRBC. A monoclonal anti-glycophonn A antibody (a generous gift of 
Marjolein Bos, CLB, Amsterdam) was used to construct EA-mouse 
IgG!. Both types of antibodies were used in various dilutions, re-
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suiting in erythrocytes sensitized with a range of IgG molecules 
per cell. After incubation for 30 mm with continuous gentle agita­
tion, cells were washed thrice with PBS containing 0.1Й bovine se­
rum albumin (Cohn fraction V, Sigma, St.Louis, Mo., USA), suspended 
at 2.5x106 cells/ml in RPMI 1640 medium plus 10% FCS, and used im­
mediately. Target cell numbers were calculated by counting unlabel-
led HRBC, which were included in all experiments for each dilution 
of sensitizing antiserum. 
Various concentrations of effector cells (in RPMI 1640 medium with 
10% FCS) were seeded in U-bottomed microtiter plates (Costar, Cam­
bridge, Mass., USA) in a volume of 100 μΐ/well. Hundred microliters 
of target cells were supplemented to the wells, plates were centn-
fuged (2 mm, 50 g, room temperature) and incubated for 1Θ h at 
370C. After incubation, plates were centrifuged (10 mm, 400 g, 
room temperature), 100 μΐ of supernatant fluid was collected and 
counted in an LKB gamma counter. The ADCC was expressed as percent 
cytotoxicity, which was calculated as follows: 100 χ (A-B/C-B), 
where A is mean cpm of test sample; B, mean cpm of spontaneous 
51Cr release (i.e. ^Cr release by labelled target cells in me­
dium only); and C, mean cpm of the maximal ^Сг release that was 
obtained by addition of 20% saponin (Coulter, Dunstable, U.K.) to 
the target cells. The average spontaneous release ± standard devia­
tion of the HRBC was 3% ± "Іл, and release from uncoated target 
cells incubated with monocytes did not exceed spontaneous release. 
In all experiments tests were conducted in triplicate and the re­
sults expressed as mean ± standard deviation. 
2.6. Quantitation of erythrocyte sensitization. 
Since ADCC is critically dependent on the degree of target cell 
sensitization, this variable was studied in more detail. Erythro-
cyte-bound antibodies were quantvtated by their ability to inhibit 
the binding of standardized amounts of ^^1-lgG by anti-IgG anti-
sera. The binding of ^^1-lqG was quantitated by precipitation of 
the immune complexes with 6% PEG, as has recently been described in 
detail (26). 
3. RESULTS 
3.1. Cytotoxic activity of monocytes against erythrocytes sensitiz­
ed with human IgG or mouse IqG1 
Monocytes from HR and LR donors were tested for their cytotoxic ac­
tivity against two types of sensitized HRBC. HR monocytes were cy­
totoxic to EA-human IgG, as well as to EA-mouse IqGI (Fig.1). 
The target cells were maximally sensitized with antibodies in this 
experiment, and it can be observed that HR monocytes killed both 
types of target cells with equal effectiveness. LR monocytes, how-
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Fig.1. Lysis of erythrocytes, maximally sensitized with human IgG 
(A) or mouse IgG1 (B), by monocytes from an HR (·) and an LR 
(A) individual. The results are representative of similar 
experiments using monocytes from six LR and seven HR indivi­
duals. 
ever, were less cytotoxic to EA-mouse IgGI than HR monocytes, 
whereas cytotoxicity to EA-human IgG was the same as with HR mono­
cytes. In control experiments it was shown that both unsensitized 
HRBC, as well as HRBC sensitized with F(abl)2 fragments of the 
mouse IqGI mAb (against qlycophonn A), were not killed by human 
monocytes (results not shown). This indicates that the observed ef­
fects are Fc-mediated. The differences between monocytes from HR 
and LR individuals were found for a larqe number of donors. The 
maximal level of cytotoxicity to EA-mouse IqGI was found to be 
47.6±5.6Ä (mean + SD; n=12) with LR monocytes, and 69.5+1.TS (n=16) 
with HR monocytes. Maximal cytolysis of EA-human IgG was 68.1+3.355 
(n=9) with LR monocytes, and 69.7+4.7% (n=4) with HR monocytes. 
Furthermore, this pattern was observed to remain constant for indi-
vidual donors who were followed over a period of 1.5 years. 
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Cytotoxicity 
Fig.2. Effect of monoclonal anti-FcyR antibodies on the lysis by HR 
monocytes of erythrocytes, maximally sensitized with human 
IqG (A) or mouse IgG1 (B). Monocytes and target cells were 
incubated either in RPMI 1640 medium plus 10% FCS alone 
(control) (·; dashed line), or in medium containing either 
anti-FcyRII mAb IV.3 (culture supernatant, 1:80)(ш) or CIKM5 
(ascites fluid, 1:100) (•), or anti-FcyRI mAb 10.1 (acites 
fluid, 1:1000)(x). Results are representative for four expe­
riments. 
3.2. Characterization of monocyte ADCC by different monoclonal 
anti-FcyR antibodies 
Different anti-FcyR mAb were tested for their effect on ADCC media­
ted by monocytes with EA-human IgG and EA-mouse IgG1 as target 
cells. Two anti-FcyRII mAb, IV.3, and CIKM5 both inhibited the cy­
totoxicity of monocytes to EA-mouse IgG1, whereas cytotoxicity to 
EA-human IgG was not affected (Fig.2). Both antibodies were pre­
viously found to inhibit the binding of mouse IqG1 to FcyRII 
(5,6,18), and react with different epitopes on this FcyR (Dr. Tet-
teroo, personal communication). Another mAb 10.1, which specifical­
ly binds to the Fc binding epitope of FcyRI (4), inhibited the cy­
totoxicity to EA-human IgG, whereas ADCC to the other type of tar-
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get cells was unaffected (Fig.2). These observations indicate that 
FcyRI mediates the cytotoxicity of monocytes to EA-human IgG, and 
that FcyRII mediates the kill of EA-mouse IgGI. Similar results 
were obtained when LR monocytes were used (data not shown). 
3.3. Effects of homologous and heterologous IqG on ADCC mediated by 
FcyRI and FcyRII. 
After having defined the structures on monocytes which mediate the 
kill of the two types of target cells, we investigated the inhibi-
tory effect of monomenc Ig on target cell lysis. Fig.3 shows that 
monomenc human IgG inhibits in a dose-dependent way the cytotoxi-
city of monocytes to EA-human IgG, whereas kill of EA-mouse IgGI 
was not affected. Similar results were obtained using HR monocytes 
(data not shown). 
Cytotoxicity 
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Fig.3. Effect of monomenc human IqG on monocyte-mediated lysis of 
erythrocytes, maximally sensitized with human IgG (A) or 
mouse IgG1 (B). Monocytes from an LR individual were incu-
bated with target cells in RPMI 1640 medium with 10% FCS 
alone (control) (·; dashed line), or in medium containing 
human IgG at a concentration of 1 цд/ті (χ), 10 μς/ιηΐ (•), 
or 25 μg/πü (•). Results are representative for three expe-
riments. 
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Mouse immunoglobulins have previously been used frequently to dis-
sect the heterogeneity of human monocyte FcyR (e.g. in 18,27). 
Fig.4 shows that mIgG2a inhibited the ADCC to EA-human IgG, whereas 
ADCC to EA-mouse IgGI remained unaffected. The cytotoxicity of mo-
nocytes to EA-mouse IgG1 was observed to be inhibited by mlgGI, in 
a dose-dependent way. Mouse immunoglobulins of the IgG2b isotype 
had no influence on the killing of both types of target cells. 
Inh ib i t ion of ADCC 
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Fig.4. Inhibition of monocyte cytotoxicity to sensitized erythro-
cytes by monomenc mouse immunoglobulins of different iso-
types. The effector to target ratio was 1.5, monocytes were 
from an HR individual, and target cells were maximally sen-
sitized. The percentage inhibition was calculated as fol-
lows: 
% Cytotoxicity with inhibitor 
χ 100 
% Cytotoxicity in medium with 10% FCS 
This experiment was repeated four times with comparable 
suits. 
re-
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3.4. Effect of degree of sensitization on ADCC 
Until now target cells were used which were maximally sensitized. 
We have previously observed that the degree of erythrocyte sensiti­
zation obtained with anti-Rhesus D antibody and with anti-glycopho-
n n A mAb shows large differences. Erythrocytes were found to bind 
maximally ± 20,000 human IgG anti-Rhesus D molecules/HRBC whereas 
they could be sensitized with as much as 400,000 mouse IgG1 anti-
glycophonn A molecules/target cell without agglutination (26). 
Since the degree of target cell sensitization influences ADCC, we 
quantitated this parameter in more detail, and studied its effect 
on monocyte cytotoxicity. Striking differences were observed when 
EA-human IgG and EA-mouse IqGI were compared as target cells for 
cytotoxicity by monocytes (Fig.5). Half-maximal cytotoxicity of mo­
nocytes to EA-human IgG was observed with targets containing ap­
proximately 5,500 IgG molecules, whereas for half-maximal cytolysis 
Cytotoxicity • 
(»/„I 
60 
40 
20-
5 10 
EA-mouse IgGi (HR) 
EA-mouse IgGi(LR) 
— ι ' — ι 
50O 1,000 50 100 
Ant ibody m o l e c u l e s / e r y t h r o c y t e U I C T 3 ) 
Fig.5. Effect of ligand density on ADCC of human monocytes to two 
types of sensitized erythrocytes. Cytotoxic activity was 
studied with monocytes from individuals of both the HR (·-·) 
and LR (A 4) phenotype. Effector to target ratio was 1.8. 
75 
of EA-mouse IgGI, approximately 100,000 IgG molecules per HRBC were 
needed when HR monocytes were used (Table 1). In contrast, approxi­
mately 200,000 molecules of mouse IgGI per HRBC were needed for 
half-maximal lysis with LR monocytes. Furthermore, as described in 
section 3.1, the maximal level of monocyte-mediated lysis of EA-
mouse IgGI was always lower than that of HR monocytes. 
3.5. Mechanisms involved in ADCC of erythrocytes 
Direct cytolysis, but not phagocytosis, is known to play the most 
important role in monocyte-mediated cytotoxicity to HRBC, sensitiz­
ed with anti-rhesus D antibodies (12). We investigated whether the 
same is true for cytotoxicity against EA-mouse IgG1. We therefore 
studied ADCC of monocytes to the two types of target cells both in 
the presence and absence of 0.15 mM lodoacetate (a concentration 
which completely inhibits phagocytosis)(28). Cytolysis of EA-human 
IgG was not affected at all, whereas lysis of EA-mouse IgG1 was on­
ly inhibited by 4.6+1.3Й (mean ± SD, 2 experiments). We next inves­
tigated the possible contribution of tumour necrosis factor (TNF) 
to cytolysis of sensitized erythrocytes by performing ADCC experi­
ments in the presence of neutralizing anti-TNF antiserum, which 
yielded similar results as those in the absence of antiserum (data 
not shown). 
Table 1. Cytotoxic activity of monocytes from HR and LR individuals 
against two types of sensitized erythrocytes 
Target cells Target cell sensitization Ρ 
(IgG molecules/cell χ IO-') 
at half-maximal cytotoxicity with 
High Responder Low Responder 
Monocytes Monocytes 
EA-human IgG 5.3 + 2.2 (8)a 5.8 ± 2.0 (10) NSb 
EA-mouse IgG1 95.5 t 45.8 (8) 206 t 67.9 (10) P<0.003 
a. Values represent means standard deviation, with the number of 
experiments performed in parentheses. 
b. Statistical analysis: Wilcoxon two-sample test 
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α. DISCUSSION 
Human monocytes express two types of receptors for the Fc moiety of 
IgG, FcyRI and FcyRII (1,2). These receptors can be modulated se­
lectively by immobilized immune complexes, which indicates that 
they represent independent membrane structures (7). Most studies of 
antibody dependent cell-mediated cytotoxicity (ADCC) by monocytes 
have focused on the role of FcyRI. In the present study we have 
compared the cytotoxic activity mediated by FcyRI and by FcyRII. 
Human erythrocytes sensitized with either human IgG (EA-human IgG) 
or with mouse IgG1 (EA-mouse IgGI) were used as target cells. When 
sensitization was maximal, both types of target cells were lysed at 
a similar effector to target ratio. Monoclonal anti-FcyR antibodies 
as well as purified (monomeric) immunoglobulins were used to inves­
tigate which type of FcyR was involved. Anti-FcyRI mAb 10.1 (4) was 
found to inhibit cytolysis of EA-human IgG but not of EA-mouse 
IqG1. Lysis of EA-human IgG (but not EA-mouse IqGI) was also inhi­
bited by human IgG and by mouse IgG2a. FcyRI therefore appears to 
be responsible for monocyte ADCC towards EA-human IgG. Two mAb 
against FcyRII, IV.3 (5) and CIKM5 (6), as well as monomeric mouse 
IgGI were able to inhibit cytolysis of EA-mouse IgG1. These find­
ings indicate that FcyRII is involved in lysis of mouse IgGI-sensi-
tized target cells. Recently, Graziano and Fänger (29) demonstrated 
that hybndoma cells IV.3, which bear the antibody directed to 
FcyRII, can be lysed by human monocytes, which also indicates that 
FcyRII can function as a trigger molecule in ADCC. 
It is well known that FcyRII is a polymorphic structure. This 
structural polymorphism is reflected in polymorphism of the mitoge-
nic effect of mouse IgGI anti-CD3 antibodies (8,9). Monocytes from 
"low-responder"(LR) individuals can interact only weakly with mouse 
IgG1, as measured in rosette assays (18). The two different forms 
of FcyRII are both recognized by mAb IV.3, but have different iso-
electric focussing patterns (10). Although we found that both LR 
and HR monocytes were able to lyse EA-mouse IgG1, the percentage of 
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specific lysis was consistently higher for HR monocytes than for LR 
monocytes. Similarly, Graziano and Fänger (29) observed that both 
HR and LR monocytes could kill hybndoma cells bearing anti-FcyRII 
antibody, bot only the HR monocytes could in addition also kill hy-
bndoma cells bearing mouse IgG1 with "irrelevant" specificity. 
An important parameter in ADCC is the degree of target cell sensi-
tization (17). Cytotoxicity mediated by FcyRI was found to be much 
more efficient than that mediated by FcyRII. Approximately 20 times 
more IgG molecules were needed per target cell for half-maximal 
lysis mediated by this last receptor when HR monocytes were test-
ed. When LR monocytes were used, approximately twice as many mlgGI 
molecules/HRBC were needed to get half-maximal lysis, compared with 
HR monocytes. The lower efficiency of ligand-binding by FcyRII re-
lative to FcyRI, as well as the difference between HR and LR mono-
cytes have previously also been observed when analyzing EA-roset-
ting between monocytes and HRBC sensitized with human IgG or mouse 
IgGI (26). At least 30 times more mouse IgG1 than human IgG molecu-
les had to be present per HRBC for half-maximal rosettinq with mo-
nocytes from HR individuals. With LR monocytes this number was 
twice as high аз for HR monocytes. 
The significance for immunotherapy of differences in cytotoxic ef­
ficiency between FcyRI and FcyRII is illustrated by experiments re­
ported by Steplewski et al. (16). These authors showed that a mlgGI 
anti-tumour mAb was not able to induce cytolysis with monocytes as 
effector cells, but the mIgG2a isotype-switch variant of the same 
antibody was perfectly able to induce kill of tumour cells, both in 
vitro and in vivo (in nude mice). The physiological significance of 
FcyRI, however, has been questioned before (4), since this receptor 
has a high affinity for monomenc human IgG (Ka 10-10 M-1)(1,6) 
and is likely to be saturated with human IgG which is present at 
approximately 10"^M in serum. FcyRII on the other hand will not, 
or to a much lesser extent, be blocked by human IgG (see for in­
stance Fig.3). 
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Monocyte-mediated cytotoxicity of sensitized HRBC did not depend on 
phagocytosis, as indicated by experiments performed in the presence 
of the phagocytosis-inhibitor lodoacetate (28) which yielded simi­
lar results as those in the absence of this substance. It has been 
shown, previously, that FcyRI-mediated cytolysis is not dependent 
on phagocytosis and can be attributed to the release of lysosomal 
enzymes by monocytes (13). Reactive oxygen species did not play an 
important role in cytotoxicity of monocytes to sensitized HRBC 
(30). It was recently found that tumour necrosis factor (TNF) plays 
a role in monocyte-mediated cytotoxicity against tumour cells 
(31). When we investigated the contribution of this molecule to cy­
tolysis of sensitized erythrocytes, no effect could be observed. We 
therefore conclude, that both types of FcyR mediate kill of sensi­
tized erythrocytes, not by phagocytosis, but by a cytolytic mecha­
nism which may involve the secretion of lysosomal enzymes by mono­
cytes (13). 
In conclusion, we found that not only FcyRI but also FcyRII on hu­
man monocytes is functional in ADCC to erythrocytes. Furthermore, 
the cytotoxicity mediated by FcyRII was polymorphic, in concordance 
with the results found previously in anti-CD3 induced Τ cell proli­
feration (θ,9) and in rosette assays (1B). The degree of sensitiza­
tion of target cells required for half-maximal cytotoxicity is much 
higher for FcyRII-mediated lysis, and in this respect the efficacy 
of killing by FcyRII is much lower than for FcyRI. 
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SUMMARY 
Two types of IgG Fc receptors, FcyRI and FcyRII, are present on hu­
man monocytes. They can be assayed by EA-rosetting, using erythro­
cytes sensitized with human IgG or mouse IgGI, respectively. On 
mouse macrophages, FcyRI is sensitive to trypsin while FcyRII is 
trypsin-resistant. We have now studied the effects of the proteoly­
tic enzymes pronase and trypsin on human monocyte Fey receptors. 
Trypsin nor pronase caused a decrease in rosetting mediated by hu­
man monocyte FcyRI. Human monocyte FcyRII is polymorphic, as has 
been demonstrated previously in studies on Τ cell proliferation in­
duced by mouse IgG1 anti-CD3 antibodies. Monocytes are required for 
this proliferation, and individuals can either be high-responder or 
low-responder depending on the strength of the interaction of mono­
cyte FcyRII with mouse IgG1. We observed that the interaction of 
low-responder monocytes with mouse IgGI was dramatically increased 
(to the level exhibited by high-responder monocytes) by treating 
the monocytes with proteolytic enzymes. Since the number of Fc re­
ceptors was not affected (as measured by immunofluorescence using 
anti-FcyR monoclonal antibodies), we conclude that the affinity for 
ligand was increased by proteolysis. At sub-optimal sensitization 
of indicator erythrocytes, the enhancing effect of protease-treat-
ment could also be demonstrated with high-responder monocytes, both 
in EA-rosetting and in antibody-dependent cytotoxicity. 
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1. INTRODUCTION 
Human monocytes constitutively express two types of receptors for 
the Fc moiety of IgG: FcyRI and FcyRII. FcyRI has a high affinity 
for both monomenc and complexed human IqG, while FcyRII has only a 
low affinity for complexed human IgG. This latter receptor cross-
reacts with mouse IgGI, and is structurally polymorphic (reviewed 
in 1,2). Monocytes from different donors interact either strongly 
or weakly with mouse IgGI (high-, respectively low-responder indi­
viduals; HR or LR), as observed in studies on Τ cell proliferation 
induced by mouse IgGI anti-CD3 antibodies (3) and in rosetting ex­
periments with mouse IgGI-sensitized erythrocytes (4,5). 
Knowledge of the protease sensitivity of human monocyte FcyR is 
fragmentary. FcyRI of human monocytes was reported to be resistant 
to both trypsin (6) and pronase (7), whereas the effects on FcyRII 
have not been described before. The different types of FcyR present 
on mouse macrophages exhibit a differential sensitivity to trypsin 
(reviewed in Θ). Since the data on the effects of proteases on hu­
man monocyte FcyR are incomplete we carried out a detailed study of 
the effects of trypsin and pronase on FcyRI and FcyRII of human mo­
nocytes. 
2. MATERIALS AND METHODS 
2.1. Monocytes 
Cytapheresis of healthy volunteers was applied to obtain white 
blood cell suspensions. Monocytes were isolated from these suspen­
sions by Percoli (Pharmacia, Uppsala, Sweden) centrifugation and 
counterflow centrifugation as described before (9). Monocyte sus­
pensions consisted for at least 90% of monocytes (evaluated in cy-
tocentrifuge preparations after staining for non-specific esterase 
and with May-Griinwald-Giemsa) and viability was higher than 98% 
(assessed by trypan blue exclusion). Isolated cells were either 
used immediately or were cryopreserved (10) and stored in liquid 
nitrogen until use. Most experiments were performed with cryopre­
served monocytes, but all types of experiments were performed at 
least once using freshly isolated cells, which yielded similar re­
sults. 
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2.2. Τ cell proliferation assay 
The accessory function of monocytes in anti-CD3 induced Τ cell pro­
liferation was studied for all donors as described before (3). 
Anti-CD3 mAb used were WT32 (mIgG2a) (11), and UCHT1 (mlgd) (12), 
a kind gift of Dr. Beverley (London, U.K.). 
2.3. Anti-FcyR monoclonal ant ibodies 
Anti-FcyRI monoclonal antibodies used were 10.1 provided by Dr. 
Hogg (13), and 32.2 from Dr. Anderson (2). Two mAb reactive with 
FcyRII were used; IV.3 a gift from Dr. Anderson (14), and CIKM5 
provided by Dr. Pilkington (15). The following anti-FcyRIII mAb 
were employed: anti-Leu 11a (16), and anti-Leu 11b (17), both from 
Becton Dickinson (Mountain View, Ca.). 
2.4. Treatment with proteolytic enzymes 
Monocytes were incubated in suspension (at a concentration of 4x10 
cells/ml) with RPMI 1640 medium alone (control) or with medium con­
taining either 0.5 mg/ml trypsin, or 0.2 mg/ml pronase (both from 
Boehnnger, Mannheim, FRG), for 30 m m at З^С. After three washes, 
cells were resuspended in RPMI 1640 medium containing 5% FCS and 
rosette formation was assayed as described below. Losses of cells 
after treatment with proteases were small and amounted to 6.0+4.9% 
(n=4; freshly isolated monocytes), and 15.5±10.3?S (n=16; cryopre-
served monocytes), relative to cells incubated in medium alone. 
Viability of cells after proteolysis was always higher than 955». 
In some experiments monocyte-monolayers were prepared in microtitre 
plates as described before (9). Briefly, 100 μΐ of a cell suspen­
sion (4x106 cells/ml in RPMI 1640 with 10% FCS) were dispensed into 
individual wells of flat-bottomed microtitre plates (Costar, Cam­
bridge, MA) and incubated for 1 h at 370C. After two washes, wells 
were supplemented with RPMI 1640 medium alone (control), or with 
medium containing either 0.5 mg/ml trypsin or 0.2 mg/ml pronase and 
plates were incubated for 30 m m at 370C. After two washes, sensi­
tized erythrocytes were added and binding was quantitated as des­
cribed below. Viability of monocytes was high (> 95%, assessed by 
trypan blue exclusion) and was not decreased by protease treatment, 
nor was the number of cells per well influenced as evaluated by mi­
croscopical examination. 
2.5. Immunofluorescence 
The expression of different monocyte antigens on enzyme-treated 
cells was assayed by indirect immunofluorescence, using various mAb 
and a fluorescein-conjugated F(ab')2 fraction of sheep anti-mouse 
IgG antiserum (Cappel, Malvern, Pa.). Complement receptor type 3 
was evaluated by using mAb 0KM1 (18) from Becton Dickinson (Moun­
tain View, Ca.), monocyte/macrophage specific antigen p55 (CD14) by 
mAb Mo2 (19) from Coulter Immunology (Hialeah, Fl.), and the diffe­
rent types of FcyR by the mAb described in section 2.3. Fluores­
cence was determined with an Ortho 50-H flow cytometer. In each 
sample the fluorescence intensity from 10,000 cells was measured. 
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2.6 EA-rosetting 
Two types of indicator cells were used for EA-rosette assays. Rhe­
sus D-positive human erythrocytes (HRBC) were sensitized either 
with a human alloserum against rhesus D (Merz 4 Dade, Dudingen, 
Switzerland), or with a mouse IgGI mAb against glycophonn A (ob­
tained from M. Bos, CLB, Amsterdam). In some experiments, HRBC were 
sensitized with F(abl)2 fragments of the mlgGI anti-glycophonn A 
mAb. Preparation of F(ab,)2 fragments and sensitization of HRBC 
were performed as described before (9). 
Rosetting was studied using two different methods, a microscopic 
and a photometric one. The microscopic assay was performed essen­
tially as described before (9). Briefly, to 200 μι of cells (at 
2x106/ml in RPMI 1640 with 5Ä PCS) 50 μΐ of sensitized HRBC suspen­
sion (0.5Ä v/v) were added, the samples were centrifuged 4 min at 
20 g, and incubated for 1 h at 40C. Cells with at least three bound 
HRBC were scored as rosettes, using a microscope with 400 χ final 
magnification. Unsensitized HRBC were included in each experiment, 
and never found to form rosettes with any of the cells tested (nei­
ther protease-treated, nor untreated). At least 200 cells were 
scored per incubation. 
In inhibition experiments anti-FcyR mAb were added to monocytes af­
ter incubation with proteases, and experiments were further perfor­
med under similar conditions as described above. 
Binding of sensitized HRBC (and non-sensitized HRBC as a control 
for non-specific binding) to monocyte-monolayers was evaluated af­
ter incubation for 1 h at 40C. Quantitation of binding was perform­
ed photometrically at 450 nm using the pseudoperoxidase activity of 
HRBC as indicator (9). Binding indices were calculated, in order to 
correct for variations in background absorbance values between dif­
ferent experiments, as follows: 
И - (E450/EA450)] χ 100 = binding index, where E450 is extinction 
at 450 nm in wells to which HRBC without sensitizing antibody were 
added, and EA450 is extinction at 450 nm in wells to which 
sensitized HRBC were added. All determinations were performed in 
duplicate, and the variability was less than 10%. 
2.7. Cytotoxicity assay 
Monocytes were tested for their ADCC capacity in a ^Ст release 
assay in which antibody-coated HRBC were used as targets. 10 HRBC 
were suspended in 0.3 ml PBS containing 100 цСі 51cr (sodium 
Chromate, Radiochemical Centre, Amersham, U.K.) and incubated at 
370C. After 30 mm, the incubation volume was increased to 1 ml, 
and an equal volume of sensitizing antibody (or PBS, as a control) 
was added. After incubation for 30 m m at 370C with continuous 
gentle agitation, cells were washed thrice with PBS containing 0.15« 
bovine serum albumin (Cohn fraction V, Sigma, St.Louis, Mo.), sus­
pended at 2.5x106 HRBC/ml in RPMI 1640 medium plus 10Й FCS, and 
used immediately. Target cell numbers were calculated by counting 
unlabelled HRBC, which were included in all experiments. 
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Various concentrations of effector cells (protease-treated or, as a 
control, untreated), suspended in RPMI 1640 medium with 10Ä FCS, 
were seeded in U-bottomed microtitre plates (Costar, Cambridge, 
Ma.) in a volume of 100 μΐ/well. Hundred microliters of target 
cells were supplemented to the wells, plates were centnfuged (2 
mm, 50 g) and incubated for 18 h at 370C. After incubation, plates 
were centnfuged (10 min, 400 g), 100 μΐ of supernatant fluid was 
collected and counted in a LKB gamma counter. The ADCC was expres­
sed as percent cytotoxicity, calculated as follows: 100 χ 
(A-B/C-B), where A is mean cpm of test sample; B, mean cpm of spon­
taneous -^Сг release (i.e. ''Cr release by labelled target 
cells in medium only); and C, mean cpm of the maximal 5ΐ£
Γ
 re­
lease that was obtained by addition of 20% saponin (Coulter, Dun­
stable, U.K.) to the target cells. The average spontaneous release 
± SO of HRBC was 3S ± 1%, and release from unsensitized HRBC incu­
bated with monocytes did not exceed spontaneous release. 
2.8. Statistics 
The Wilcoxon two-sample test was used to evaluate the statistical 
significance of differences in EA-rosette formation between pro­
tease-treated and untreated cells. 
3. RESULTS AND DISCUSSION 
We have studied the effects of proteases by examining the resetting 
mediated by FcyRI and Fcyll on human monocytes. The Fcy receptors 
Table 1. Effect of Trypsin and Pronase on EA-rosetting between 
high-responder monocytes and two types of optimally sensi­
tized erythrocytes 
Binding of sensitized erythrocytes 
EA-human IgG EA-mouse IgGI 
Incubation % Rosettes Binding % Rosettes Binding 
with relative to relative to 
Control {%) Control (3) 
Buffer 79.2±7.5 (5)a 100 70.5±8.2 (4) 100 
Trypsin 77.9+4.4 (5) 98 78.9±7.6 (4) 112 
Pronase 76.2t10.5(4) 96 84.4±7.3 (4) 120 
a. Data were obtained with monocytes from three different donors, 
and results represent the mean ± SD, with number of individual 
experiments in parentheses 
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EA-human IgG EA-mouse IgGI E-Fiab'b 
Fig.1. Effect of trypsin and pronase on EA-rosetting between low-
responder monocytes and erythrocytes sensitized with either 
human IgG, mouse IgGI, or F(ab')2 fragments of mouse IgGI. 
Monocytes were incubated in RPMI 1640 medium alone (control) 
or in medium containing either trypsin or pronase, washed, 
and rosettinq with maximally sensitized erythrocytes was 
scored microscopically. Rosetting was performed with mono­
cytes from four donors, and results are expressed as means ± 
SD of either three (EA-human IgG), nine (EA-mouse IgGI), or 
two (E-F(abl)2) individual experiments. 
were assayed by using erythrocytes sensitized either with human IgG 
(EA-human IgG; FcyRI) or with mouse IgG1 (EA-mouse IgGI; FcyRII) 
(5,14). When monocytes from high-responder individuals were used, 
neither trypsin, nor pronase had any significant effect on rosette 
formation with optimally sensitized indicator HRBC (Table 1). 
Monocytes from about 30% of Caucasian individuals (LR) interact 
much more weakly with EA-mouse IgGI than monocytes from the other 
(HR) donors (4,5), although FcyRII are present in similar amounts 
(14). When LR monocytes were tested, the degree of EA-human IgG 
rosetting was similar to that of HR monocytes {±70% rosettes), but 
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Fig.2. Effect of trypsin on rosette formation between low-responder 
monocytes and erythrocytes, sensitized at different dilu­
tions of mouse IgG1 anti-glycophonn A antibody. LR monocyt­
es were incubated with medium only (o-o), or with medium 
containing trypsin (·-·). After washing, the binding of sen­
sitized erythrocytes was assayed photometrically. For compa­
rison, the results obtained with untreated high-responder 
monocytes (Δ-Δ) are also depicted, results are representa­
tive for four experiments. 
only about 20SÓ rosettes were formed with EA-mouse IgGI (Fig.1). Si-
milarly to the results obtained with HR monocytes, no significant 
effects of the proteases were found on FcyRI-mediated rosette for-
mation. Surprisingly, a greatly enhanced rosette formation with 
EA-mouse IgGI (FcyRII-mediated) was seen when LR cells were treated 
with trypsin (p<0.003) or with pronase (p<0.0002). This effect was 
obtained with both freshly isolated and cryopreserved monocytes 
from all LR donors we tested. The Fc-dependency of EA-rosetting 
with protease-treated monocytes was demonstrated in a control expe-
riment. Human erythrocytes were optimally sensitized with FCab'^ 
fragments of anti-glycophonn A mouse IgGI antibody (as we used be-
fore; 9), and rosette formation with protease-treated (and untreat-
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ed) monocytes was studied. We never observed any rosette formation 
using F(ab'^-sensitized HRBC, neither with untreated, nor with 
protease-treated monocytes (Fig.1). The experiments described above 
were carried out with erythrocytes that were maximally sensitized 
with mouse IgG1. Subsequently, we studied the effects of proteases 
on EA-mouse IgGI rosetting of LR monocytes in some more detail, 
using HRBC sensitized with a range of mouse IgGI molecules per 
cell. Erythrocytes were sensitized at different dilutions of mouse 
IgG1 anti-glycophonn A mAb, resulting in sensitizations varying 
from about 10,000 to 400,000 mouse IgG1 molecules/HRBC (20). A dra-
matic enhancement of EA-mouse IgGI rosette formation was observed 
when LR monocytes were treated with trypsin (Fig.2), and similar 
results were obtained with pronase (data not shown). The degree of 
EA-mouse IgGI rosetting of LR monocytes after trypsin treatment was 
found to be comparable to that of untreated HR monocytes (Fig.2). 
EA-mouse IgG1 rosetting of HR monocytes was also enhanced after 
protease treatment when we used sub-optimally sensitized indicator 
HRBC (Table 2). 
Table 2. Effect of trypsin on rosetting between HR monocytes and 
EA-mouse IgG1a 
Dilution of sensitizing Expt. 1 Expt. 2 
mouse IgG1 antibody 
(x10-3) control trypsin control trypsin 
1:4 66+4b 72±7 52±3 68+7 
1:8 41+4 68+6 45±5 59+4 
1:16 32+2 58±4 10+2 40+3 
a. Monocyte-monolayers in microtitre wells were incubated with RPMI 
1640 medium alone (control), or with medium containing trypsin 
for 30 m m at 370C. After washing, binding of indicator erythro-
cytes, sensitized at different dilutions of mouse IgG1 anti-gly-
cophonn A, was quantitated photometrically. 
b. Results represent binding indices calculated as described in Ma-
terials and Methods, and are expressed as means ± SD. 
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We next tested whether this enhanced EA-rosette formation with 
mouse IgGI-sensitized HRBC by LR monocytes was mediated by FcyRII. 
Anti-FcyRII mAb IV.3 was found to inhibit the EA-mouse IgGI roset-
ting with LR cells after protease treatment by B4.5±5.5SS (n=2), 
whereas anti-FcyRI mAb 10.1 only caused an inhibition of 10.2±3.4й 
(n=2). Monoclonal antibody IV.3 has previously been shown to block 
only rosetting between monocytes and EA-mouse IgGI and not rosette 
formation with EA-human IqG (5,14). Furthermore, it has been demon­
strated previously that anti-FcyRI mAb 10.1 completely inhibits ro­
sette formation between EA-human IgG and human monocytes (13). 
We next studied the antibody-dependent cell-mediated cytotoxicity 
(ADCC) of monocytes towards sensitized HRBC. When HR monocytes were 
treated with pronase, their ADCC activity to sub-optimally sensi­
tized EA-mouse IgGI was found to increase drastically (Fig.3). Si­
milar data were obtained when LR monocytes were used (Table 3), and 
also after treatment with trypsin (data not shown). 
Table 3. Effect of pronase on cytotoxicity of LR monocytes to ery­
throcytes, suboptimally sensitized with mouse IgG1a 
Effector to target ratio % cytotoxicity 
control pronase 
0.25:1 5.3+1.2b 7.5+0.6 
0.5:1 7.2±1.4 15.0+1.4 
1:1 11.0±2.0 25.3+1.9 
2:1 13.0±1.0 35.2+3.θ 
a. Monocytes were incubated in RPMI 1640 medium alone (control) or 
in medium supplemented with pronase for 30 m m at 370C. After 
washing, the cells were incubated with 5lQ
r
 labelled HRBC 
(sensitized with + 186,000 molecules of mouse IgG1 per erythro­
cyte) at different effector to target ratio's for 18 h and 
5'Cr release was determined. 
b. Means + SD of triplicate determinations in a representative ex­
periment. 
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The effect of proteases on the expression of FcyR by monocytes was 
studied using immunofluorescence analysis. FcyRI was evaluated by 
using mAb 32.2 and 10.1, directed against different epitopes on the 
receptor, FcyRII by mAb IV.3 and CIKM5, also reacting with diffe­
rent determinants (Dr. Tetteroo, personal communication). Proteo­
lysis either had no effect, or slightly reduced the expression of 
FcyRI and FcyRII on monocytes (Fig.4). A third type of FcyR, 
FcyRIII (CD16) has been described on human granulocytes, macrophag­
es and null cells (2) but not on monocytes. Using two anti-CD16 
mAb, anti-Leu 11a and anti-Leu 11b, no induction of this receptor 
was observed after protease treatment of monocytes. Enzymatic acti­
vity of the proteases was confirmed by studying the binding of mAb 
cytotoxicity , 
(Ίο) 
0.4 1 0.8 1 1J6 1 
effector to target ratio 
Fig.3. Effect of pronase on cytotoxicity of HR monocytes to ery­
throcytes, sub-optimally sensitized with mouse IgG1. High-
responder monocytes were incubated in the absence (G) or 
presence (H) of pronase, washed and incubated with ^Сг 
labelled HRBC (sensitized with ± 36,000 molecules of mouse 
IgGI per erythrocyte) at three different effector to target 
ratio's for 18 h, after which -""ICr release was determin­
ed. Results show the mean ± SD of triplicate determinations 
in one experiment, which was repeated thrice with comparable 
results. 
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Fig.4. Immunofluorescence analysis of FcyRI and Fcyll on monocytes 
after trypsin treatment. Monocytes were incubated in RPMI 
1640 medium alone (Control; a,b) or in medium containing 
trypsin (c,d). After washing, the expression of FcyRI and II 
was evaluated with a flow cytometer by using mAb 10.1 (a,c) 
and IV.3 (b,d), respectively. Fluorescence was recorded as 
arbitrary units on a linear scale, using RPMI 1640 medium 
containing 10% FCS alone as a control for non-specific bind­
ing (dashed-line). This experiment was repeated twice, em­
ploying both trypsin and pronase (data not shown) with com­
parable results. 
to antigens of known proteolytic sensitivity. After protease treat­
ment, binding of mAb Mo2 (which binds to the protease-sensitive 
CD14 antigen (19)) was reduced by 98% (mean of two experiments) by 
trypsinization, and by 99% after treatment with pronase. Binding of 
mAb 0KM1, which is known to be protease-resistant (19), was not re­
duced by proteolysis. 
Pronase has previously been found to decrease the interaction of 
anti-FcyRIII mAb B73.1 with human lymphocytes (21), while trypsin 
selectively affected mouse macrophage FcyRI (reactive with mIgG2a), 
but not mouse macrophage FcyRII (reactive with mIgG1/2b),or 
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fluorescence intensity 
mouse FcyRIII (for mIgG3)(8). We found no inhibition of human mono-
cyte FcyRI by these proteases,whereas FcyRII was dramatically in-
creased. 
4. CONCLUDING REMARKS 
In agreement with previous reports (6,7,22,23), we found that human 
monocyte FcyRI was not inhibited by the proteases trypsin and pro-
nase. In this regard, human and mouse monocyte FcyR, which are ge-
nerally assumed to be homologous, appear to differ from each 
other. The most remarkable result of our study was that with human 
LR monocytes both EA-mouse IgGI rosetting and ADCC against mouse 
IgGI-sensitized HRBC (both mediated by FcyRII) were found to be en-
hanced considerably by proteolysis. Surprisingly, after protease 
treatment LR monocytes exhibited a similar degree of EA-mouse IgGI 
rosetting as did (untreated) HR monocytes. When sub-optimally sen-
sitized indicator HRBC were used, a protease-induced increase of 
both EA-mouse IgGI rosetting and ADCC against mouse IgG1-sensitized 
HRBC could also be demonstrated with HR monocytes. As the expres-
sion of monocyte FcyR does not increase, it is likely that the af-
finity for IgG is enhanced by limited proteolysis. This is consis-
tent with studies of Cosío et al. (7,23), who reported that trypsin 
or pronase treatment induces an increase in affinity of human mono-
cytes for rabbit IgG immune complexes, without affecting the number 
of binding sites for rabbit IgG. This enzyme-mediated modulation of 
FcyR interactions with ligands may play an important role in vivo 
at places with increased concentrations of proteases, e.g. at in-
flammatory sites (24). 
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CONVERSION OF THE TYPE II Fc RECEPTOR FOR HUMAN IqG ON MONOCYTES 
FROM LOW TO HIGH AFFINITY BY PROTEOLYSIS 
Jan G.J. van de Winkel, René van Ommen, Peter J.A. Capel, 
RoberL A.P. Koene, and Wil J.M. Tax 
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SUMMARY 
The effect of proteolytic enzymes on the low-affinity Fc receptor 
for human IgG, FcyRII, present on human monocytes, was investigat-
ed. For this purpose, the high-affinity Fc receptor, FcyRI was se-
lectively modulated from the monocytes using immobilized immune 
complexes. Proteolysis of such modulated monocytes induced an in-
creased interaction with erythrocytes sensitized with human IgG 
(EA-human IgG). FcyRII appears to mediate this interaction. This 
conclusion is supported by the observation that after proteolysis, 
the FcyRII-mediated binding of EA-mouse IgG1 becomes susceptible to 
inhibition by (monomenc) human IgG. Studies on the effect of pro-
teolytic enzymes were also performed with cell line K562, which ex-
presses only FcyRII and not FcyRI. A dramatic increase in rosetting 
with EA-human IgG was observed when K562 cells were treated with 
proteases, and this increase could be inhibited by anti-FcyRII mo-
noclonal antibodies. The expression of FcyRII was not influenced by 
proteolysis as evidenced by immunofluorescence studies, and neither 
were FcyRI or FcyRIII induced. We conclude that proteolysis in-
creases the affinity of FcyRII for human IgG, and we speculate that 
such a proteolysis-induced increase of affinity might also occur in 
vivo, e.g. at inflammatory sites. 
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1. INTRODUCTION 
Human monocytes constitutively possess two types of receptors for 
the Fc portion of IgG, FcyRI and FcyRII. FcyRI has an approximate 
molecular weight of 70 kDa and is defined by monoclonal antibodies 
(mAb) 32.2 (1) and 10.1 (2), whereas FcyRII has an approximate mo-
lecular weight of 40 kDa and is recognized - inter alia - by mAb 
IV.3 (3) and CIKM5 (4) (reviewed in 5). FcyRI binds both monomenc 
and aggregated or complexed human IgG with high affinity (5,6). 
FcyRII was defined originally by its interaction with mouse IqG1 
(7,8). This receptor has low affinity for aggregated human IgG and 
no detectable affinity for monomenc human IgG (5,6). These recep-
tors can be assayed in rosetting experiments by using erythrocytes 
sensitized either with human IgG (EA-human IgG; FcyRI) or with 
mouse IqG1 (EA-mouse IgG1; FcyRII) (3,9). 
It is well known that FcyRI on human monocytes is trypsin (10) and 
pronase (11) resistant. The effects of proteolytic enzymes on 
FcyRII on human monocytes are unknown, and were investigated in 
this study. For this purpose, FcyRI was first modulated, by inter-
action with immobilized immune complexes, from the apical surface 
of the monocytes (12). Treatment of these modulated cells (which 
still bear FcyRII) with the proteolytic enzymes trypsin or pronase, 
increased the binding of EA-human IgG. This suggested that proteo-
lysis increased the interaction of FcyRII with human IgG. Because 
of the complexity of experiments with monocytes, due to the pre-
sence of two types of FcyR, experiments were performed with K562 
cells. These cells express only FcyRII and no FcyRI (3,5,6). Also 
on this cell line protease treatment induced increased interaction 
with human IgG, which could furthermore be inhibited by anti-FcyRII 
antibodies. Our results suggest that proteases can increase the af-
finity of FcyRII for human IgG. Since proteolytic enzymes can also 
be released in vivo, e.g. at inflammatory sites (13), we speculate 
that FcyRII might function in vivo as a "standby" Fc receptor for 
human IgG. 
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2 . MATERIALS AND METHODS 
2.1 Cells 
Cytapheresis of healthy volunteers was applied to obtain white 
blood cell suspensions. Monocytes were isolated from these suspen-
sions by Percoli (Pharmacia, Uppsala, Sweden) centrifugation and 
counterflow centrifugation as described before (14). Monocyte sus-
pensions consisted for at least 90% of monocytes (evaluated in cy-
tocentnfuge preparations after staining for non-specific esterase 
and with May-Grünwald-Giemsa), and viability was high (> 98%, 
assessed by trypan blue exclusion). Isolated cells were cryopre-
served (15) and stored in liquid nitrogen until use. In some expe-
riments we used the erythromyeloid cell line K562, which was cul-
tured in RPMI 1640 medium supplemented with 10Й FCS, 2 mM glutami-
ne, 1 mM sodium pyruvate, and gentamycin (50 μg/ml). 
2.2 Anti-FcyR antibodies 
Anti-FcyRI monoclonal antibodies used were 32.2 provided by Dr. C. 
Anderson (1), and 10.1 from Dr. N. Hogg (2). Two mAb with reactivi­
ty to FcyRII were used, IV.3 a gift from Dr. С Anderson (3), and 
CIKM5 provided by Dr. G. Pilkington (4). The following anti-FcyRIII 
mAb were tested: anti-leu 11a (16), and anti-leu lib (17), both 
from Becton Dickinson (Mountain View,Ca.). 
2.3 FcyR-modulation 
The method used for selective FcyRI-modulation was performed exact­
ly as described previously (12). Briefly, flat-bottomed microtitre 
plates (Costar, Cambridge, Mass.) were coated with DNP-BSA (Calbio-
chem-Behnng, La Jol la, Ca.), and subsequently incubated with PBS 
alone (Control), or with a saturating concentration of a chromato-
graphically purified myeloma protein, reactive with DNP. Mouse 
IgG2a myeloma 5T2 (18) was provided by Dr. J. Radi. Monocytes were 
incubated in microtitre wells for 90 mm at 370C. After washing, 
cells were treated with proteolytic enzymes or with medium alone, 
and EA-rosetting was quantitated as described below. 
2.4 Treatment with proteolytic enzymes 
Monocyte-monolayers were incubated with RPMI 1640 medium alone 
(control) or with medium containing either 0.5 mg/ml trypsin, or 
0.2 mg/ml pronase (both from Boehnnger Mannheim, FRG) for 30 mm 
at 370C. After two washes, sensitized erythrocytes were added and 
binding was quantitated as described below. Viability of monocytes 
was high (> 95%, assessed by trypan blue exclusion) and was not de­
creased by protease treatment, nor was the number of cells per well 
influenced as evaluated by microscopal examination. 
K562 cells were incubated in suspension (at a concentration of 4 χ 
106 cells/ml) with RPMI 1640 medium alone (control) or with medium 
containing either 0.5 mg/ml pronase, or 1 mg/ml trypsin for 90 min 
at IPC. After three washes, cells were resuspended in RPMI 1640 me­
dium containing 5% FCS and rosette formation was assayed as des-
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cribed below. No substantial loss of cells was observed after 
treatment with proteases (5.2±4.45S, relative to cells incubated in 
medium alone; mean ± SD, nine individual experiments), and viabili­
ty always exceeded 95%. 
In some experiments protease inhibitors were used, which were pre-
incubated for 30 mm at room temperature with proteases, before ad­
dition to the cells. The following inhibitors were employed, soy­
bean trypsin inhibitor (used in an amount of 0.5 mg per mg of tryp­
sin), Na-tosyl lysyl chloromethyl ketone (TLCK; used in a concen­
tration of 0.Θ mM), and phenylmethyIsulphonyl fluoride (PMSF; used 
in a concentration of 0.4 mM). All inhibitors were obtained from 
Sigma (St.Louis, Mo.). 
2.5 EA-rosettinq 
Two types of indicator cells were used for EA-rosette assays. 
Rhesus D-positive human erythrocytes were sensitized either with a 
human alloserum against rhesus D (Merz & Dade, Düdingen, Switzer-
land), or with a mouse IgG1 mAb against glycophonn A (obtained 
from M.Bos, CLB, Amsterdam). Sensitization was performed as des-
cribed before (14). In some experiments the exact number of antibo-
dy molecules per HRBC was quantitated using a recently developed 
radiometric assay (19). 
Binding of sensitized HRBC (and non-sensitized HRBC as a control 
for non-specific binding) to monocyte monolayers was evaluated af-
ter incubation for 1 h at 40C. Quantitation of binding was perform-
ed photometrically at 450 nm using the pseudoperoxidase activity of 
HRBC as indicator (14). Binding indices were calculated, in order 
to correct for variations in background absorbance values between 
different experiments, as follows: 
[ 1 - (E450/EA450) ] χ 100 = binding index, where E450 is extinc­
tion at 450 nm in wells to which HRBC without sensitizing antibody 
were added, and EA450 is extinction at 450 nm in wells to which 
sensitized HRBC were added. All determinations were performed in 
duplicate, and the variability was less than 10л. 
In some experiments, enzyme-treated monocytes were incubated with 
monomenc human IgG for 15 mm at 4PC, prior to addition of sensi­
tized HRBC. Human IgG was purified from human serum by (NH4)2S04 
precipitation and DEAE-Sephadex (Pharmacia, Uppsala, Sweden) chro­
matography, consisted for more than 99.9% of human IgG as evaluated 
by Immunoelectrophoresis and radial immunodiffusion, and was deple­
ted of aggregates by ultracent π fuqat ion (1 h at 100,000 g, 4 0C). 
After incubation of monolayers with sensitized HRBC for 1 h at ¿PC, 
binding was assayed photometrically, and percentages inhibition 
were calculated by comparing absorbances in the absence and presen-
ce of inhibitor, as described before (9). 
Rosetting with K562 cells was scored microscopically, essentially 
as described before (14). Briefly, to 200 μΐ cells (at 2x106/ml in 
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RPMI 1640 with 5Й FCS), 50 μΐ sensitized HRBC suspension (0.5Й v/v) 
were added, the samples were centnfuged 2 mm at 20 g, and incu­
bated for 1 h at 40C. K562 cells with at least three bound HRBC 
were scored as rosettes, using a microscope with 400x final magni­
fication. Unsensitized HRBC were included in each experiment, and 
were never found to form rosettes with K562 cells (neither pro-
tease-treated, nor untreated). At least 200 cells were scored per 
incubation. In inhibition experiments anti-FcyR mAb were added to 
K562 cells after incubation with proteases, experiments were fur­
ther performed under similar conditions as above. 
2.6 Immunofluorescence 
The expression of FcyR on enzyme-treated cells was assayed by indi­
rect immunofluorescence, using different anti-FcyR mAb and fluores-
cein-conjugated FÇab1^ fraction of sheep anti-mouse IgG antibody 
(Cappel, Malvern, Pa.). Fluorescence was determined with an Ortho 
50-H flow cytometer. In each sample the fluorescence intensity from 
10,000 cells was measured. 
3. RESULTS AND DISCUSSION 
When monocytes are incubated in the presence of substrate-immobili-
zed immune complexes containing mouse IgG2a antibody the subseguent 
binding of EA-human IgG is strongly decreased, while binding of 
EA-mouse IgG1 is hardly affected under these conditions (12). This 
suggests that the high-affinity FcyRI is modulated from the apical 
surface of the cells to the substrate-adherent side while FcyRII 
remains unaffected. When after such modulation monocytes were incu-
bated with the protease trypsin, an increase in binding of EA-human 
IgG was observed (Fig.1). Monocyte binding of EA-mouse IgG1 was 
also found to be enhanced by trypsin. Similar results were obtained 
with the proteolytic enzyme pronase (data not shown). Since the 
high-affinity FcyRI was not detectable on the apical surface of mo-
nocytes after incubation with immune complex coated substrates, 
these results suggest that FcyRII can mediate interaction with 
EA-human IgG after treatment of monocytes with proteases. This con-
clusion was supported by the observation that monomenc human IgG 
nearly completely inhibited the rosetting between trypsin- or pro-
nase-treated monocytes and EA-mouse IgG1, whereas untreated mono-
cytes were not susceptible to such inhibition (Fig.2). Inhibition 
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Fig.1. Effect of trypsin on monocyte-mediated binding of erythrocy­
tes sensitized with human IgG or mouse IgGI, after incuba­
tion of monocytes with (•) or without (a) substrate-immobi­
lized immune complexes. Monocyte-monolayers were incubated 
either with RPMI 1640 medium alone (control) or with medium 
containing trypsin, and after washing, binding of sensitized 
erythrocytes was assayed photometrically. Results are repre­
sentative for seven experiments. 
of (FcyRI-mediated) rosetting between monocytes and EA-human IgG by 
monomenc human IgG was not affected by treatment of monocytes with 
proteolytic enzymes. 
Because the presence of two types of FcyR on monocytes makes stu­
dies with these cells relatively complex, we extended these obser­
vations using a cell line, K562 which expresses only FcyRII 
(3,5,6). This human cell line has a very low affinity for human IgG 
(6) and hardly forms EA-rosettes with human IgG-sensitized erythro­
cytes (9,14). EA-rosetting between K562 cells and erythrocytes sen­
sitized with human IgG could be increased markedly by treatment of 
K562 with proteases (Fig.3a). The number of human IgG molecules per 
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Fig.2. Inhibition by monomeric human IgG of rosette formation be-
tween sensitized erythrocytes and monocytes. Monocyte-mono-
layers in microtitre wells were incubated either with RPMI 
1640 medium only (control) or with medium containing either 
trypsin, or pronase. After washing, binding of sensitized 
erythrocytes was assayed photometrically. This experiment 
was repeated five times with comparable results. 
erythrocyte necessary to obtain half-maximal rosetting was observed 
to be approximately 5,000. This is similar to the values reported 
for EA-rosetting between (untreated) monocytes and human IgG-sensi-
tized erythrocytes (19,20). The rosette formation between enzyme-
treated K562 cells and EA-human IgG could be inhibited completely 
by different monoclonal anti-FcyRII antibodies, but not by monoclo-
nal antibodies directed against FcyRI (Fig.3b). Monoclonal antibo-
dies IV.3 and CIKM5 have previously been shown to block only 
EA-rosetting between human leukocytes and EA-mouse IgG1, and not 
rosette formation with EA-human IgG (3,4,9). These antibodies 
recognize different epitopes on FcyRII (Dr. Tetteroo, personal 
communication). It has been demonstrated previously that monoclonal 
anti-FcyRI antibody 10.1 completely inhibits the rosette formation 
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Fig.3. Rosette formation between human IgG-sensitized erythrocytes 
and K562 cells, a) K562 cells were incubated in the absence 
(o) or presence (·) of pronase, washed and rosetting with 
erythrocytes, sensitized with a range of human IqG molecul-
es/cell was scored by a microscope; b) after pronase incuba-
tion, either RPMI 1640 medium alone (control) or medium sup-
plemented with an anti-Fey receptor antibody was added, and 
rosetting was evaluated with optimally sensitized indicator 
erythrocytes i.e. with 10,600 human IgG molecules/erythrocy-
te. Experiments were repeated at least thrice using both 
pronase and trypsin (data not shown) with comparable re-
sults. 
against an epitope on FcyRI distinct from the liqand binding site 
(1), and was used as a control antibody. 
The effect of proteolytic enzymes on the expression of Fc receptors 
by K562 was studied using immunofluorescence analysis. Proteolysis 
had no effect on the expression of FcyRII, as evaluated by using 
two anti-FcyRII monoclonal antibodies (Fig.4). Expression of FcyRI 
could not be observed on protease-treated K562 cells using monoclo-
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Control Pronase 
Fluorescence intensity 
Fig.4. Immunofluorescence analysis of FcyRII on K562 cells after 
pronase treatment. K562 cells were incubated in RPMI 1640 
medium alone (control) or medium containing pronase. After 
washing, the expression of the low-affinity FcyR was evalua-
ted with a flowcytometer. Fluorescence was recorded as arbi-
trary units on a linear scale, using RPMI 1640 medium con-
taining 10% FCS alone as a control for non-specific binding 
(dashed line). This experiment was repeated twice, employing 
both pronase and trypsin (data not shown) with comparable 
results. 
could not be observed on protease-treated K562 cells using monoclo-
nal antibodies 10.1 and 32.2 directed against two different antige-
nic determinants on this receptor (1,2), neither was a third type 
of FcyR (FcyRIII) expressed on K562 cells (with or without incuba-
tion in the presence of proteolytic enzymes). This third type of 
FcyR is expressed by human macrophages, granulocytes, and certain 
types of lymphocytes, and is defined by several antibodies belong-
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ing to the CD16 cluster (4,5). The anti-CD16 antibodies tested by 
us were Anti-Leu11a (16) and Anti-Leu11b (17). On monocytes, no in-
crease in FcyRI or II expression was found after enzyme-treatment, 
and no induction of FcyRIII was detectable (data not shown). Since 
the expression of FcyRII does not increase by protease treatment 
and the binding of both monomenc and complexed human IgG increas-
es, the most likely explanation for these observations is that the 
affinity of FcyRII for human IgG increases considerably. This hypo-
thesis was supported by the finding that binding of both monomenc 
as well as heat-aggregaied human IgG was observed to increase 
sharply after protease treatment of K562 cells (data not shown). 
Experiments with different enzyme inhibitors showed that the enzy-
matic activity of both trypsin (demonstrated by using soybean tryp-
sin inhibitor and TLCK) and pronase (by employing PMSF) is essen-
tial for the observed effects on FcyR (data not shown). 
In conclusion, we found that proteolytic enzymes can influence the 
degree of interaction of human IgG with FcyR. The most dramatic ef-
fects were observed for the low-affinity FcyRII on human monocytes 
of which the interaction with human IgG (both monomenc and com-
plexed) increased profoundly after interaction with proteases. As 
the expression of FcyRII was found to remain stable it is likely 
that the affinity increases drastically. It has previously been 
reported (11,21), that trypsin and pronase treatment induces an in-
crease in the affinity of human monocytes for rabbit IgG immune 
complexes, without affecting the number of binding sites for rabbit 
IgG. At the time, FcyRII had not yet been discovered. It seems li-
kely that these effects are also based on the increased affinity of 
FcyRII as we have observed in the current study. Previously des-
cribed effects of modulatory conditions (for instance the effect of 
Interferon-y on monocyte FcyRI) primarily influenced the number of 
receptors and not their affinity for ligand (6). We speculate that 
in vivo proteolytic enzymes can have an important effect on the 
function of human monocyte FcyRII, because high concentrations of 
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proteolytic enzymes have been reported for instance in areas of in­
flammation (13). It has furthermore been shown that interaction of 
immune complexes with macrophages can induce the release of pro­
teases (22). Another source of proteolytic enzymes could be acti­
vated Τ cells (23). Recently it was reported that Con A superna-
tants from human mononuclear cells induced an increased EA-rabbit 
IgG rosetting of human monocytes, which could be inhibited by seri­
ne esterase inhibitors (e.g. PMSF) (24). 
4. CONCLUDING REMARKS 
We think that our results point to the importance of the low-affi-
nity FcyRII on human monocytes for the immune system. The physiolo­
gical significance of FcyRI has been questioned before (2), since 
this receptor has a high affinity for monomenc human IgG (Ka= 
lO^-IO9 M"1) (4,5) and is likely to be saturated with human 
IgG which is present at approximately 10~5 M in serum. Further­
more, Ceuppens et al. (25) have described a family with deficiency 
of FcyRI without any evidence of disease symptoms or serological 
abnormalities. FcyRII on the other hand will not be blocked by hu­
man serum IgG. This structure might function as a "standby" Fc re­
ceptor for IgG with a neglegible affinity for human IqG under nor­
mal conditions and an increase of this affinity by the activity of 
proteolytic enzymes, released locally during an inflammatory res­
ponse. 
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CHAPTER 9 
DISCUSSION AND SUMMARY 
DISCUSSION AND SUMMARY 
In this thesis we have studied in detail human monocyte receptors 
for the Fc moiety of IgG, FcyR receptors, with special emphasis on 
the heterologous interactions between human FcyR and mouse immuno-
globulins. This latter aspect seems important in view of the grow-
ing interest in the application of mouse monoclonal antibodies in 
immunotherapy. A brief overview of the distribution and functions 
of FcR is given in Chapter 1. 
In Chapter 2 we describe a new method for the characterization of 
Fc receptors on human monocytes and cell lines by EA-rosetting. 
Binding of sensitized erythrocytes to monolayers of cells in micro-
titre plates is quantitated by employing the pseudoperoxidase acti-
vity of erythrocytes in a photometric way. We furthermore studied 
the amount of negative charge on different types of indicator ery-
throcytes, by an alcian blue binding assay (1), which appears to be 
an important parameter in this type of EA-rosette assays. Human 
erythrocytes were observed to possess a much higher membrane nega-
tive charge than either sheep or rabbit erythrocytes, which may be 
advantageous in EA-rosette methods by lowering the degree of non-
specific binding (and thus increasing the signal to noise ratio). 
The different types of FcyR on human monocytes have been character-
ized by using the photometric assay (Chapter 3). Two types of FcyR 
could be distinguished by EA-rosetting. The first type of FcyR 
forms rosettes with human erythrocytes sensitized by human IgG 
(EA-human IgG, FcyRI). This type of rosetting could be inhibited by 
monomenc mouse (m)IgG2a and by all the human IgG subclasses. An-
other type of FcyR could be assayed by using erythrocytes sensitiz-
ed with a mouse IgGI antibody (EA-mouse IgG1, FcyRII). This recep-
tor was observed to be specific for mlgGI and does not bind monome-
nc mlgGZa or mlgGZb nor, surprisingly, human IqG. These studies 
suggest the presence of two independent FcyR on human monocytes, 
which is further supported by the results obtained with human cell 
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lines, expressing either one or both types of FcyR. FcyRII, which 
interacts well with mlgGI, was studied in more detail, especially 
in view of the previously reported polymorphism in mitogenic effect 
of mouse IgGI anti-CD3 mAb in humans. About 30л of Caucasian indi­
viduals (low-responders; LR) possess monocytes that do not support 
Τ cell proliferation by mlgGI anti-CD3 antibodies, whereas monocyt­
es from the remaining 70л (high-responder individuals; HR) support 
the mitogenesis very effectively (2). In previous studies using 
EA-mouse IgG1 rosetting it had been shown (3) that the polymorphism 
in mitogenic effect of mlgGI anti-CD3 antibodies is due to a poly­
morphism of monocyte FcyRII. We now demonstrate that the difference 
between HR and LR individuals in binding of mouse IgGI to FcyRII is 
guantitative rather than qualitative. 
The affinities of the two types of FcyR were analyzed by comparing 
binding of indicator erythrocytes, sensitized with calibrated num­
bers of IgG molecules/cell, in EA-rosette assays (Chapter 4). Quan­
titation of the degree of erythrocyte sensitization was performed 
using a new type of radiometric assay. Erythrocytes which were sen­
sitized with a human alloserum against rhesus D (EA-human IgG) 
bound maximally approximately 20,000 molecules/cell. The other type 
of indicator erythrocytes, which were constructed by using an 
anti-glycophonn A monoclonal antibody (EA-mouse IgGI), could con­
tain up to 400,000 mlgGI molecules per HRBC (without the occurrence 
of agglutination). When EA-rosette formation between monocytes and 
these indicator erythrocytes was evaluated, we found that half-
maximal rosetting was obtained with EA-human IgG, sensitized with 
human IgG at less than 3,000 molecules/cell. At least 30 times more 
mouse IgG1 molecules/HRBC had to be present for half-maximal roset­
ting with HR monocytes. Since it was recently found that human mo­
nocytes express ± 36,000 FcyRII molecules, and ± 20,000 FcyRI mole­
cules per cell (4), the affinity of FcyRII for its ligand (mouse 
IgGI) is much lower than the affinity of FcyRI for the ligand human 
IgG. LR monocytes were found to require indicator cells with appro­
ximately twice the number of mlgGI molecules/HRBC for half-maximal 
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rosetting, compared to HR monocytes. This suggests that either far 
less FcyRII are present, or that the affinity of FcyRII on LR mono­
cytes for mlgGI is much lower than on HR monocytes. As anti-FcyRII 
mAb IV.3 has been observed to bind with similar intensity to both 
HR and LR monocytes (5), the second possibility seems most likely. 
The interrelation between the two types of FcyR was analyzed by mo­
dulation studies described in Chapter 5. In these experiments we 
used substrate-immobilized immune complexes containing Ig of diffe­
rent classes and subclasses. Monocytes were incubated in microtitre 
wells containing immune complexes, and binding of the two types of 
indicator HRBC to the apical surface of the monocytes was then as­
sayed by the photometric method. It has been shown previously that 
FcyR on mouse macrophages were modulated to the substrate-adherent 
part of the cells when these were incubated with immune complexes 
coated to a solid support (6). No effect on the binding of sensi­
tized HRBC was found when monocytes were incubated with immune com­
plexes containing mouse IgE, IgA or IgM, or F(ab')2 fragments of 
rabbit IgG. High concentrations of immune complexes containing IgG 
of mouse, goat or rabbit were able to induce a decrease in binding 
of both types of sensitized erythrocytes, suggestive of co-modula­
tion of FcyRI and FcyRII. At lower concentrations of immune com­
plexes we observed more selective patterns of modulation. Under 
these conditions, immune complexes containing mlgGZa or rabbit IgG 
mainly affected the binding of EA-human IgG (FcyRI modulation), 
whereas mlgGI or mIgG2b, as well as goat IgG preferently induced 
FcyRII-modulation. The removal of FcyRII from the apical surface of 
monocytes to the substrate adherent part was confirmed by using 
anti-FcyRII mAb IV.3. These studies indicate that both types of 
FcyR have affinity for all types of IgG tested, but that the degree 
of interaction differs. They furthermore show that the two types of 
FcyR are independently organized in the membrane, which makes se­
lective regulation theoretically possible. Such regulation has al­
ready been shown by studies in which the immunomodulatory effects 
of interferon-γ were analyzed. This lymphokine selectively in-
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creased the expression of FcyRI on monocytes, whereas FcyRII was 
not upregulated (7). The concept of two distinct types of FcyR on 
human monocytes has been established now, and their main character-
istics are summarized in Table 1. 
In Chapter 6, we studied the functional activity of both types of 
FcyR in antibody-dependent cell-mediated cytotoxicity (ADCC), using 
sensitized erythrocytes as target cells. We observed that EA-human 
IgG, as well as EA-mouse IgGI were effectively killed by human mo-
nocytes, suggesting that both VcyR were cytotoxic trigger molecul-
es. This was supported by inhibition studies using anti-FcyR mAb 
and different monomeric Ig preparations. Cytolysis of EA-human IgG 
was inhibited by both monomeric human IgG and mIgG2a, and also by 
anti-FcyRI mAb 10.1. In contrast, lysis of EA-mouse IgG1 was de-
creased by monomeric mlgd in a dose-dependent way and by two 
anti-FcyRII mAb, IV.3 and CIKM5 (reacting with different epitopes 
on FcyRII). The efficacy of cytotoxicity mediated by either of the 
FcyR was evaluated by using targets sensitized with calibrated num-
bers of IgG molecules. FcyRI was found to be much more effective 
than FcyRII in cytolysis of sensitized HRBC. Furthermore, the poly-
morphism of FcyRII described above was also reflected in the anti-
body-dependent cytotoxicity of monocytes. 
In Chapter 7 we studied the effects of proteolysis os human monocy-
te FcyR.Neither trypsin,nor pronase caused a decrease in rosetting 
mediated by FcyRI.When the effects of protease-treatment on the po-
lymorphic FcyRII were studied, we observed a dramatically increased 
interaction of LR monocytes with mouse IgGI.EA-rosetting between LR 
monocytes and EA-mouse IgG1 was enhanced considerably by proteoly-
sis, up to the level exhibited by HR monocytes.As the number of 
FcyR was not increased (as measured by immunofluorescense using 
anti-FcyR mAb), the affinity for this ligand must be increased by 
proteolysis. An enhancing effect of protease-treatment could also 
be demonstrated with HR monocytes,when sub-optimally sensitized 
indicator HRBC were used, both in EA-rosetting as well as in ADCC. 
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Table 1. Characteristics of FcyR receptors expressed on human monocytes 
Characteristics FCYRI Ref. FcyRII Ref. 
Molecular weight 
Distribution: 
- peripheral blood 
- c e l l l inee 
Number of s i t e s / c e l l 
A f f i n i t y for human IgG 
FcyR-binding s i t e on IgG 
Specif ic i ty for human 
IgG subclasses 
Specif icity for mouse 
IgG subclasses 
Croaslinking of anti-CD3 
antibodies: 
- isotype 
% individuals 
supporting nutogenesis 
Monoclonal anti-FcyR 
antibodies 
72 kDa 
monocytes (neutro­
phils, after in­
duction) 
HL-60,U937 
l-AxlO1* 
Ka=10e-109M-1 
CH2 domain 
hIgG3>hIgG1>hIgG4 
»hIgG2 
mIgG2a=mIgG3» 
mlgGI,mIgG2b 
mIgG2a (0KT3,WT32) 
± 100«Ь 
(8) 
(8,10-13) 
(4,16-18) 
(16-1B) 
(21,22) 
(16,17, 
23,24) 
(14,16, 
25-27) 
(2,5,13) 
40 kDa 
monocytes, В cells, 
thrombocytes, neutro­
phils, eosinophils 
H.-60, U937, K562 
Daudi, Raji 
103-4x104 
Ka=105-106M-1 
NO3 
hIgG1>hIgG2,hIgG4» 
hIgG3 
mIgG1>mIgG2b» 
mIgG2a,mIgG3 
mlgGI (Leu-4fWT31, 
UCHT1 ) 
± 70й of Caucasian 
individuals, ± 15S 
of Asian individuals 
(5,9) 
(5,9,14,15) 
(4,19) 
(20) 
(20) 
(5,14,26,27) 
(2,3,5,28) 
32.2,10.1 (11,13) IV.3,CIKM5,2E1,KuFc79 (5,29-31) 
a. ND: not determined 
b. world-wide only one "defective" family reported (32) 
The studies on the effects of proteolysis on FcyRII were extended 
in Chapter 8. We first selectively modulated FcyRI from monocytes 
by using immobilized immune complexes. Proteolysis of such modulat-
ed monocytes induced an increased interaction with erythrocytes 
sensitized with human IgG. Surprisingly, this interaction with hu-
man IgG appeared to be mediated by FcyRII. This explanation was 
supported by the observation that after protease-treatment binding 
of EA-mouse IgGI to monocytes became susceptible to inhibition by 
monomenc human IgG. Because of the complexity of experiments with 
monocytes, due to the presence of two types of FcyR, we also per-
formed experiments with K562 cells. These cells express only FcyRII 
and no FcyRI (5,10,33). A dramatic increase in rosettinq with EA-
human IgG was found when K562 cells were treated with proteases. 
This increase could furthermore be inhibited by anti-FcyRII antibo-
dies. The expression of FcyRII on these cells was not influenced by 
proteolysis as evidenced by immunofluorescence studies, neither 
were other types of FcyR induced. 
On the basis of these studies we have developed a new hypothesis on 
the role of the low-affinity FcyRII on human monocytes in the im-
mune system. Due to their low affinity FcyRII will not be blocked 
by human IgG under normal conditions, in contrast to FcyRI (which 
possess an extremely high affinity for monomenc human IgG). How-
ever, FcyRII can be induced to bind hlgG under "special" condi-
tions, when proteolytic enzymes are present. Elevated concentra-
tions of proteolytic enzymes have been reported to be present at 
inflammatory sites (34). Furthermore, the release of proteases has 
also been observed after interaction of macrophages with immune 
complexes (35). Thus at inflammatory sites, the freely available 
FcyRII will acquire affinity for human IgG and will consequently be 
able to subserve in immunologic effector functions at these sites. 
Recently, a promising new imaging technique has been described by 
Rubin et al. by which sites of focal inflammation in both animals 
and man can be localized. In this technique, 111 Indium-labelled 
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non-specific human IgG was injected into patients suspected of in-
flammation, and at defined intervals, gamma imaging was carried 
out. Focal sites of inflammation could be correctly identified in 
most patients, with a high specificity. This approach seems useful 
in many clinical situations, for instance for patients with pos-
sible intra-abdominal abscesses following surgery or trauma 
(36,37). The mechanism underlying this phenomenon is unknown. From 
our own results we postulate that modulation of FcyRII-affinity for 
human IgG by proteolysis may explain the selective localization of 
human IgG at the inflammatory site. 
As can be read above, knowledge about human FcyR has rapidly in-
creased during the last few years. To obtain a more thorough under-
standing of their structures and biological functioning, however, 
analysis of the genes encoding these molecules is essential. Three 
types of FcyR on human cells have been cloned up to now, which re-
vealed that they are all members of the immunoglobulin superfami-
ly. FcyRII was the first human FcyR to be cloned. At the DNA level 
this receptor was homologous to the mouse macrophage FcyRII. This 
receptor, which has been given the cluster of differentiation as-
signment CDw32, was found to possess two extracellular immunoglobu-
lin-like domains. Transfectants expressing the receptor bound human 
IgG with a very low affinity which confirms earlier studies (20, 
38,39). Another type of human FcyR, FcyRIII (CD16) has also been 
cloned recently. This type of FcyR is expressed by a variety of 
cells, amongst which are neutrophils, large granular lymphocytes, 
and macrophages, but not monocytes (33). This receptor also posses-
ses an extracellular part containing two immunoglobulin-related 
segments. It expresses a low affinity for IgG upon transfection to 
COS cells (Ka= 5x105M-1). Most remarkably, this work revealed an 
unusual type of membrane anchor for this receptor, which was linked 
via a phosphatidylinositol glycan (40). The high-affinity FcyRI was 
also reported to be cloned by Dr. David Simmons (Massachusetts Ge-
neral Hospital), and contains three immunoglobulin-like extracellu-
lar domains. Upon transfection, this molecule bound human IgG with 
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the expected high affinity thus confirming that its function was 
embodied in this single molecule (41). Also from another type of 
recombinant DNA technology intriguing new approaches to the unra-
velling of FcyR-propertíes are possible. These studies use site-
directed mutagenesis to modify immunoglobulins at the genetic le-
vel, and by such experiments the exact binding site on IqG for 
FcyRI could be attributed to only one single amino acid in the CH2 
domain (22). 
By these new types of experimental approaches our insight into the 
structure of the immune system will increase enormously which will 
hopefully also benefit human patients. Such studies will certainly 
also have consequences for our understanding of the function of 
these receptors. One example of this is our new hypothesis on the 
function of low affinity FcyRII at inflammatory sites. This theory 
must be validated by subsequent studies, but if it proves to be 
correct, it can serve as a model of how the mononuclear phagocyte 
system exerts its important defense function in the inflammatory 
process. 
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SAMENVATTING 
SAMENVATTING 
In dit proefschrift is onderzoek beschreven aan een type receptoren 
dat een cruciale rol speelt in het immuunsysteem van de mens. Deze 
receptoren kunnen een binding aangaan met het Fc-deel van immuun-
globulinen en na binding kan een veelvoud van biologische effecten 
optreden. De studies concentreren zich rond receptoren voor IgG, 
FcyR, op humane monocyten, waarbij met name de interacties met mui-
ze antistoffen zijn bestudeerd. Dit laatste aspect lijkt vooral van 
belang omdat heterocytophiele interacties een belangrijke rol zul-
len spelen wanneer monoclonale muize antistoffen worden gebruikt 
voor immuuntherapie bij de mens. 
Een korte inleiding tot het onderwerp van dit proefschrift wordt 
gepresenteerd in hoofdstuk 1. 
In hoofdstuk 2 wordt een nieuwe methode beschreven waarmee Fe re-
ceptoren op humane monocyten en cellijnen kunnen worden gekarakte-
riseerd met behulp van EA rozettenng. Deze techniek maakt gebruik 
van de pseudoperoxidase activiteit van de indicator erythrocyten, 
die fotometrisch kan worden bepaald. Tevens worden experimenten be-
schreven waarmee de negatieve lading van de membraan van erythrocy-
ten wordt bepaald in een bindingsassay die gebruik maakt van de 
kationische kleurstof Alciaan Blauw. Erythrocyten van humane origi-
ne blijken een hoge negatieve lading te bezitten, die mogelijk bij-
draagt aan hun geringe met-specifieke binding, en daarmee aan hun 
uitstekende bruikbaarheid als indicatorcel in de fotometrische EA 
rozettenng. 
In hoofdstuk 3 worden de verschillende types FcyR op humane monocy-
ten nader gekarakteriseerd met behulp van de fotometrische EA-ro-
zettenng. Een tweetal types FcyR kan worden onderscheiden, FcyRI 
die rozettenng met humaan IgG-beladen erythrocyten (EA-humaan IgG) 
medieert, en FcyRII die erythrocyten beladen met muis IgG1 anti-
stoffen (EA-muis IgGI) bindt. FcyRI blijkt affiniteit voor zowel 
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monomeer humaan IgG (van alle vier de subklassen), als voor muis 
IgG2a te bezitten, terwijl FcyRII alleen antistoffen van het muis 
IgGI isotype goed lijkt te kunnen binden. FcyRII wordt nader geana­
lyseerd, omdat deze receptor betrokken is bij een polymorfisme in 
mitogeniciteit van muis IgGI anti-CD3 antistoffen. Monocyten van 
het grootste deel (±70SS) van de mensen in West-Europa blijken de 
inductie van Τ cel proliferatie door muis IgGI anti-CD3 antistoffen 
te ondersteunen (zogenaamde "high-responder" individuen; HR), ter­
wijl monocyten van de overige individuen dit niet doen ("low-res-
ponder" individuen; LR). Uit experimenten in dit hoofdstuk blijkt 
dat dit polymorfisme berust op een kwantitatief, en niet een abso­
luut verschil in binding van muis IgG1 aan FcyRII van HR en LR mo­
nocyten. 
In hoofdstuk 4 wordt de affiniteit van beide FcyR voor hun liganden 
nader geanalyseerd in EA rozettermgsassays. Hierin wordt gebruik 
gemaakt van indicator erythrocyten beladen met nauwkeurig gekwanti­
ficeerde aantallen IgG moleculen. Bepaling van de mate van sensibi-
lisatie gebeurt met een nieuwe radiometrische methode. Rozettering 
van monocyten met EA-humaan IgG blijkt reeds half-maximaal te zijn 
wanneer erythrocyten worden gebruikt met minder dan 3000 moleculen 
humaan IgG per erythrocyt. Voor half-maximale rozettering met EA-
muis IgGI zijn minstens 30 maal zoveel muis IgG1 moleculen per ery­
throcyt nodig. Dit wijst op aanzienlijke af fimteitsverschillen 
tussen beide types FcyR voor hun liganden. LR monocyten blijken 
verder ongeveer dubbel zoveel muis IgGI moleculen per erythrocyt 
nodig te hebben als HR monocyten om dezelfde mate van rozettering 
te bereiken. Daar de expressie van FcyRII gelijk is op monocyten 
van Ж en LR, wijst dit op een verschil in affiniteit van deze re­
ceptor tussen beide types monocyten. 
In hoofdstuk 5 wordt de relatie tussen beide FcyR in detail geana­
lyseerd in modulatie experimenten. Daarin wordt gebruik gemaakt van 
substraat-geïmmobiliseerde immuuncomplexen. Wanneer de interactie 
van een FcyR met een geïmmobiliseerd immuuncomplex tot modulatie 
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van de receptor heeft gevoerd, zal de binding van antistof-beladen 
erythrocyten aan de bovenkant van de monocyten zijn gereduceerd. 
Uit deze studies is gebleken dat FcyR alleen affiniteit bezitten 
voor immuuncomplexen gemaakt met antistoffen van de IgG klasse en 
niet van andere klassen Ig. Hoge concentraties IgG-immuuncomplexen 
induceren co-modulatie van FcyRI en FcyRII, terwijl bij zeer lage 
concentraties selectieve modulatie wordt waargenomen. Dit wijst er-
op dat beide FcyR affiniteit bezitten voor elk van de IgG's, maar 
dat de mate van affiniteit voor elk van de IgG's verschilt. Tevens 
blijkt uit deze experimenten dat de receptoren onafhankelijk van 
elkaar zijn georganiseerd in de celmembraan van humane monocyten. 
In hoofdstuk 6 wordt de functionele aktiviteit van beide types FcyR 
onderzocht in cytotoxiciteit van monocyten tegen gesensibiliseerde 
erythrocyten (antistof-afhankelijke celgemedieerde cytotoxie: 
ADCC). Zowel erythrocyten beladen met humaan IgG, als met muis 
IgG1, blijken te worden gelyseerd na incubatie met monocyten. Deze 
cytolyse blijkt door respectievelijk FcyRI en FcyRII te worden ge-
medieerd. Dit kon worden aangetoond door inhibitie-studies met mo-
nomere immuunglobulines van diverse isotypes en met anti-FcyR mono-
clonale antistoffen. De cytotoxische effectiviteit van beide types 
FcyR verschilt drastisch: FcyRI is veel effectiever dan FcyRII. Te-
vens komt de polymorfie van FcyRII ook tot uitdrukking in de cyto-
toxiciteit van monocyten tegen muis IgG1 gesensibiliseerde erythro-
cyten. 
In hoofdstuk 7 worden de effecten van proteolytische enzymen op mo-
nocytaire FcyR onderzocht. Behandeling van monocyten met trypsine 
of pronase remt de (FcyRI-gemedieerde) rozetvorming met EA-humaan 
IgG niet. Wanneer de effecten van deze proteases op de polymorfe 
FcyRII worden geanalyseerd, blijkt er een sterke verhoging van ro-
zettenng van LR monocyten met EA-muis IgG1 plaats te vinden na 
Proteolyse. Deze verhoging is dusdanig sterk dat de rozettenng van 
met protease behandelde LR monocyten overeenkomt met die van onbe-
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handelde HR monocyten. Omdat de expressie van FcyRII met wordt 
verhoogd door Proteolyse, (zoals blijkt uit immuunfluorescentie 
analyses) lijkt het aannemelijk dat de affiniteit van FcyRII voor 
muis IgGI sterk toeneemt. Een potentierend effect van Proteolyse 
kan ook worden waargenomen met HR monocyten, wanneer sub-optimaal 
beladen erythrocyten worden gebruikt, zowel in EA-rozettering als 
in ADCC. 
De effecten van proteolytische enzymen op FcyRII worden nader ge-
analyseerd in experimenten beschreven in hoofdstuk 8. In deze stu-
die wordt FcyRI eerst selectief van monocyten gemoduleerd door in-
cubatie van de cellen met substraat-geïmmobiliseerde immuuncom-
plexen. Proteolyse van deze monocyten blijkt een sterke verhoging 
in binding van EA-humaan IgG te induceren die opmerkelijk genoeg, 
door FcyRII wordt gemedieerd. Behandeling van monocyten met proteo-
lytische enzymen leidt dus tot een sterke toename van de affiniteit 
van FcyRII voor humaan IgG. Deze hypothese wordt ondersteund door 
de bevinding dat na proteolytische behandeling de rozettenng van 
monocyten met EA-muis IgG kan worden geremd door monomeer humaan 
IgG, een remming die niet optreedt bij onbehandelde cellen. Omdat 
experimenten met monocyten erg complex zijn, vanwege de gelijktij-
dige expressie van zowel FcyRI als FcyRII, werden ook studies met 
de cellijn K562 uitgevoerd. Deze cellijn expnmeert van beide re-
ceptoren alleen FcyRII. Ook hier wordt na Proteolyse een drama-
tische toename van rozettenng met humaan IgG-beladen erythrocyten 
gevonden, die bovendien volledig te remmen blijkt met monoclonale 
antistoffen gericht tegen FcyRII. Daar de expressie van FcyRII niet 
wordt verhoogd, noch enig ander type FcyR wordt geïnduceerd, lijkt 
ook op K562 de affiniteit van FcyRII voor humaan IgG sterk toe te 
nemen na behandeling met proteases. Deze bevindingen geven mogelijk 
een aanwijzing over de fysiologische betekenis van FcyRII. Aange-
zien proteolytische enzymen ook kunnen vrijkomen bij ontstekings-
processen, is het denkbaar dat FcyRII fungeert als een receptor die 
onder normale condities geen affiniteit heeft voor monomeer humaan 
IgG (en dus ook niet verzadigd zal zijn door de hoge concentratie 
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IgG in serum), maar een hoge affiniteit voor humaan IgG verwerft 
tijdens en ter plaatse van een ontstekingsreactie. 
Samenvattend blijkt uit dit onderzoek dat humane monocyten een 
tweetal Fcy receptoren tot expressie brengen. Deze receptoren be-
zitten verschillende bindingskarakteristieken voor immuunglobulinen 
en zijn onafhankelijk van elkaar georganiseerd in de membraan. Bei-
de structuren kunnen als "tngger-molecuul" in ADCC fungeren. 
FcyRII is een polymorfe structuur; het verschil in affiniteit voor 
muis IgG1 tussen HR en LR individuen blijkt van kwantitatieve, niet 
van kwalitatieve aard. Behandeling van LR monocyten met proteoly-
tische enzymen induceert een verhoging van de affiniteit van FcyRII 
tot een niveau dat wordt aangetroffen bij (onbehandelde) monocyten 
van HR. In tegenstelling tot FcyRI, heeft FcyRII onder normale con-
dities geen affiniteit voor monomeer humaan IqG. Deze affiniteit 
kan echter sterk worden verhoogd door behandeling van monocyten met 
proteolytische enzymen. Aangezien dergelijke enzymen ook in vivo in 
verhoogde concentraties worden aangetrofen, bijvoorbeeld in ontste-
kingsgebieden, zou FcyRII kunnen fungeren als een "standby" recep-
tor voor humaan IgG. 
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III 
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receptor, die in ontstekingsgebieden kan worden geacti­
veerd, aannemelijk. 
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